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ABSTRACT 
 
 
Since the realization of plant genetic modification, transgenic plants have been utilized 
as platform for the production of valuable recombinant proteins or also known as plant 
molecular farming (PMF). The plant offers an economical system to reduce cost, the possibility 
of large scale production and is free of pathogens. The plant also provides versatility of 
products to accumulate from industrial enzymes, peptides, and pharmaceuticals. Recent 
advancement of RNA as regulator of gene expression and antiviral responses has shown a new 
area of research where transgenic plants are used to accumulate therapeutic RNAs. In this 
study, the reliability of transgenic plants as a platform for the production of industrial enzyme, 
subunit vaccine and therapeutic RNAs are being evaluated. Key factors that determine the 
success of molecular farming include 1) robustness of plant genetic transformation, 2) 
accumulation of large levels of recombinant product, 3) versatility of products to be 
accumulated, 4) stability of products, and 5) bioactivity of plant-derived products. 
The first study demonstrated the accumulation of starch-degrading enzyme, 
amylopullulanase (APU) derived from bacteria Thermoanaerobacter thermohydrosulfuricus 
in maize seed. Accumulation of thermostable APU in transgenic maize seed resulted in direct 
starch processing into glucose and simple sugars without the addition of exogenous enzyme. 
Subsequent fermentation reaction showed 40.2% conversion of starch into bioethanol. This 
study showed simplification of starch-based bioethanol production from maize grains using a 
biotechnology approach. 
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The feasibility of the plant as the production system for the accumulation of antigen is 
demonstrated in the second study. Conserved nucleoprotein (NP) gene was expressed in maize 
seed. This conserved protein showed potential application as a universal vaccine for influenza 
virus. Our study suggested that maize-derived NP was immunogenic and could induce 
antibody responses upon administration in pigs and mice. Maize NP seeds remained stable and 
active at room temperature. This result showed that the plant is able to produce product and 
maintain immunogenicity.  
Thirdly, the plant was utilized as a production system for the accumulation of dsRNA 
as a vaccine for shrimp viral pathogen. Our result showed the accumulation of long dsRNAs 
specific to white spot syndrome virus (WSSV) and infectious myonecrosis virus (IMNV). 
Shrimp bioassay of soybean-derived dsRNA specific to WSSV showed moderate protection 
against viral challenge and indicated activity of plant-derived dsRNA. While the accumulation 
levels of dsRNAs in transgenic plants was far from economically efficient, our result showed 
that the plant was able to accumulate foreign dsRNA. Our result showed that accumulation 
level needs to be improved for plant use as an efficient platform for accumulation of 
therapeutics RNA. 
Concern over antibiotic or herbicide resistance selectable marker has brought attention 
for an alternative selectable marker. In the last study, a non-antibiotic selectable marker was 
assessed as a selection system for maize Agrobacterium-mediated transformation. The ptxD 
gene conferring phosphite oxidoreducatase enzyme enables transformed cells to utilize 
phosphite as phosphorous source while non-transformed cells cannot. Phosphite selection 
resulted in positive identification of transgenic events.  
viii 
 
The present study shows the feasibility and reliability of plants as a production system 
for a variety of products from enzyme, antigen and dsRNA.  
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CHAPTER 1: INTRODUCTION 
 
 General Introduction 
Genetic engineering technique allows manipulation of microorganisms, plants, and 
animals to carry, express and stably inherit desirable traits (Cohen et al. 1973; Fraley et al. 
1983; Jaenisch and Mintz 1974). This technique is important for basic research in order to 
understand gene function or metabolic pathways and imply valuable applications for 
therapeutics. Genetic modification of plants was first reported in the early 1980’s as shown by 
the production of transgenic plants via transformation procedure (Bevan et al. 1983; Fraley et 
al. 1983; Herrera-Estrella et al. 1983). Emphasizing the significance on plant, genetic 
engineering can be utilized to improve yield, agronomic traits of crops, and produce 
recombinant proteins such as vaccines and drugs by means of transgenic plants (Gasser and 
Fraley 1989; Prado et al. 2014; Twyman et al. 2003).  
The Agrobacterium-mediated transformation method is widely known for its stable and 
relatively low copy number integration of transgene into the host genome (Gelvin 2003; Ishida 
et al. 2007). The gene of interest is delivered into host genome along with selectable marker 
gene. The selectable marker gene is useful to eliminate non-transgenic material for the 
identification of transgenic events and is also effective as a weed control system in the field. 
Antibiotics (hygromycin, kanamycin) and herbicide resistance (bialaphos, glyphosate) genes 
have been widely utilized as selectable markers for plant transformation (Bevan et al. 1983; 
Spencer et al. 1990; Sundar and Sakthivel 2008). However, the products derived from these 
genes have caused concern regarding biosafety. An alternative selection system to avoid the 
utilization of herbicides or antibiotic genes is needed (Dale et al. 2002). The selectable marker 
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should not only eliminate non-transgenic plants but also be non-toxic, easy to apply and does 
not contaminate environment (Hare and Chua 2002). A recent study demonstrated ptxd gene 
encoding phosphite oxidoreductase enzyme as selectable marker for Arabidopsis and tobacco 
transformation (Lopez-Arredondo and Herrera-Estrella 2013). The PTXD enzyme is involved 
in the conversion of phosphite (Phi) into phosphate (Pi). Phi is a non-metabolized form of 
phosphorous while Pi is the active form of phosphorous that involves in many biological 
processes. The expression of ptxd gene enables transgenic plant to survive on media containing 
Phi by metabolizing Phi into Pi. In this dissertation, one case study is presented providing 
assessment of ptxd gene as candidate selectable marker for Agrobacterium-mediated maize 
transformation.  
Over thirty years transgenic plants have been predominantly utilized as a factory for 
the production of economically valuable recombinant proteins (also known as molecular 
farming). Several examples of molecular farming products are industrial enzymes, antibodies, 
antigens, and vaccines (Ramessar et al. 2008; Sack et al. 2015). Plant system offers several 
advantages in term of scalability, relatively low cost, and free from human or animal pathogens 
therefore providing a safe environment (Twyman et al. 2003). Human growth hormone and 
interferon were among the first molecular farming products that have been successfully 
expressed in plants (Barta et al. 1986; De Zoeten et al. 1989). Several plant derived 
recombinant pharmaceuticals such as avidin (Hood et al. 1997), trypsin (Hood 2002; Woodard 
et al. 2003), and beta glucuronidase (Witcher et al. 1998) have been produced and 
commercialized by formal Prodigen, a biotech company specializing in plant-derived 
pharmaceuticals and industrials. In this dissertation, three studies regarding application of 
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molecular farming in crop plants for the production of industrial enzyme and vaccines are 
demonstrated.  
The first study provides a great example of industrial application of plant genetic 
engineering. Thermostable amylopullulanse (APU) enzyme of bacteria Thermoanaerobacter 
thermohydrosulfuricum was accumulated in maize seed. This enzyme has dual functions, 
allowing digestion of both α-1,4 and α-1,6 linkages of starch. Expression of APU allowed 
direct starch hydrolysis at high temperature and reduced the requirement of exogenous alpha 
amylase. Hydrolyzed starch could be further utilized for bioethanol production. In the period 
of providing renewable fuel, this technology has given great contribution to the production of 
an alternative energy. 
The second study shows utilization of the plant as a factory for antigen production. 
Other than useful as production system, this study provides proof of concept for the 
immunogenicity and efficacy of plant-derived pharmaceuticals. Nucleoprotein (NP) gene of 
H3N2 swine origin influenza virus was expressed in maize endosperm. This conserved protein 
has been considered as universal vaccine candidate for influenza. The concept of a universal 
vaccine is to provide broad spectrum protection and reduce epidemics before strain specific 
vaccines available. Oral administration of maize-derived NP in mice induced a humoral 
immune response. This work showed the immunogenicity of the plant-derived antigen. 
The third study explores new avenue of double stranded RNA (dsRNA) molecules as 
an antiviral agent for shrimp infectious viral diseases. First reported in Caenorhabditis elegans, 
dsRNAs triggers production small interfering RNAs (siRNAs) that leads to gene silencing. 
Many reports showed that this mechanism is conserved among most eukaryotic organism. 
Through similar mechanism, dsRNA specific to virus pathogen in shrimp leads to activation 
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of antiviral genes. Injection of virus-specific dsRNA in shrimp provides protection against a 
lethal challenge of virus suggesting efficacy of dsRNA as vaccine. In this project, transgenic 
plants were utilized as a system for the production of therapeutic RNA. Injection of plant-
derived dsRNA provided partial protection against lethal challenge of virus. This could be due 
to low accumulation of specific dsRNA in transgenic plants. However, this study provides 
useful information of an attempt to accumulate dsRNA vaccine in plants.  
 
Dissertation Organization   
This dissertation is organized into six chapters with four chapters formatted for journal 
publication. Chapter 1 provides general introduction and literature review of plant molecular 
farming. Chapter 2 demonstrates the application of plant genetic engineering for industrial 
purpose. Chapters 3 and 4 focus on the applications of transgenic plants as vaccines for 
infectious diseases in animals. Chapter 5 explains an assessment of new candidate selectable 
maker for maize Agrobacterium-mediated transformation protocol. Chapter 6 presents 
summary and general conclusion of the works also provides future directions.  
Chapter 2 describes the application of transgenic plants for industrial purpose. In this 
study, thermostable amylopullulanase (APU) enzyme from bacteria Thermoanaerobacter 
thermohydrosulfuricus was expressed in maize seed endosperm. This work has been published 
in Plant Cell Reports journal. This work was collaboration between Drs. Kan Wang and Jay-
Lin Jane from the department of Food Science and Human Nutrition of Iowa State University. 
My role in this project included designing construct, screening and analysis of transgenic 
materials, green house work, enzyme activity assay, and data analysis. Dr. Chang-Joo Lee 
conducted bioethanol assay and chromatography. Tracy Pepper provided the service of 
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Electron Microscopy Imaging of starch granules. Together with Dr. Kan Wang, we prepared 
the manuscript. Drs. Jay-Lin Jane and Kan Wang provided valuable inputs for experimental 
design, discussion and results analysis.        
Chapter 3 demonstrates accumulation of antigen in maize seed as a potential candidate 
of influenza universal vaccine. This work presents proof of concept of immunogenicity of 
plant-derived antigen and has been published in the journal of Plant Cell Reports. This project 
was conceptualized by Drs. Brad Bosworth, Hank Harris and Kan Wang. I designed gene 
construct; maintained transgenic materials; performed molecular and protein analyses; mouse 
assay; and data analysis. Dr. Ryan vander Veen kindly provided H3N2 NP gene and technical 
assistance for the experiment. Dr. Joan Cunnick provided training and was instrumental for 
the mouse study. Dr. Mark Mogler performed pigs study. Meaghan Nelson and Pam Whitson 
assisted in the mouse experiment. I prepared the manuscript with Dr.Kan Wang. Drs.Brad 
Bosworth, Joan Cunnick, Hank Harris and Mark Mogler provided useful scientific discussion 
for the project and publication.  
Chapter 4 presents the production of recombinant double stranded RNA (dsRNA) 
molecules in transgenic plants as vaccine for shrimp infectious diseases. Drs. Lyric 
Bartholomay and Kan Wang designed the project and provided significant inputs for the 
experiment and data interpretation. My role in this project was designing the vector construct 
for dsRNA expression in maize and soybean, performed screening and molecular analysis of 
transgenic materials, and wrote manuscript. Jill Gander provided dsRNA gene for infectious 
myonecrosis virus (IMNV) and white spot syndrome virus (WSSV). Dr. Supraja Puttamredy 
designed and performed shrimp assays.  
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Chapter 5 explains assessment of new candidate marker for Agrobacterium-mediated 
maize transformation protocol. Drs. Luis Estrella-Herrera, Damar-Lopez Arredondo and Kan 
Wang designed the experiment and actively engaged in useful discussion for the project. I 
performed transformation experiment of Hi-II and B104, PCR, and Southern blot analysis. Dr. 
Xing Xu initiated the project and conducted phosphite kill curve experiments. Bronwyn Frame 
provided useful expertise and discussion about the transformation experiment.    
Chapter 6 presents a general conclusion, summarizing all the studies conducted in 
previous chapters. All projects were under the guidance and supervision of my major professor, 
Dr. Kan Wang. Future direction and improvement are also outlined in this chapter. Bronwyn 
Frame, Marcy Main, Katey Warnberg, and Diane Luth of Plant Transformation Facility of 
Iowa State University performed the maize and soybean transformation as well as greenhouse 
care for transgenic plants described in chapters 2, 3 and 4.       
 
Literature Review 
1.1.1 Plant expression system for recombinant proteins production 
Over the past two decades, plants have been utilized for the production of heterologous 
proteins including therapeutics, vaccines and industrial enzymes. Plant recombinant proteins 
have been expressed in different platforms such as leafy crops, cereal grains, fruit and 
vegetable (Dai et al. 2000; Mason et al. 2002; Stoger et al. 2000). Leafy crops (tobacco, alfalfa 
and lettuce) provide large biomass, fast turnaround production time, and multiple harvesting 
times per year. Leaf-based production system is suitable for products that need immediate 
purification if not stored frozen or dried because the leaf is not a stable environment due to the 
presence of proteolytic enzymes (Twyman et al. 2003). Furthermore, metabolites such as 
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nicotine or alkaloids in tobacco and oxalic acid in alfalfa are toxic and should be removed from 
the final products (Fischer et al. 2004). 
Tobacco is the predominant leafy plant host for heterologous protein expression. It has 
been extensively studied and transformation protocol for this plant has been established. 
Tobacco has been utilized to express vaccines, antibodies, and cytokines (Tremblay et al. 
2010). Recent paper reported the production of tobacco-derived monoclonal antibodies 
Zmapp® produced by Protalix that was used to treat Ebola patients (Qiu et al. 2014). Alfalfa 
is another leafy plant majorly utilized for heterologous protein expression. Alfalfa does not 
only provide large dry biomass but also allows continuous production of recombinant proteins 
that can be harvested multiple times (up to 9 times) per year (Khoudi et al. 1999; Twyman et 
al. 2003). Medicago, Inc (http://www.medicago.com/English/Home/default.aspx) is a 
biotechnology company focused on production of vaccines, antibodies and biosimilars using 
tobacco and alfalfa as their platforms.  
Exploitation of food crops for the production of pharmaceuticals, vaccines, antibodies 
or industrial enzymes emphasize practical application of plant-derived recombinant products. 
Vegetable, fruit and seed can be beneficial for the oral delivery of pharmaceuticals and 
vaccines, allowing direct incorporation in the diet therefore reduce purification cost. Corn, 
soybean, rice, potato and banana are among popular systems for this purpose (Hudson et al. 
2014; Lamphear et al. 2004; Mason et al. 2002; Ou et al. 2014; Tacket et al. 1998). However, 
fruit and vegetable have short half-life and would not be appropriate for highly valuable 
products. On the other hand, a seed-based production system supports a stable environment 
for long-term storage at ambient temperature without affecting bioactivity of the products 
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(Kusnadi et al. 1997). This feature reflects the simplification of transportation and removes the 
necessity of cold-chain for vaccines or pharmaceuticals (Ma et al. 2005).  
Many studies revealed reliability of plant system as the future of low cost platform for 
the production of highly valuable proteins. However, it’s not until 20 years later that the first 
plant recombinant protein Elelyso (taliglucerase alfa) expressed in carrot cell culture was 
approved by FDA and released into the market in 2012. This product is sold at 75% price of 
its competitor product Cerezyme which proved that plant-based system could reduce the 
burden of cost (Fox 2012; Maxmen 2012).  
 
1.1.2 Plant transformation 
There are several plant transformation methods that have been developed to facilitate 
the expression of recombinant proteins in plants. The choice of transformation method could 
be based on the type of gene expression (transient or stable), copy number insertion and plant 
host species. Transient expression can be achieved using particle bombardment, infection with 
modified viral vectors or agroinfiltration (Negrouk et al. 2005). Transient expression is a 
simple method for a rapid gene expression without integration the gene of interest into the host 
genome. DNA of interest is delivered to the plant host cells that resulted in a gene expression 
that lasts only for a certain period of time and recombinant proteins can be harvested thereafter 
(Ponappa et al. 1999). This method would be appropriate when confirmation of the protein 
expressed is necessary in order to check quality of the product prior to mass production and 
for a product that needs immediate purification or is prone to degradation such as vaccines 
(Fischer et al. 1999a). However, there is variability in the level of gene expression that depends 
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on transformation efficiency or the tissue that is being transformed (Schledzewski and Mendel 
1994).  
Stable gene expression (nuclear or plastid genome) can be achieved using particle 
bombardment or Agrobacterium-mediated transformation (Fischer et al. 2004). Particle 
bombardment leads to higher proportion of transgenic events with multiple copies of 
transgene. Majority of transgenic plants for molecular farming are produced using the 
Agrobacterium-mediated method. This method resulted in a low copy number and stable 
insertion of the transgene into the plant host genome (Shou et al. 2004). A single copy 
transgene is usually desired for breeding purpose in order to develop new variety or hybrid 
with a certain trait (Stam et al. 1997). Multiple copies of the transgene could lead to higher 
gene expression. However, it has been reported that multiple copies of transgene could cause 
homology-dependent gene silencing (Matzke et al. 1994). Stable gene expression takes longer 
time compared to transient assays because transgenic plants need to be generated first. 
However, stable integration provides seed bank that can be grown for generations for 
continuous production of recombinant proteins (Lu et al. 2015).  
 
1.1.3 Strategies for Increasing Plant Molecular Farming Products 
The objective of plant molecular farming is mass production of valuable proteins at 
low cost. Level of protein expression is the most important factor in molecular farming for the 
production to be economically efficient. However, despite the advantages offered by the plant 
system, the accumulation of recombinant proteins is relatively low (Kermode 2006). Elements 
of the DNA expression construct such as promoter, optimized gene of interest and regulatory 
elements (intron, enhancer, and terminator) are the key components to increase expression of 
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the desired products. Components of the construct could be endogenous or combined with 
elements from other organisms. In many cases, combination of the optimized elements resulted 
in high yield proteins. This section will discuss the important elements abovementioned in 
details along with examples that have been reported before.  
 
Promoter 
Promoter is an essential element that drives and directs gene expression leading to the 
accumulation of desired recombinant proteins. Gene expression can be directed constitutively, 
targeted to a specific tissue or activated in the presence of an inducer depending on the 
promoter (Datta et al. 1998; Kuhlemeier et al. 1987). A constitutive promoter drives gene 
expression in almost all parts of the plant, allowing accumulation and extraction of proteins 
from all parts of the plant at any developmental stages (Lu et al. 2015). Tissue specific 
promoters are available for the accumulation of recombinant proteins in certain tissue or organ 
such as seed, tuber, pollen, stem, and root. Tissue specific accumulation will simplify 
harvesting, extraction and storage of recombinant proteins. Furthermore, it minimizes 
contamination to the environment since the transgene is only transcribed in specific location 
(Twyman et al. 2003). Inducible promoters offer spatial and temporal regulation of protein 
expression (Borghi 2010) in which transcription can be activated when necessary.  
The cauliflower mosaic virus 35S (CaMV 35S) is the most widely used constitutive 
promoter derived from plant virus (Odell et al. 1985). This promoter works very well in dicots 
but leads to low expression in monocots unless the intron is included within 5’ of the promoter 
(Vain et al. 1996). High yield of recombinant proteins have been reported using this promoter 
(Hellwig et al. 2004). Several studies showed that the expression level could be varied between 
tissues and in some cases activity of CaMV 35S leads to gene silencing that might be caused 
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by the fact that the promoter is originated from virus (Elmayan and Vaucheret 1996; Potenza 
et al. 2004). Under this condition the endogenous promoter is preferred that resulted in higher 
gene expression (Howard and Hood 2015). However, strong promoters could cause phenotype 
aberrant, male sterility, low seed set and stunted growth (Clough et al. 2006; Hood et al. 2003). 
Seed-specific protein accumulation is an appealing choice for molecular farming. The 
seed is a natural organ for protein storage and provides a stable environment for proteins. 
Several seed-specific promoters (maize 27kDa γ-zein, rice globulin-1, and soybean β-
conglycinin) have been utilized for molecular farming to accumulate vaccines, antibodies and 
industrial enzymes (Hood 2002; Hudson et al. 2014; Powell et al. 2011; Stoger et al. 2005). 
Maize seed-derived recombinant proteins driven by the 27 kDa γ-zein promoter have been 
utilized as an oral feeding vaccine for diarrhea (Chikwamba et al. 2002) and direct production 
bioethanol from maize grains (Nahampun et al. 2013). Recent publication reported a high 
accumulation of cellobiohydrolase II enzyme in maize endosperm that reached up to 34% of 
total soluble proteins (TSP) (Devaiah et al. 2013). Recombinant proteins expression in soybean 
seed driven by β-conglycinin promoter have also been reported to accumulate antigen, growth 
factor, and subunit vaccines with proteins accumulation ranged between 1.5 – 2.4 % TSP (Ding 
et al. 2006; Moravec et al. 2007; Powell et al. 2011). .   
 
Regulatory elements 
Gene expression can be improved by adding regulatory elements such as introns and 
untranslated regions (3’ and 5’ UTR). Intron-mediated enhancement gene expression has been 
reported in various plant species (Chiera et al. 2007; Lu et al. 2008; Mascarenhas et al. 1990; 
Rose 2004). Intron might contribute to mRNA stability leading to higher transcript 
accumulation in the cytoplasm (Callis et al. 1987; Gallegos and Rose 2015; Luehrsen and 
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Walbot 1991; Tanaka et al. 1990). A study by Chen et al. (1988) showed improvement of gene 
expression when 170 bp intron of soybean β-conglycinin gene was fused downstream the 
CaMV 35S promoter in tobacco. Previous study reported inclusion of the first intron of ubi-1 
promoter upstream of the insert enhanced gene expression in Arabidopsis (Norris et al. 1993). 
Intron-mediated enhancement gene expression has been reviewed by Lu et al. (2015). 
Untranslated regions of highly expressed genes can enhance the level of protein 
expression by increasing translation initiation and efficiency (Sawant et al. 1999). This element 
can be fused in the 5’ or 3’ end of the insert. A previous report showed the 5’UTR of rice 
alcohol dehydrogenase (adh1) increased gene expression both in the monocot and dicot (Sugio 
et al. 2008). Addition of 5’ UTR downstream of CaMV 35S resulted in a 35 fold enhancement 
of luciferase expression (Rothstein et al. 1987). Gene expression enhancement influenced by 
3’UTR addition downstream of the gene of interest has been reported for several crops such 
as rice (Chan and Yu 1998), maize (Bailey-Serres and Dawe 1996), and alfalfa (Ortega et al. 
2006). 
 
Subcellular targeting 
Recombinant protein expression could be guided into subcellular compartments 
(endoplasmic reticulum, protein bodies, apoplast and vacuoles) by fusing a localization signal 
in the N or C terminal of the insert. The endoplasmic reticulum (ER) lumen provides chaperons 
and enzymes needed for the proper protein folding, post translational modification and protein 
stability that contribute to protein accumulation (Hamorsky et al. 2015). The ER-retention 
signal (KDEL/HDEL motif) plays a role to retain proteins inside the ER that resulted in the 5 
fold increased accumulation of recombinant protein (Guan et al. 2013; Hood et al. 2007; Yang 
et al. 2005). Fusion of barley alpha amylase signal peptide (BAASS) in the 5’ of laccase gene 
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led to high protein accumulation in the apoplast (Hood et al. 2007). The most abundant storage 
protein in maize is γ-Zein which is synthesized by rough ER and stored in the form of protein 
bodies (PB). The formation of PB is induced by N-terminal proline-rich domain of γ-zein. 
Fusion of this domain with gene of interest resulted in the increase of recombinant protein 
accumulation in maize seed (Alvarez et al. 2010).  
 
Codon usage 
Codon usage preference (http://www.kazusa.or.jp/codon/(Nakamura et al. 2000)) 
differs between organisms, kingdoms, and genomes (nuclear vs plastid)  (Hiwasa-Tanase et al. 
2011; Streatfield 2007). The preference of codon usage depends on the abundance of tRNAs 
that might affect the efficiency of translation. Codon optimization is usually necessary when 
the gene to be expressed is derived from a different organisms in order to match the most 
abundant tRNAs in the host system (Desai et al. 2010; Hiwasa-Tanase et al. 2011; Rouwendal 
et al. 1997). Several reports demonstrated codon optimization increased translation efficiency 
that lead to higher protein accumulation compared with the native version (Mechold et al. 
2005; Sattarzadeh et al. 2010; Suo et al. 2006). Current advances in molecular biology allow 
gene to be synthesized as desired. 
 
Post translational modification  
Most of the animal-derived pharmaceuticals (immunoglobulins, vaccines, and 
cytokines) are glycoproteins that need post translational modification such as glycosylation or 
hydroxylation (Xu et al. 2011) for a proper protein folding, stability, and activity. These 
proteins are usually translated as pre-protein then processed in the ER and Golgi for further 
modification (Gomord and Faye 2004). A number of studies have demonstrated the ability of 
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plants to do such modification resulted in the identical version to their mammalian cell 
products (Stoger et al. 2014). Co-expression of therapeutics along with its native 
glycosyltransferases enzyme can also be used as a strategy in order to ensure correct proteins 
are accumulated in transgenic plants (Gomord and Faye 2004). A study demonstrated co-
expression of human collagen I alpha 1 (CIα1) and human prolyl 4-hydroxylases (P4H) led to 
proper hydroxylation of CIα1 in transgenic maize seed which was comparable to its native 
form (Xu et al. 2011). 
 
Chloroplast expression 
Agrobacterium-mediated transformation causes random insertion, consequently a 
transgene could be inserted anywhere in the genome. Position effect often affects the 
expression of the insert and its surrounding. Negative impacts sometimes can be observed such 
as stunted growth, defect in development or gene silencing (Lu et al. 2015). Another option of 
stable gene expression is using chloroplast transformation. Chloroplasts are cellular organelles 
that contain their own genome and translation machinery (Maliga 2004). Chloroplast is 
inherited maternally and thus, provides an approach that can minimize contamination to the 
environment by preventing outcross of transgenic plants with the wild type (Daniell et al. 
2001). Furthermore, chloroplasts lack epigenetic effects that may cause silencing (Cardi et al. 
2010). Each cell contains high copies of chloroplast genome that is varied among tissues. For 
example, a leaf cell may contain up to 10,000 copies of the genome (Cardi et al. 2010), 
allowing a high expression level of proteins. Previous studies showed the accumulation of 
recombinant proteins can reach up to 50% of total soluble protein (TSP) by using this system 
(Lentz et al. 2010). Several studies have reported high accumulation of pharmaceuticals in 
15 
 
transgenic plants using the chloroplast expression system (Cardi et al. 2010; Lossl and Waheed 
2011).  
 
1.1.4 Maize and Soybean 
Maize and soybean are among the major cultivated and consumed crops worldwide, 
providing supplies for food, feed, and energy (Lobell et al. 2011). It is well known that maize 
and soybean offer advantages for the accumulation of foreign proteins (Herman and Schmidt 
2015; Twyman et al. 2003). Seeds of maize and soybean have a large size and high protein 
content. Both crops are transformable and thus, offer advantage for easy genetic manipulation 
(Menkhaus et al. 2004). These crops are natural component of animal feed which will be 
convenient for the accumulation of industrial enzymes or therapeutics. More importantly, seed 
may offer a cheaper alternative system for the production of valuable recombinant proteins 
(Lau and Sun 2009).   
Maize is a very attractive crop for the accumulation of recombinant proteins because it 
is the largest grain produced annually (Stoger et al. 2005). Maize seed does not contain gluten 
or allergens and is also certified as generally regarded as safe for food consumption (GRAS) 
by the FDA. Moreover, currently around 88% of maize grown in the USA is transgenic. 
Expression of therapeutics in food crop would be beneficial for developing countries in order 
to develop affordable vaccines and drugs (Lu et al. 2015; Ramessar et al. 2008). Numerous 
studies have reported the diverse products of maize-derived recombinant proteins such as 
antigens, enzymes, vaccines and antibodies (Giddings et al. 2000; Howard and Hood 2015; 
Ramessar et al. 2008). The first commercialized recombinant proteins, Avidin was expressed 
in maize (Hood et al. 1997). High level production of avidin in maize showed the feasibility 
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of the transgenic plant as a bioreactor for the accumulation of valuable proteins. The S protein 
of swine transmissible gastroenteritis virus (TGEV) has been produced in maize. Oral 
administration of maize-expressed S protein induced neutralizing antibodies in the young pig 
(Lamphear et al. 2004). 
Soybean seed could be an alternative to a cheaper system for vaccine or 
pharmaceuticals production. Soybean is a natural component of animal feed because of the 
high protein content (±40% dry weight) (Liu 1997). Soybean offers several different food 
formulation such as soy food, soy milk or as a meat replacement for a vegetarian option (Lusas 
and Riaz 1995) which could be advantageous for pharmaceutical applications or improve 
nutritional value. Soybean plants provide advantage in its ability to use atmospheric nitrogen 
through symbiotic relationship thus reduce the necessity to supply nitrogen in the form of 
fertilizer (Herman and Schmidt 2015). Furthermore, soybean is a self-pollinating plant thus 
could minimize cross contamination to the environment (Stoger et al. 2005). An antigen 
Staphylococcal enterotoxin B (SEB) was expressed at a high level in soybean seeds. Anti-SEB 
titers was found in blood serum of mice immunized with soybean-derived SEB (Hudson et al. 
2014). Production of human growth hormone has been reported in soybean seed driven by β-
conglycinin promoter (Russell et al. 2005). Soybean has been utilized as an expression system 
of human Thyroglobulin (hTG), a 660 kDa homodimeric protein that is commonly used for 
the diagnosis of thyroid disease (Powell et al. 2011). In this study, hTG was expressed in 
soybean seeds. Protein analyses showed proper assembly of hTG in transgenic soybean 
suggested that soybean could be utilized as a system to express large and complex protein. 
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1.1.5 Plant Molecular Farming (PMF) 
The plant accumulates natural chemicals or secondary metabolites that are commonly 
involved in the plant defense against pathogens and adaptation to the environment (Bourgaud 
et al. 2001). These metabolites have been applied in various applications such as traditional 
medicine and as natural pigments (Bourgaud et al. 2001). This feature makes plant a 
prospective host for molecular farming to produce economic valuable recombinant proteins or 
secondary metabolites (Franken et al. 1997). The propensity of using the plant system was 
revolutionized by the evidence of stable integration of foreign gene into plant genome (Fraley 
et al. 1983) which was a hallmark that plant can be engineered to produce desired products.  
Animal cell cultures, bacteria, yeast, and fungi have been used before as systems for 
the production of proteins or peptides that are valuable for industry, drugs and therapeutics 
(Demain and Vaishnav 2009; Giddings et al. 2000; Schillberg et al. 2005). However, these 
systems are expensive and limited in scale and bioactivity. Benefits provided by the plant 
system are a cheaper platform compared to other systems (microorganism and mammalian), 
the cost can be 2-10% of microorganism or 0.1% mammalian (Twyman et al. 2003); biomass 
can be scaled up and possibly stored indefinitely in seeds while maintaining bioactivity 
(Whitelam et al. 1993); proper protein folding due to availability of post translational 
modification machinery (Streatfield 2007); and the plant does not carry animal pathogens thus 
reduce the possibility of contamination (Twyman et al. 2003).  
 
1.1.5.1 Plant-derived industrial enzyme 
Industrial enzymes are generally used as catalyst for the conversion of raw materials 
into intermediate or final products that are useful for food, feed, textile, paper and energy 
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industries. Various studies have demonstrated the feasibility of transgenic plants to accumulate 
industrial enzymes (alpha amylase, laccase, phytase, cellobiose) (Howard and Hood 2015). 
The first evidence of heterologous expression of α-amylase from Bacillus licheniformis was 
reported in tobacco (Pen et al. 1992). This enzyme is commonly used in the food industry to 
produce high-fructose corn syrup, ethanol or added in detergents to remove starch (Richardson 
et al. 2002). Transglutaminase, an enzyme commonly used in the food industry, has been 
expressed in transgenic rice (Claparols et al. 2004). Expression of glucosyltranasfereases 
(gtfD) from Streptococcus mutans in transgenic maize seed led to the accumulation of novel 
glucans, polymers with many applications in food industry for example as thickening agent 
(Zhang et al. 2007).  
Alpha amylase is not only an important enzyme for food application but also valuable 
for bioethanol production. First generation bioethanol is produced from starch materials that 
have been digested into small sugars then fermented into ethanol. Alpha amylase enzyme is 
required for the conversion of starch into glucose. Several studies demonstrating α-amylase 
expression in transgenic plants have been reported (Austin et al. 1995; Czihal et al. 1999; 
Kumagai et al. 2000). Expression of thermostable amylopullulanase in transgenic maize  led 
to the starch auto hydrolysis into simple sugars (Chiang et al. 2005) that can be directly utilized 
to produce bioethanol from maize seeds (Nahampun et al. 2013).  
Second-generation biofuel has been produced from lignocellulosic material such as 
corn stover, sugarcane and switch grass (Vohra et al. 2014). Cellulose hydrolysis is a difficult 
process and several enzymes are required to convert cellulose into glucose or simple sugars. 
Multiple cellulosic degrading enzymes, E1 endo-1,4-β-D-glucanase of Acidothermus 
cellulolyticus and  cellobiohydrolase of Trichoderma reesei have been expressed in transgenic 
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maize seed and lead to the increased bioethanol production from cellulose (Hood et al. 2007). 
Several studies reporting similar attempts have also been reported (Biswas et al. 2006; Jung et 
al. 2010; Oraby et al. 2007; Ransom et al. 2007; Taylor Ii et al. 2008) 
 
Amylopullulanase (enzyme of the study) 
 A growing concern of the greenhouse gas effect on the environment has brought the 
attention to replace fossil fuel with renewable energy that is safe for the environment. The 
United States and Brazil are leading countries in bioethanol production and consumption to 
replace fossil fuel (Goldemberg 2007). The United States produced 58% (±14.3 billion 
gallons) of ethanol globally in 2014 that is majorly produced from maize grains. A low cost 
strategy for bioethanol production is needed to make bioethanol affordable. Approximately 
less than 3% of maize grains of the global supply are allocated for bioethanol production 
(http://www.ethanolrfa.org/). Maize grains provide high content of starch as the source of 
glucose for fermentation to make ethanol. Starch processing involves gelatinization in the 
presence of water and heat in order to break down starch crystalline structures and ready for 
enzyme attack. Subsequent steps require starch degrading enzymes (α-amylase and 
glucoamylase) to degrade starch into glucose (Richardson et al. 2002) followed by yeast 
fermentation to produce ethanol. Starch degradation is performed at high temperature therefore 
a highly thermostable enzyme is needed in this process (Nielsen and Borchert 2000).  
Starch is composed of amylose, a linear glucose polymer linked with α-1,4 glucosidic 
bond and amylopectin, amylose with α-1,6 linkages at branch point (Mojović et al. 2006). Two 
types of enzymes are needed to convert starch into fermentable sugars. These enzymes should 
be applied exogenously during the process. The α-amylase enzyme is added during 
liquefaction step to digest α-1,4 linkages of starch into small sugars (Konsula and 
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Liakopoulou-Kyriakides 2004). The second enzyme, amyloglucosidase is involved in the 
digestion of α-1,4 and α-1,6 linkages from the non-reducing ends for complete conversion of 
starch into glucose (Quigley et al. 1998).  
A number of papers reported alpha amylase enzyme with dual activity to digest both 
α-1,4 and α-1,6 of starch that is called amylopullulanase (APU) (Mathupala et al. 1993). 
Amylopullulanase has been isolated from different thermostable bacteria (Chen et al. 2001; 
Hatada et al. 1996; Zareian et al. 2010). In general, this enzyme is optimum at high temperature 
90°C, pH 6.0 and has dual catalytic sites for  α-1,4 and α-1,6 glucosidic linkages (Mathupala 
et al. 1993). The advance of genetic engineering offers the utilization of transgenic plants as 
platform to accumulate starch degrading enzyme (Torney et al. 2007). Incorporation of 
thermostable APU enzyme in seeds offers a benefit for direct ethanol production from maize 
kernels. The strategy of seed accumulation reduces the necessity of special storage condition 
as the enzyme is protected from proteolysis and thus remains stable even after several years 
(Kusnadi et al. 1997). Furthermore, APU has dual activity and therefore simplifies starch 
processing since only one enzyme is needed. Attempts at producing APU in transgenic plants 
have been reported in rice (Chiang et al. 2005) and maize (Nahampun et al. 2013). In both 
studies, direct hydrolysis of starch into smaller sugars was observed. Expression of APU in 
maize kernels led to 40% conversion of starch into bioethanol without the addition of 
exogenous enzymes (Nahampun et al. 2013).  
 
1.1.5.2 Plant-derived biopharmaceuticals 
Biopharmaceuticals are usually produced in animal cells, bacteria or fungi (Giddings 
et al. 2000). The mammalian cell is preferable since this system expresses identical product 
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with their origin. The drawback of using this system is that it costly and available only on a 
limited scale (Daniell et al. 2001). On the other hand, using microorganism to produce 
pharmaceuticals offers the advantage of scaling up but the product might not be identical with 
the desired one. This is due to the fact that microorganisms do not possess machinery for the 
translational modification and most of pharmaceuticals are glycosylated (Streatfield and 
Howard 2003). Currently, plants have been used to manufacture drugs, antibodies and vaccines. 
Enkephalins was one of the earliest biopharmaceuticals expressed in transgenic plant useful as 
painkiller (Vandekerckhove et al. 1989). In 2012, transgenic carrot cell culture expressing 
taliglucerase alpha for Gaucher disease treatment was approved by the FDA (Maxmen 2012). 
Recent progress on plant-derived products that have been approved for commercialization or in 
the clinical trials have been reviewed elsewhere (Fahad et al. 2015; Moustafa et al. 2015; Sack 
et al. 2015).  
A report demonstrating first plant-derived antibody was reported (Hiatt et al. 1989) 
showing the accumulation and assembly of immunoglobulins in tobacco. More evidences 
regarding plant-production of antibodies were reported afterwards (Artsaenko et al. 1998; 
Fischer et al. 1999b; Sack et al. 2015). These antibodies are important to treat pathogenic 
diseases not only for human but also to prevent mortality that leads to economic loss in 
livestock. Arabidopsis derived antibodies (IgA) designed for the passive immunization against 
enterotoxigenic E. coli infection prolonged protection of weaned piglets from diarrhea (Virdi 
et al. 2013). The most recent example of plant antibodies were derived from tobacco to treat 
Ebola virus in human (Qiu et al. 2014).  
Time and scale are the limiting factors in vaccine production. Vaccines have to be 
quickly produced in enough quantity in order to prevent an epidemic. Transient expression in 
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plants offers production system of pharmaceuticals that can be achieved in 2-4 weeks (Negrouk 
et al. 2005). Plant-derived vaccines also offer oral delivery which possibly removes the 
necessity of needle injection and the requirement of protein purification, and thus allows easy 
administration (Nochi et al. 2007). Oral administration also enhances the chance of inducing 
mucosal immunity which is important factor for stronger immune response. Plant-derived 
vaccines have been produced for pathogenic diseases such as hepatitis B (Kapusta et al. 1999), 
enterotoxin E.coli (Chikwamba et al. 2002) and influenza (Nahampun et al. 2015). Orally-fed 
mice with transgenic tomato expressing respiratory syncytial virus-F protein (RSV-F) induced 
the production of IgG and IgA antibodies indicating serum and mucosal immunity (Sandhu et 
al. 2000). Evidence of plant derived antigens have been reviewed many times (Daniell et al. 
2001; Fischer et al. 2004; Giddings et al. 2000; Ma et al. 2005; Moustafa et al. 2015; Obembe 
et al. 2011; Sack et al. 2015) 
 
Maize expressed subunit influenza vaccine (protein vaccine of the study) 
 Influenza A viruses cause annual epidemics and pandemics that result in lethality to 
humans and animals. The first prominent case of influenza, Spanish flu happened in 1918 that 
took millions of lives but the virus was isolated not until 1933 (Smith et al. 1933). Evolution 
of influenza A viruses show their ability to escape one season and emerge in the next season 
through antigenic shift and drift (Krammer 2015; Zhang et al. 2015). Vaccine development for 
influenza involves prediction and reformulation based on the circulating strains. Current 
formulation of influenza vaccines are mixes of two types influenza A strains (the 2009 H1N1 
pandemic and H3N2) and one strain of influenza B virus. Constant reformulation causes 
vaccines design becomes challenging and the process takes time to develop (Gerdil 2003). The 
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2009 H1N1 pandemic resulted in transmission from swine into human has caused a great 
concern and called for a better vaccine development (Medina and García-Sastre 2011).  
Universal vaccines have emerged as the strategy to provide broad protection (Neirynck 
et al. 1999) before the strain specific vaccines are produced in order to alleviate the infection 
and prevent an epidemic. Universal vaccines are based on conserved proteins that are less 
likely to undergo mutation. The fact that the proteins are similar among strains raises the 
possibility that these proteins might induce cross-reactivity against different strains. 
Hemaglutinin (HA), neuraminidase (NA), matrix ectodomain (M2e) and nucleoprotein (NP) 
are conserved proteins that have been extensively studied for universal influenza vaccines 
(Krammer 2015; Neirynck et al. 1999).  
The NP protein shows around 90% amino acids sequence similarity among influenza 
strains. This protein functions in the encapsulation of genetic materials of the virus (Krammer 
2015; Portela and Digard 2002). Several studies showed strong immune responses induced by 
NP against lethal challenge of virus (Epstein et al. 2005; Kim et al. 2013; Lei et al. 2015). 
Recently, a universal vaccine candidate for influenza developed by Okairòs is being tested by 
the US Food and Drug Administration (FDA) for human application 
(http://www.fda.gov/BiologicsBloodVaccines/ScienceResearch/ucm353397.htm) (Vitelli et 
al. 2013). This vaccine is based on M1 and NP expressed in PanAd3 virus vector derived from 
ape. Intranasal administration showed strong humoral and cell-mediated immune responses 
against lethal challenge of influenza virus.  
Subunit vaccines production in maize seed provides beneficial applications due to the 
fact that this crop is a natural component for food and feed. Vaccines can be administered as 
part of a feeding regime, delivered orally or through injection (Daniell et al. 2009). Antigens 
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can be routinely applied as preparedness for the seasonal flu. Since the antigens are preserved 
in seed there is no need for exceptional storing. Nucleoprotein of H3N2 has been accumulated 
in maize seed up to 0.06% TSP (Nahampun et al. 2015). Immune responses elicited against 
NP have been reviewed (Hillaire et al. 2011; Krammer 2015). The results observed are varied 
due to different methods of proteins expression, delivery, dose and adjuvant. Recent 
publication demonstrated CTB adjuvant could lead to higher humoral and cell mediated 
immune response against influenza (Lei et al. 2015).  
 
Plant-derived therapeutics RNA (RNA vaccine of the study) 
RNA interference (RNAi) was first demonstrated in C. elegans by (Fire et al. 1998) 
and also known as post translational gene silencing (PTGS) in plant or quelling in fungi (English 
et al. 1996). In this mechanism, foreign double stranded RNA (dsRNA) is recognized as 
invasive virus and chopped into 20-24 nucleotides (nt) small interfering RNAs (siRNAs) by 
DICER enzyme. Subsequently, one of the strands of siRNA is loaded into RISC (RNA 
interference silencing complex) that targets the complementary mRNA in a sequence specific 
manner and causes degradation of the mRNA target (Baulcombe 2004). 
 Recent studies showed that RNAi activates immune response related genes upon 
infection with virus or pathogen. This breakthrough leads the research to explore the avenue of 
antiviral mechanism using dsRNA or siRNA (Huvenne and Smagghe 2010). This concept was 
tested by the administration (injection or oral) of in-vitro transcribed or chemically synthesized 
specific dsRNA that led to gene silencing (Kumar et al. 2009). Synthetic antisense RNA 
oligonucleotide targeting NS1 gene of H1N5 influenza virus have shown to inhibit virus 
replication (Wu et al. 2008). The dsRNA molecules have also been reported as vaccine for viral 
pathogens in shrimp. The dsRNA molecule was specifically designed to target infectious 
25 
 
myonecrosis virus (IMNV) (Loy et al. 2012). In the study, injection of dsRNA into shrimp 
resulted in 100% protection against lethal challenge of IMNV. Antiviral effect was influence 
by the length of dsRNA and specificity of target region. Specific target induced high protection 
even under low dose of dsRNA.  
Transgenic plants have been extensively studied as platform for recombinant proteins 
production. However, studies regarding the application of transgenic plants to accumulate RNA 
are still limited. Report by (Zhou et al. 2004) demonstrated expression of dsRNA targeting non-
structural (NS1) gene of influenza A virus in transgenic tobacco resulted in the accumulation 
of siRNA. Transfection of mammalian cells with plant-derived siRNA followed by infection 
with influenza virus strain suppressed virus replication. The potential of ncRNA as therapeutics 
targeting mRNA correspond to mutated diseases has also been reported (Gavrilov and Saltzman 
2012; Sioud 2004). Recent patent described a method for the accumulation of dsRNA/siRNA 
in transgenic plants. Plant-derived siRNA was utilized as oral vaccine that is useful as 
therapeutics for diseases such as HIV and Hepatitis C (Lam 2014). These evidences indicate 
the feasibility of plant-derived siRNA as therapeutics. 
 
1.1.6 From protein to RNA 
Previous concept believed that only little percentage of the genome is coding sequence 
while majority of the genome consists of intron or junk (non-coding) sequences. It is not until 
recently scientists found that around 90% of eukaryotic genome is transcribed and the non-
coding RNAs (ncRNAs) are involved in many biological processes (Jacquier 2009). There are 
different regulatory ncRNAs such as long or small double stranded RNA (dsRNA), small 
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interfering RNAs (siRNAs), microRNA (miRNA) and hairpin RNA (hpRNA). Basic 
mechanism of these RNAs is through RNA interference pathway (RNAi).  
Numerous studies were reported to investigate the function of these ncRNAs and in 
recent years, a lot of information are available demonstrating the roles or ncRNAs in regulating 
gene expression (Mercer et al. 2009). Recent finding showed that pathogen immunity and 
antiviral response is conveyed through an RNAi mechanism. RNAi approach has been utilized 
for the improvement of plant pathogens resistance (Eamens et al. 2008; Kumar et al. 2009), 
foliar herbicide in the form of dsRNA (San Miguel and Scott 2015; Zhou et al. 2004) and 
pharmaceuticals (Gavrilov and Saltzman 2012; Sioud 2004). Nowadays, utilization of 
transgenic plants is shifted not only for protein production but also towards RNA expression. 
A number of studies have reported the application of RNAi to increase plant (viruses 
and insect pests) resistance and prevent economic loss caused by pathogens (Mao et al. 2007). 
A hairpin RNA (hpRNA) construct is designed to target specific gene that can cause lethality 
to the pathogens. Hairpin RNA construct targeting barley yellow dwarf virus increased virus 
resistance in barley (Fusaro et al. 2006). The first commercial product of gene silencing was 
the transgenic papaya resistant to papaya ringspot virus (PRSV) released by Monsanto and 
potato resistance to potato leafroll virus and PVY (Fuchs and Gonsalves 2007).  RNAi has also 
been used to prevent damage caused by plant-feeding insect. Report on plant-derived dsRNA 
feeding experiment to control insect was reported (Baum et al. 2007). Transgenic maize 
expressing hpRNA targeting vacuolar ATPase (v-ATPase) gene caused lethality on western 
corn rootworm after feeding assay. Expression of dsRNA targeting P450 monooxygenase gene 
caused mortality of lepidopteran Helicoperva armigera (Mao et al. 2007).  Double stranded 
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RNA targeting v-ATPase subunit C of western corn rootworm Diabrotica virgifera virgifera 
LeConte caused lethality to the insect and protected corn root from damage (Li et al. 2015).  
MicroRNAs (miRNAs) are non-coding RNA encoded in the genome and found to 
regulate many processes such as gene expression of eukaryotic (Jacquier 2009; Mercer et al. 
2009). It is estimated that 60% of human genes are controlled by miRNAs. Recent publication 
showed horizontal delivery of miRNA from dietary food showing plant miRNA168a derived 
from rice could suppress the low-density lipoprotein receptor adaptor protein 1 (LDLRAP1) 
mRNA in mouse (Zhang et al. 2012). However, there is disagreement regarding the results 
(Dickinson et al. 2013; Snow et al. 2013). The discrepancy is mostly caused by the inefficient 
absorption of small RNAs (sRNAs) into the blood stream in order to trigger silencing or mRNA 
target degradation.  
Unsuccessful attempt of plant-derived RNA as vaccine was reported (Svancarova et al. 
2015). Similar with protein as subunit vaccine, the effect of RNA to induce immune response 
is determined by dose or concentration. Length of dsRNA is also important aspect in inducing 
antiviral mechanism (Reynolds et al. 2006). Recent papers showed there are several factors that 
might influence the uptake of sRNAs (Hirschi et al. 2015). The controversy involving different 
result obtained from dietary miRNA indicating that there is still long road to go for this 
application as therapeutics (Castanotto and Rossi 2009).  
 
1.1.7 Alternative selectable markers for maize transformation  
Identification of transgenic events is a critical factor in the plant transformation 
procedure. The ratio of transformed cells is usually low therefore a selection system is needed 
for the recovery of transgenic events. Marker genes have allowed such identification to 
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differentiate transformed cells from the non-transformed ones (Miki and McHugh 2004). 
Selectable markers can be categorized into positive and negative selection. Positive selection 
supports the growth of transformed cells in the media containing selection agents. On the other 
hand, negative selection caused cell death to the transformed cells (Miki and McHugh 2004; 
Penna et al. 2002).  
Currently, common selectable markers for plant transformation methods usually confer 
antibiotic or herbicide resistance genes (De Block et al. 1987; Hille et al. 1986; Howe et al. 
2002; Valvekens et al. 1988). Neomycin phosphotransferase II (nptII) gene confers resistance 
gene to aminoglycoside antibiotics (kanamycin, neomycin, gentamycin) (Herrera-Estrella et 
al. 1983) was one of the first products of plant genetic engineering that  functions as selectable 
marker for the identification of transgenic plants. Hygromycin phosphotransferase (hpt) is 
another antibiotic gene that has been robustly utilized as selectable marker for rice 
transformation (Main et al. 2015). On the other hand, bar gene encodes for bialaphos resistance 
gene is routinely used for the selection in maize Agrobacterium-mediated transformation 
method (Frame et al. 2002; Spencer et al. 1990). Most of these genes are derived from bacteria 
which have caused concern regarding biosafety (such as toxicity and possibility of horizontal 
transfer). Although there is no strong evidence that proves this issue, public acceptance 
towards genetically modified plants containing these products have been difficult (Key et al. 
2008; Miki and McHugh 2004; Ramessar et al. 2007; Rosellini 2011).  
Several studies have reported alternative selection system for plant transformation in 
order to minimize the utilization of antibiotics or herbicides resistance genes (Miki and 
McHugh 2004). Visual markers provide easy observation to human eye and have been utilized 
as alternative to antibiotic or herbicide markers (Naing et al. 2015). Anthocyanin gene has 
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been proposed as an alternative to kanamycin selection for apple, strawberry and potato 
transformation (Kortstee et al. 2011). Furthermore, anthocyanin has been considered as anti-
cancer agent therefore would also offer health benefit. Long list of alternative selectable 
marker genes for plant transformation has been reviewed recently (Breyer et al. 2014; Rosellini 
2011). 
 Phosphomannose isomerase (PMI) is a non-antibiotic selectable marker that has been 
extensively studied. The selection system is based on the alternative carbon source using 
mannose as selection agent. Most plants could not metabolize mannose and PMI enzyme 
allows transformed cells to convert mannose-6-phosphate into fructose-6-phosphate that can 
be metabolized by plants. The PMI/mas selection system has been reported in transformation 
of many plant species such as maize, rice and soybean (Joersbo 2001; Negrotto et al. 2000). 
The trehalose-6-P synthase (AtTPS1) gene from Arabidopsis thaliana was reported as selection 
marker for the transformation of Arabidopsis and tobacco. This gene plays role in sugar 
metabolism during embryo development and allows transgenic identification in the media 
containing glucose as selection agent (Leyman et al. 2006). 
Recent publication presented phosphite oxidoreductase (ptxd) gene as a novel 
dominant selectable marker for plant transformation (Lopez-Arredondo and Herrera-Estrella 
2013). The PTXD enzyme involves in the conversion of phosphite (Phi) into phosphate (Pi). 
Phi is non-metabolizing form of phosphorous that can interfere with plant growth (Sukarno et 
al. 1993; Thi Bich Thao et al. 2009). Uniqueness offered by phosphite selection is that this 
system allows toxic compound (phosphite) to be converted into useful compound (phosphate) 
for plant growth. This selection system minimizes escape events and provides nutritional value 
for plant (Lopez-Arredondo and Herrera-Estrella 2013).  
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CHAPTER 2: ECTOPIC EXPRESSION OF BACTERIAL AMYLOPULLULANASE 
ENHANCES BIOETHANOL PRODUCTION FROM MAIZE GRAIN 
 
Modified from a paper published in Plant Cell Reports (2013) 32:1393-1405 
 
Hartinio N Nahampun, Chang Joo Lee, Jay-Lin Jane, Kan Wang 
 
Key message: Heterologous expression of amylopullulanase in maize seeds leads to partial 
starch degradation into fermentable sugars, which enhances direct bioethanol production from 
maize grain.  
 
Abstract  
Utilization of maize in bioethanol industry in the United States reached ±13.3 billions of 
gallons in 2012, most of which was derived from maize grain. Starch hydrolysis for bioethanol 
industry requires the addition of thermostable alpha amylase and amyloglucosidase (AMG) 
enzymes to break down the α-1,4 and α-1,6 glucosidic bonds of starch that limits the cost 
effectiveness of the process on an industrial scale due to its high cost. Transgenic plants 
expressing a thermostable starch-degrading enzyme can overcome this problem by omitting 
the addition of exogenous enzymes during the starch hydrolysis process. In this study, we 
generated transgenic maize plants expressing an amylopullulanase (APU) enzyme from the 
bacterium Thermohydrosulfuricus thermohydrosulfuricus. A truncated version of the dual 
functional APU (TrAPU) that possesses both alpha-amylase and pullulanase activities was 
produced in maize endosperm tissue using a seed specific promoter of 27-kD gamma zein. A 
number of analyses were performed at 85°C, a temperature typically used for starch 
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processing. Firstly, enzymatic assay and thin layer chromatography analysis showed direct 
starch hydrolysis into glucose. Additionally, scanning electron microscopy illustrated porous 
and broken granules, suggesting starch auto-hydrolysis. Finally, bioethanol assay 
demonstrated that a 40.2±2.63% (14.7±0.90 g ethanol per 100g seed) maize starch to ethanol 
conversion was achieved from the TrAPU seeds. Conversion efficiency was improved to reach 
90.5% (33.1±0.66 g ethanol per 100g seed) when commercial amyloglucosidase was added 
after direct hydrolysis of TrAPU maize seeds. Our results provide evidence that enzymes for 
starch hydrolysis can be produced in maize seeds to enhance bioethanol production. 
Keywords: Amylopullulanase, bioethanol, starch, transgenic maize  
 
Introduction 
 The world’s dependency on fossil fuels and the increasing demand for petroleum have 
raised concerns about future energy security. To reduce our dependence on fossil fuels, new 
forms of renewable energy need to be produced. Ideally, this new energy source would not 
only provide a solution to overcome an energy shortage but also create a cheaper and cleaner 
form of energy. Feedstock that is useful for biofuel production, such as sucrose, starchy 
materials and cellulosic biomass, have been investigated through extensive research and their 
potential as a fossil fuel substitute has been explored by some countries (Hahn-Hägerdal et al. 
2006; Balat and Balat 2009). Lignocellulosic biomass is the most abundant polymer on earth 
and recent research has been focused on cellulosic ethanol. However, hydrolysis of 
lignocellulosic materials is a slow, energy consuming and difficult process (Sanchez and 
Cardona 2008) even with recent improvements have been aimed at increasing cellulosic 
digestibility (Harrison et al. 2011; Brunecky et al. 2011; Zhang et al. 2012; Park et al. 2011; 
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Heinonen et al. 2012). Starchy materials such as maize grain are still the most exploited 
polymers for biofuel production. In fact, maize-based ethanol production in the United States 
reached ±13.3 billion gallons in 2012 and 26% of bioethanol was produced from maize grain, 
counting for 2.97 % of worldwide grain supplies (USA department of energy and USDA 
January 2013, 2013 ethanol industry outlook). This number is projected to be increased in the 
future.  
Wet milling and dry grinding are the two main processes used to produce bioethanol 
from maize grain. The latter process is the most adopted strategy for bioethanol production in 
the U.S. Ethanol, thin silage and DDGS (distillers dry grain with sugar) are the main products 
of the dry grinding process (Bialas et al. 2010). Milled maize grain is gelatinized first at high 
temperatures in the presence of chemicals such as calcium oxide and ammonium to activate 
enzymes and adjust the pH. Alpha amylase enzyme is then added in the liquefaction process. 
The pH is lowered to the 4.2-4.5 range prior to the addition of the second enzyme, usually 
glucoamylase. Finally, the process is completed with fermentation to produce ethanol in the 
presence of nitrogen and urea. In theory, 718 liters of ethanol per ton of starch is the expected 
outcome of this process (Castro et al. 2011).  
 Starch consists of two types of molecules: a linear glucose polymer linked with α-1,4 
glucosidic bonds (amylose), and a highly branched glucose polymer that has α-1,6 branching 
linkages connecting linear chain (amylopectin). It has versatile applications in many industries 
such as in the sugar syrup, paper, textile, and biofuel industries (Muralikrishna and Nirmala 
2005). Starch has a compact crystalline structure and is difficult to solubilize. Starch 
processing is carried out at high temperature to increase its solubility prior to enzyme 
digestions (Matsumoto 1982). Therefore, a thermostable starch-degrading enzyme is essential 
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in this process. Conventional starch hydrolysis requires thermostable alpha amylase, usually 
from bacteria Bacillus licheniformis and B. stearothermophilus, to liquefy starch. This process 
is performed at 105 °C to cut α-1,4 glucosidic linkages with its endo-acting mode of action 
(Singh and Soni 2001). Starch debranching enzyme, usually β-amylase, pullulanase or 
glucoamylase, is subsequently added at 60-65 °C for starch saccharification to further digest 
α-1,4 and α-1,6 linkages (Douglas Crabb and Mitchinson 1997; Matsumoto 1982). Starch is 
hydrolyzed into glucose before it can be converted into bioethanol through the fermentation 
process.  
 Amylopullulanase is a type II pullulanase enzyme bearing both the alpha amylase and 
pullulanase activities responsible for digesting the alpha 1,4 and 1,6 glucosidic linkages of 
starch, respectively (Vieille and Zeikus 2001). Molecular analysis of APU from bacteria 
Thermoanaerobacter, Bacillus, Clostridium and Geobacillus thermoleovorans NP33 showed 
a single active site for both alpha amylase and pullulanase activities (Saha et al. 1991); however 
several aerobic bacteria such as Bacillus sp. KSM1378 and B. circulans F-2 have different 
active sites for each activity (Sata et al. 1989; Hatada et al. 1996). Biochemical characteristics 
of this enzyme have been extensively studied (Saha et al. 1990; Saha et al. 1991). APU was 
mostly isolated from thermophilic bacteria with optimum enzyme activity at temperatures 
between 90 to 120 °C. A recent report demonstrated APU enzyme isolated from actinomycetes 
Streptomyces erumpens MTCC 7317 (Kar et al. 2008). The thermostability of APU, along with 
its activity at a broad pH range (pH 5.0-6.5, optimum pH 6.0), make it suitable for industrial 
applications (Vieille and Zeikus 2001).  
Attempts to express starch degrading enzymes in transgenic plants have been 
documented in several plant species. For example, bacteria alpha amylases have been produced 
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in tobacco (Jan Pen 1992), narbon beans (Czihal et al. 1999) and sweet potato (Santa-Maria et 
al. 2011). Constitutive expression of thermophilic alpha amylase from Thermotoga maritime 
under 35S promoter activity caused conversion of starch into maltose (G2) after root 
homogenate was incubated at 80 °C for 14 hours (Santa-Maria et al. 2011). Xu and colleagues 
reported two transgenic rice lines expressing alpha amylase from Bacillus stearothermophilus 
(Xu et al. 2008a) and fungal glucoamylase of from Aspergillus awamori (Xu et al. 2008b) in 
seeds. Their studies presented evidence that combination of the two transgenic rice lines could 
digest maize starch into glucose. On the other hand, truncated form of the dual-function APU 
enzyme from T. hydrosulfuricum has been expressed in developing and germinated rice seeds 
under glutelin and alpha amylase promoters, respectively. Their work showed direct starch 
hydrolysis as well as enriched protein flour in rice, which is valuable for food industry (Chiang 
et al. 2005). These findings demonstrate that genetically engineered plants expressing starch 
hydrolyzing enzymes have potential to improve starch processing and can be useful for 
industrial applications. 
Transgenic plants can be a cheap and practical tool for accumulating recombinant 
enzymes. Since maize grain is still the major crop utilized for bioethanol production, over 
expression of a starch-degrading enzyme in maize seeds can increase starch digestibility, avoid 
chemical pretreatments such as acid (Chung and Lai 2006) or protease (Pérez-Carrillo et al. 
2008), and make unnecessary the addition of commercial starch degrading enzymes. The 
technology of transgenic plants expressing alpha amylase and APU has been patented 
(Lanahan et al. 2006, US Patent No.: 7,102,057 B2; Yu and Fu, 2004, US Patent No.: 6,737,563 
B2), respectively. The patents describe that this technology is feasible to produce functional 
enzymes and allow self-starch processing in plants. Syngenta AG has also released and 
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commercialized Enogen™, a maize hybrid expressing alpha amylase for efficient starch 
hydrolysis and higher bioethanol yields 
(http://www.syngenta.com/country/us/en/enogen/Pages/Home.aspx). Here we report 
generating transgenic maize seeds overexpressing APU gene from T. thermohydrosulfuricus 
and utilizing these APU-expressing seeds for bioethanol production without adding external 
enzymes. Our study showed that incubation of the APU maize slurry at 80°C resulted in starch 
digestion into smaller sugar molecules. Extended incubation for several hours followed by 
yeast fermentation resulted in the production of bioethanol. This finding is important for easier 
bioethanol production from maize grains and reducing the burden of the starch hydrolysis 
process.   
   
Materials and Methods 
DNA Construct  
APU gene of Thermoanaerobacter thermohydrosulfuricus is a 5 kb long gene. Site-directed 
mutagenesis study revealed a 3-kb region (nucleotide 2899-5678) of the gene was essential for 
enzyme activity (Saha et al. 1990). Truncated APU (nucleotide 2899-5678 GenBank No. 
AAA23201) was codon-optimized based on the codon usage frequencies for maize expression 
(http://www.kazusa.or.jp/codon/) and synthesized (Genscript, Piscataway, NJ). Vector 
construct of APU expression in maize endosperm is depicted in Figure 1. APU expression was 
driven by 27-γ zein endosperm specific promoter (Marks et al. 1985). A FLAG-epitope tag 
(Knappik and Pluckthun 1994) was fused in the N-terminal of APU and maize γ-zein signal 
peptide (Marks et al. 1985) was added in the 5’ end of the APU gene. C-terminal SEKDEL 
(ER-retention signal) (Munro and Pelham 1987) and VSP (soybean vegetative storage protein) 
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terminator (Mason et al. 1993) were added downstream of the APU gene, respectively. A 
complete APU DNA cassette was cloned into the Pst I-EcoR I sites of pTF101.1 (Paz et al. 
2004) binary vector containing bar gene conferring bialaphos (herbicide) resistance as a 
screenable marker for putative transgenic events to obtain the pNAP03 construct. The vector 
construct pNAP03 was transformed into Agrobacterium tumefaciens EHA101. 
 
Maize transformation 
Immature zygotic embryo of the Hi-II maize genotype was utilized in the transformation 
activity (Frame et al. 2002). Maize Hi-II immature embryos were infected with A. tumefaciens 
EHA101 carrying pNAP03 plasmid by the Plant Transformation Facility of Iowa State 
University. Bialaphos was applied to screen putative transgenic events. Transgenic plants were 
generated and advanced in the greenhouse to obtain T1 seeds. APU transgenic maize was self-
crossed or backcrossed with B73 for seeds propagation.  
 
Southern blot analysis  
Copy numbers of the APU transgene were determined by Southern blot. Genomic DNA was 
prepared from young leaves of T1 plants as described by (Murray and Thompson 1980). 
Aliquots (10 µg) of genomic DNA were digested with Hind III enzyme then digestion products 
were separated in 0.8 % agarose gel. Digested DNA was cross-linked into a membrane 
(Ambion® BrightStar®-Plus Positively Charged Nylon Membrane) using a cross-linker 
apparatus then pre-hybridized in Church’s buffer for 2 hours at 65 °C before the probe was 
added. An APU specific probe was amplified from pNAP03 plasmid by PCR using forward 
(5’ TGTAGGTGATTTGCGTG 3’) and reverse (5’ TGTCTCTCCACCTTGACTCT 3’) 
primer pair (Figure 1). The probe was labeled with 32P dCTP and hybridized to the membrane, 
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followed by an overnight incubation at 65 °C. The membrane was washed 4 times with high 
stringency washing solution. The film was developed after 16 hours exposure at -80 °C. 
 
RNA isolation and RT-PCR 
APU transcription level was analyzed using reverse-transcriptase PCR (RT-PCR) method. 
Total RNA was extracted using Qiagen RNeasy Plant Mini kit (Qiagen Inc, Valencia, CA) 
following supplier’s instructions. Complementary DNA (cDNA) was synthesized from 1 µg 
of the total RNA using SuperSCript™ II reverse transcriptase (Invitrogen, Grand Island, NY) 
in a total volume of 50 µl. An aliquot of 5 µl cDNA (100 ng) was used as template for PCR to 
amplify approximately 800 bp of APU fragment using the same primer pair utilized for 
Southern blot analysis. Forward (5’ ATTCAGGTGATGGTGTGAGCCACAC 3’) and reverse 
(5’GCCACCGATCCAGACACTGTACTTCC 3’) actin primers were used as internal control 
of housekeeping gene. Equal amounts of PCR product were loaded into each well and 
transcription level was determined semi-quantitatively. 
 
Protein extraction and protein concentration determination 
A single maize kernel was ground into powder using Genogrinder 2000 at 550 stroke/ min for 
90 seconds at the Iowa State University Plant Tissue and Seed Grinding Facility. Maize powder 
was resuspended in 10 µl of sodium phosphate buffer (pH 6.6) supplemented with cocktail 
proteases per mg of maize powder as described (Moeller et al. 2009). Sample was incubated 
with shaking at 37 °C for 2 hours then centrifuged in a tabletop microcentrifuge at 13,000 rpm 
for 20 minutes. The supernatant was aliquoted into a new tube. Total soluble protein (TSP) 
concentration was measured with the Bradford method (Bradford 1976) using BSA (bovine 
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serum albumin) as standard. Protein extract was used for the Western blot, enzyme activity 
and immunoprecipitaion assays. 
 
Western blot 
Aliquots (20 µg) of protein extract from a maize kernel were boiled for 5 minutes (Laemmli 
1970). Samples were loaded into 4-15 % SDS gel (Bio-Rad) and separated at 110 volts for 90 
minutes. Western blot was carried out at room temperature unless otherwise stated. The gel 
was transferred onto a 0.2 μm nitrocellulose membrane using semi-dry blot transfer apparatus 
(Bio-Rad, Hercules, CA) following manufacturer’s instructions. The membrane was blocked 
with 5 % non-fat dry milk in phosphate buffered saline [PBS: 137 mM NaCl, 10 mM Na2HPO4, 
1.76 mM KH2PO4, pH 7.4] for 2 hours followed by washing 4 times with PBST [PBS-0.05 % 
Tween-20 (v/v)]. The membrane was probed with a 1:5,000 dilution of anti-DYKDDDD 
monoclonal antibody produced in mice (Genscript, Piscataway, NJ). The membrane was 
incubated with horseradish peroxide (HRP)-conjugated goat-anti-mouse-IgG secondary 
antibody (Sigma Aldrich, St. Louis, MO) in a 1:5,000 dilution then washed 4 times with PBST. 
The membrane was incubated with sure blue TMB substrate (KPL, Gaithersburg, MD) for 20 
minutes at room temperature for protein visualization. 
 
Determination of APU activity 
APU enzyme activity was measured with the dinitrosalycyclic acid (DNS) method (Miller 
1959) as described by (Mathupala et al. 1993). A mixture containing 40 µl of maize seed 
protein extract and 160 µl of 1.25 % pullulan in 50 mM acetate buffer (pH 6.0) containing 5 
mM calcium chloride was incubated at 85 °C for 30 minutes. The reaction was stopped by 
adding 800 µl DNS solution to the mixture, and then the sample was boiled for 15 minutes and 
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directly cooled down on ice. The samples were brought back to room temperature before 
measuring the absorbance at 635 nm. Enzyme activity was determined using glucose as 
standard. One unit of enzyme is defined as 1 µmole of glucose released per minute under assay 
conditions. 
 
Purification of APU enzyme and enterokinase cleavage 
Total protein extracted from 1 gram of maize powder was freeze-dried and diluted in 5 ml of 
Tris buffer saline [TBS: 50 mM Tris-Cl, 150 mM NaCl, pH 7.5]. The FLAG-APU fusion 
protein was captured by passing the protein extract onto a chromatography column containing 
anti-DYKDDDDK IP resin (Genscript, Piscataway, NJ). The sample was incubated at 9 °C 
while gently shaking in a rotary shaker for 16 hours. The next day, flow through was collected 
and the resin was washed 4 times with TBS. FLAG-APU bound to the resin was eluted in 5 M 
sodium chloride and concentrated using a microcon tube (EMD-Milipore, Billerica, MA) then 
diluted in PBS. Purified FLAG-APU protein was tested for Western blot, enterokinase 
cleavage and enzyme activity analyses. Enterokinase cleavage was carried out by digesting 4.2 
μg of FLAG-APU protein with 10 units of enterokinase (E4906, Sigma Aldrich, St. Louis, 
MO) in a total volume of 50 μl at room temperature for 16 hours. Enterokinase was removed 
using trypsin inhibitor resin (T0637, Sigma Aldrich, St. Louis, MO) according to 
manufacturer’s instructions. Both purified APU before and after enterokinase removal were 
utilized in enzyme assay and western blot.  
 
Starch hydrolysis and scanning electron microscope (SEM) 
Non-transgenic (negative segregant) and transgenic maize seeds were ground into powder as 
described above in the protein extraction protocol. Acetate buffer containing 5 mM CaCl2 (pH 
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6.0) was added to make a 1 % maize slurry. Samples were incubated at room temperature or 
85 °C for 30 minutes. Starch was isolated using the protocol described by (Li et al. 2008). 
Briefly, the samples were filtered through 4 layers of miracloth and the starch fraction was 
recovered by centrifugation (Avanti® J-E, Beckman Coulter) at 5000g for 10 minutes. The 
starch pellet was resuspended in 0.1 M NaCl containing 10 % toluene and then vortexed for 1 
hour. This step was repeated two more times or until clean starch was obtained. Subsequently, 
the starch was washed 3 times with distilled water and 2 times with absolute ethanol. Starch 
samples were oven-dried at 40 °C for 48 hours. Starch granule morphology was analyzed using 
an electron microscope at the Microscopy and Nanoimaging Facility of Iowa State University 
(ISU). Starch granules were mounted on silver tape and coated with gold:palladium (60:40) 
(Jane et al. 1994) then observed under digital JEOL 5800LV SEM at 1500 and 5000x 
magnitudes. 
 
Starch hydrolysis and direct bioethanol production from TrAPU maize 
Non-transgenic maize and TrAPU maize was ground into fine powder as described above. 
Starch content was measured beforehand using Total Starch (AA/AMG) kit from Megazyme 
(Bray, Ireland) following manufacturer’s instructions. A total of 100 mg maize powder was 
suspended in 10 ml of sodium acetate buffer (pH 6.0) to a final concentration of 1 %. Starch 
hydrolysis products were analyzed using thin layer chromatography (TLC) assay. TrAPU 
maize slurry was incubated at 80 °C for different periods of time (1, 3, and 4 hours or 4 hours 
plus extended incubation at 30 °C for 72 hours) and at 30 °C for 4 hours. Non-transgenic maize 
was digested with commercial α-amylase (A3403, Sigma, St. Louis, MO) at 80 °C for 90 
minutes followed by digestion with AMG (amyloglucosidase) (A7095, Sigma, St. Louis, MO) 
at 60 °C for 2 hours or incubated at 80 °C for 4 hours without enzymes addition.. Measurement 
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of bioethanol yield was carried out as follows: one gram of samples were incubated at 80 °C 
for 4 hours with or without subsequent hydrolysis with 3 units of AMG for 2 hours at 60 °C 
according to manufacturer’s instructions. The process was continued by adding 0.03 % (w/w) 
ammonium sulfate and 0.02 gram dry yeast Saccharomyces cerevisiae (Lesaffre Yeast Co., 
Milwaukee, WI). Fermentation was carried out at 30 °C for 72 hours and bioethanol yield was 
measured using high-performance liquid chromatography (HPLC).   
 
Statistical analysis 
Statistical analysis was performed using JMP 10 software (SAS Institute Inc., Cary, NC, USA). 
Data was analyzed using analysis of variance. Comparison of APU activity between lines 27, 
57 and 61 was analyzed using Student’s t-test. Comparison of reducing sugars concentration 
for bioethanol assay was analyzed with Duncan’s multiple range test. 
 
Results and Discussion 
Seed-specific expression of truncated (Tr)APU 
Characterization of APU gene from T. thermohydrosulfuricum has been studied by 
(Mathupala et al. 1993). Full-length APU encodes for a 5-kb long gene consists of an N-
terminal region for enzyme secretion and C-terminal region as a carbohydrate binding domain. 
Truncation of this APU gene in the size 2,933 bp (from nucleotide 2899-5678) carrying a 
single active site for alpha-amylase and pullulanase resulted in fully functional enzyme activity 
(Mathupala et al. 1993). Report by Lin et al. (2008) provided evidence that truncation of the 
C-terminal region of APU gene did not cause harmful effects to the enzyme function. 
In our study, the truncated APU (later referred as TrAPU) was codon optimized for 
maize expression. Codon-bias should be carefully taken into account when expressing a 
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prokaryotic gene in a eukaryotic system as it might affect protein translation efficiency 
(Campbell and Gowri 1990; Kurland 1991; Gustafsson et al. 2004). Codon-bias modification 
also has been shown to correlate with an increase in gene expression in plant. Higher 
accumulations of phytase was observed in Brassica napus transformed with codon-optimized 
Aspergillus niger phytase gene as compared to plant transformed with the native form the gene 
(Peng et al. 2006).  
APU expression cassette in maize (pNAP03) is depicted in Figure 1. Heterologous 
TrAPU gene expression was regulated by maize 27-γ zein promoter and a soybean VSP 
terminator. Maize zein signal peptide was added to the 5’ end of the APU gene to lead protein 
expression into the secretory pathway that has been shown to play role in recombinant protein 
accumulation in maize seeds (Yang et al. 2002; Moeller et al. 2009). We attached SEKDEL to 
the C-terminal of the TrAPU gene to retain the protein inside the endoplasmic reticulum (ER). 
This motif was sufficient to retain recombinant protein inside the ER and avoid further 
processing that might result in protein degradation (Munro and Pelham 1987). Previous studies 
showed enhanced recombinant protein expression when the gene of interest was fused with a 
KDEL motif (Spiegel et al. 1999; Peng et al. 2006). Marker peptide DYKDDDDK (FLAG™) 
was added to facilitate recombinant protein detection. This peptide can be fused to the N- or 
C- terminal of a protein. Its hydrophilic property exposes it to the surface, thus it does not 
interfere with the protein folding. This peptide can be cleaved by an enterokinase that 
recognizes the (DDDDK) amino acid sequence resulting in marker free protein (Einhauer and 
Jungbauer 2001).  
Vector construct pNAP03 was introduced into maize via Agrobacterium-mediated 
transformation. A total of 21 putative transgenic lines were generated. Enzymatic assay using 
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DNS method, a method used for estimating reducing sugar, was carried out to screen T1 
generation. Out of 21 lines, five lines (14, 27, 47, 57, and 61) that performed high enzyme 
activity (Table 1) were advanced to generate T2 seeds by self-pollination. Based on T2 
generation DNS assay data, three lines (27, 57, and 61) with the highest APU activities were 
chosen for further seeds production and analysis (data not shown). No noticeable phonotypical 
differences such as height or yield variance were detected in any of these lines (data not 
shown). 
Agrobacterium-mediated transformation is a commonly used technique to transform 
plants because of its stability and low copy number transgene integration into the plant genome 
(Shou et al. 2004). Single copy transgene is desirable because multiple copy numbers often 
leads to silencing or partial transgene expression (Flavell 1994; Stam et al. 1997). Southern 
blot was performed to verify transgene integration and TrAPU transgene copy numbers. Based 
on seed quantities and viability, eight transgenic lines were selected for Southern blot analysis. 
Genomic DNA from young leaves of T1 plants were digested with restriction enzyme Hind III. 
PCR-amplified 32P-labeled TrAPU probe was used to hybridize the genomic DNA. Because 
Hind III cleaves only once in the T-DNA fragment (Fig. 1), transgene copy number can be 
estimated by the number of hybridization bands present on the autoradiography images. If the 
TrAPU gene is intact, the hybridization signals should have sizes larger than 3.9 kb. As can be 
seen from Figure 2, majority of events (6 out of 8) have low copy number (less than 3) 
transgene integration. Among them one event (line 78) has one single hybridization band 
greater than 8 kb. Line 12 showed one hybridization band smaller than 3 kb. It might be caused 
by partial transgene integration.  
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 In this study, transgene copy number did not correlate with TrAPU expression (Table 
1). Lines with multiple transgene copy numbers did not necessarily have high APU activity. 
For example, among 8 Southern positive lines, the line with the highest APU activity is line 
57 (8.82 unit/µg TSP) with average specific activity of 3.05±2.44 unit/µg TSP. This line carries 
4 transgene copies. Line 47 with 6 copies showed lower APU activity (2.37±0.53 unit/µg TSP) 
compared to line 57. Two 3-copy insertion lines (lines 12 and 60) have similar APU activities, 
0.81±0.23 and 1.24±0.43 unit/µg TSP, respectively. Three 2-copy insertion lines (lines 27, 51, 
and 61) gave a wide range of activities between 0.75±0.23 to 3.4±2.06 unit/µg TSP. The only 
single copy event (line 78) had moderate activity, 1.95±0.60 unit/µg TSP. Similar observations 
have also been reported in transgenic maize expressing the fungal laccase enzyme (Hood et al. 
2003). Transgenic plant with multiple transgenes did not necessarily have higher laccase 
compared to transgenic plant carrying a single copy transgene. On the other hand, T-DNA 
could be tandemly inserted into the same chromosome, which may lead to a silencing effect 
due to RNA duplex formation during transcription that triggers RNAi mechanism (Schubert 
2006). 
 
TrAPU expression in transgenic maize  
Transcript level of TrAPU at different seed developmental stages was analyzed using 
RT-PCR. Immature maize seeds harvested at 10 and 20 DAP (day after pollination) and mature 
seeds from two potential lines (27 and 61) were analyzed. Total RNA isolated from individual 
transgenic kernel of lines 27 and 61 showed TrAPU transcription was highly present in 
immature seeds at 10 and 20 DAP and very low in mature seeds (Fig. 3a). This observation 
exhibited typical zein protein expression patterns. Zein is a major storage protein in maize and 
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constitutes 50-60 % of maize total protein. Accumulation of this protein started at 10-12 DAP 
and achieved its maximum level at 18-22 DAP (Monjardino et al. 2006). Typically the zein 
transcripts are high in immature seeds but reduced gradually during the maturation process 
(Teixeira et al. 2009). Reduced TrAPU transcript levels observed in the mature seeds here is 
likely due to the translation of transcripts into protein.  
Analysis of TrAPU expression was also conducted in different tissues by comparing 
the transcript level in leaves, roots, and seeds that were sampled from the same plant. For line 
27, TrAPU transcripts can only be detected in immature seeds, not in leaves or roots, as 
expected (Fig. 3b). However, in line 61 TrAPU expression can be observed in all tissues tested, 
which is contrary to the native activity of an endosperm specific promoter. This discrepancy 
has also been observed in transgenic plants driven by the 27-γ zein promoter as studied by 
(Russell and Fromm 1997). In that study, five out of 17 maize transgenic lines tested showed 
non-endosperm transgene expression (including leaf, pollen, embryo and maternal seed 
tissue). One possible explanation is that the transgene might be inserted behind regulatory 
elements that override the tissue specific promoter (Mark Tucker, personal communication).  
APU protein production was detected using western blot against an anti-DYKDDDDK 
antibody (Fig. 4). Two PCR-positive kernels from each line (27, 57, and 61) were examined. 
Equal amount of total protein extracted from single kernel (20 µg) was loaded into SDS-PAGE 
gel. Figure 4 shows that APU protein expression varied among lines. Line 57 showed the 
highest APU, while line 27 had the lowest APU level.  
To further examine the transgenic lines, enzymatic activity of APU was determined 
using DNS assay under optimum conditions at 85 °C for 30 minutes (Saha et al. 1991). Three 
transgenic lines, 27, 57 and, 61, were tested and non-transgenic B73 maize was utilized as a 
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negative control. Only PCR positive seeds were pooled and used for the analysis. The APU 
specific activity of each line was the average specific activity of at least 8 positive single 
kernels from three technical replications. Similarly, the enzyme specific activity was different 
between transgenic lines (27, 57, and 61) indicating variability of APU accumulation in maize 
seeds (Fig. 5). Line 57 showed the highest specific activity (23 unit/µg TSP) and line 27 
showed the lowest APU activity. Comparison of the APU activity between line 27 and lines 
57, and 61 is statistically significant (p < 0.05). No significant difference was observed 
between lines 57 and 61. There was negligible enzyme activity in non-transgenic maize (B73). 
This result showed that protein expression is correlated with enzyme activity. The high enzyme 
activity observed in line 57 was correlated with the high accumulation of the APU protein in 
this line. On the other hand, the low enzyme activity of line 27 was correlated with the low 
APU protein accumulation.  
Chiang et al (2005) showed that the expression of truncated APU in transgenic rice 
seeds led to the auto hydrolysis of starch into glucose at high temperature. They reported that 
the highest APU specific activity in rice seeds was 160 unit/min/μg TSP. This is approximately 
7-times higher than what we observed in maize seeds. One possible explanation could be the 
different starch properties and gelatinization temperatures (GT) of the maize and rice grains 
used in these studies. In general, maize has onset GT at 58.3 °C and peak temperature at 83 °C 
(Clomburg and Gonzalez 2010). On the other hand, gelatinization in Japonica rice seeds 
(Tainung 67, (Chiang et al. 2005)) generally occurs at 55-80 °C (Huang et al. 2009). The APU 
assays in Chiang’s work and this study were performed at 85 °C. It is speculated that more 
starch molecules were gelatinized and available for enzyme attack in rice grains than in maize 
grain at this temperature, which led to a higher APU specific activity value in rice.  
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Tissue specificity of the 27 gamma zein promoter in seeds has been studied previously. 
Heterologous expression of E. coli heat-labile enterotoxin (LT-B) driven by this promoter 
demonstrated recombinant protein accumulation in the starch granules of maize kernels 
(Chikwamba et al. 2003). To examine the main accumulation of the APU enzyme in transgenic 
maize lines used in this study, twenty maize kernels of lines 27, 57, and 61 were dissected and 
separated between germ and endosperm. Negative segregant from each line was utilized as 
negative control. Protein was extracted from both fractions and enzyme activity was measured. 
Results showed that APU activity was mainly observed in the endosperm fraction indicating 
its accumulation in this tissue (Fig. 6). It is interesting to note that no APU activity was detected 
in embryo fraction of line 61, even though APU transcripts were found in its leaf and root (Fig. 
3b). Because the leaf and root expression of APU transcripts, one would expect some level of 
APU enzymatic activity in embryos if the 27-kD gamma zein promoter lost its endosperm 
specificity. Further investigation is required to understand this phenomenon.   
  
FLAG™ did not interfere with TrAPU enzyme activity 
 The fusion tag known as FLAG™ is a water soluble antigenic marker peptide consists 
of eight amino acids (AspTyrLysAspAspAspAspLys/DYKDDDDK) that can be digested by 
protease to generate marker free protein (Einhauer and Jungbauer 2001). The APU enzyme 
was purified using immunoprecipitation method. Total protein (crude extract) isolated from 
seeds of line 57 (Fig. 7, lane 3) was loaded onto a column containing anti-DYKDDDDK 
agarose beads. The flow-through contained unbound APU protein (Fig. 7, lane 2). Pure APU 
was pulled down from the resin and concentrated. Each fraction was tested using western blot 
and enzyme activity assays (Fig.7 and Table 2). A total of 6.4 % of the APU enzyme was 
recovered (Fig. 7, lane 6) with a specific activity of 105.5 unit/µg TSP or 10 times higher 
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compared to the crude extract. Purified fusion FLAG-APU protein was digested with 
enterokinase (Fig. 7, lane 4) to test the effect of the FLAG tag on APU enzyme activity. As 
can be seen in Figure 7 (Lanes 4, 5 and 7), no APU band was detected using anti-FLAG 
antibody in Western analysis in samples treated with enterokinase, suggesting that FLAG was 
no longer attached to the APU enzyme. When FLAG-removed APU sample (Fig. 7, lane 7) 
was measured for APU enzyme activity, the assay showed that similar values of specific 
activity were obtained (Table 2). These results suggest that FLAG does not interfere with 
enzyme activity.  
 
Scanning electron microscope (SEM) 
 To examine whether spontaneous starch hydrolysis actually happened in APU maize, 
we performed SEM analysis on starch granules from both TrAPU and non-transgenic maize 
seeds after incubation at room temperature (22 °C) or 85 °C for 30 minutes. Starch granules 
are packed tightly in grains. Heat treatment or gelatinization can break the granules physically 
and open them for enzyme attack. Enzyme treatment on starch granules causes their 
degradation (Singh and Soni 2001). Damaged granules can be observed under such conditions 
(Naguleswaran et al. 2012).  
 As can be seen in Figure 8a and d, starch granules of TrAPU (line 57) and non-
transgenic maize at room temperature had an irregular and polygonal shape, similar 
observations were also reported by Naguleswaran et al. (2012). However, high temperature 
treatment at 85 °C of these starch samples showed that most granules of TrAPU maize were 
digested and some were broken, suggesting there was starch hydrolysis (Fig. 8e and f). On the 
other hand, heat treatment on starch granules of non-transgenic maize caused their shape 
deformation, but broken granules were hardly seen (Fig. 8b and c). The same observation has 
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been previously reported (Chung and Lai 2006; Jane et al. 1994). In these studies, maize starch 
treated with glucoamylase at 50 °C caused erosion on granule surface. Longer incubation time 
showed a more damage on granule surface (Naguleswaran et al. 2012).  
 
Sugar product analysis of TrAPU maize 
 To evaluate whether transgenic TrAPU maize seeds can be used directly for bioethanol 
production, we performed direct hydrolysis and analyzed the sugar products with thin layer 
chromatography (TLC). Because APU possesses dual enzymatic activities, we expected that 
its amylase part can hydrolyze the α-1,4 bonds and its pullulanase part can hydrolyze α-1,6 
glycosidic bonds to facilitate the production of glucose (G1), maltose (G2), or maltotriose (G3) 
(Mathupala et al. 1990). In this experiment, we included non-transgenic maize seeds that were 
incubated with the commercial grade enzymes α-amylase and amyloglucosidase (AMG), two 
commonly used enzymes in the starch degradation process, as our positive control. 
 As shown in Figure 9 (lane 3), the incubation of TrAPU maize line 57 at 80 °C for 1 
hour without addition of any external enzyme led to an autonomous starch digestion process. 
Most products were sugar molecules G1-G4 (glucose, maltose, maltotriose and maltotetraose). 
Maize-derived APU action was more efficient after 60 min incubation (lane 3) compared with 
non-transgenic maize hydrolyzed with commercial α-amylase for 90 min (lane 1). The non-
transgenic maize hydrolyzed with commercial α-amylase produced a wide spectrum of 
oligosaccharides and dextrin larger than G4 (lane 1), which cannot be utilized by yeast for 
ethanol fermentation.  There was also a substantial amount of starch not being hydrolyzed, 
which remained at the origin.  
On the other hand, the TrAPU maize was not as efficient as the non-transgenic maize 
that was hydrolyzed with both α-amylase and AMG (Fig. 9 lane 2). Complete conversion of 
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starch into glucose (G1) was observed in this sample. AMG cleaves starch from the non-
reducing end releasing glucose (Saha and Zeikus 1989). Starch hydrolysis of TrAPU maize 
was inefficient at 30 °C suggesting that APU enzyme had little activity at this temperature 
(Fig. 9 lane 7). Non-transgenic maize, as a negative control (Fig. 9 lane 8), showed little starch 
was hydrolyzed after being incubated at 80 °C for 4 hours. G1 spots observed in TrAPU maize 
incubated at 30 °C (Fig. 9 lane 7) and non-transgenic maize incubated at 80 °C (Fig. 9 lane 8) 
are likely products of endogenous starch hydrolysis activity in these samples. 
Longer incubation times (up to 4 hours) of TrAPU maize (Fig. 9 lane 3-5) showed that 
more starch molecules were converted into G1-G4 as indicated by the disappearance of sugar 
molecules larger than G5 and diminishing of undigested starch spot at the origin. Extended 
incubation for 72 hours at 30 °C after the 80 °C incubation for 4 hours did not give noticeable 
difference (Fig. 9 lane 6). Reducing sugar content analysis (Table 3) showed that TrAPU maize 
produced higher reducing sugar concentration (29.6±0.26 mg/100 mg maize) as compared with 
non-transgenic maize (8.1±0.07 mg/100 mg maize) when they were both incubated at 80°C. 
Addition of AMG in the TrAPU maize reaction resulted reducing sugar concentration (64.3 ± 
0.15 mg/100 mg maize) that was nearly the same with non-transgenic maize degraded with 
AMG (64.1 ± 0.13 mg/100 mg maize). 
Studies on enzyme hydrolysis pattern of the APU from T. ethanolicus (Saha et al. 1991) 
and Thermoanaerobacter strain B6A (Saha et al. 1990) showed glucose molecules and G2-G4 
as the main products of starch hydrolysis from different substrates (amylose; amylopectin; and 
soluble starch). Characterization of APU from Geobacillus stearothermophilus demonstrated 
maltose and maltotriose (G2-G3) were produced from starch (Zareian et al. 2010). In this 
study, sugar molecules G2-G4 were also major products produced during TrAPU maize starch 
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hydrolysis. Liquefaction of transgenic rice seeds expressing alpha amylase from B. 
stearothermophilus resulted in G5 sugar as the major product while G1-G3 were also detected 
(Xu et al. 2008a). Most of the sugar molecules were nearly converted into G1 when transgenic 
rice seeds expressing glucoamylase from A. awamori was added in the reaction (Xu et al. 
2008b).  
 
Maize-derived APU enhances bioethanol production 
Starch hydrolysis was followed by yeast fermentation to determine bioethanol 
production from TrAPU maize. Bioethanol yield measured by HPLC showed that TrAPU 
maize alone, without adding other enzymes, produced 14.7±0.90 g ethanol/100 grams of maize 
or a 40.2±2.63 % ethanol conversion of maize starch (Table 3). Yeast was able to effectively 
use G1 and G2 for fermentation but was not as efficiently using G3, and could not utilize G4 
(Nout and Bartelt 1998; Zastrow et al. 2001). It is likely that G2 and G3,  major products of 
APU hydrolysis, were utilized by yeast  to produce bioethanol from the corn sample. On the 
contrary, non-transgenic maize produced little ethanol (0.02±0.01 g ethanol/ 100 g of maize) 
when treated under the same condition. The bioethanol yield of TrAPU maize was about half 
of the bioethanol produced using non-transgenic maize hydrolyzed with AMG (32.7±0.52 g 
ethanol/100 gram of maize, 87.2±1.62 % conversion). Addition of AMG to the TrAPU maize 
increased ethanol yield and conversion efficiency to 33.1±0.66 g ethanol/100 mg maize and 
90.5±1.69%, respectively.  
 
Conclusion 
Starch is an important feedstock for bioethanol production. Starchy biomass is still 
preferred over cellulose because of its abundance and established processing. However, large 
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amounts of amylase enzyme and energy are needed during starch hydrolysis, which form the 
main avenues for improvement. One way to solve this problem is to express a starch-degrading 
enzyme in starch accumulating crop so the external enzymes needed for the hydrolysis could 
be reduced or omitted.  
Our study provided evidence that expression of a truncated version of the bacterial T. 
thermohydrosulfuricus APU enzyme in maize seed can enhance starch processing efficiency 
for bioethanol production. While our current expression level and experimental design does 
not provide 100% ethanol conversion, this study demonstrated the feasibility of such an 
approach. Future research on enhanced APU production and simultaneous saccharification 
fermentation may further improve bioethanol yield.  
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Table 1. Summary of transgene copy number and relative APU activity of T1 transgenic 
TrAPU maize lines
 
 
 
  
No Event ID Highest APU specific 
activity (unita /µg TSP)
APU specific 
activity ± SDb
Southern
copy #
1 4 2.48 1.94 ± 0.51 ND
2 5 1.47 0.99 ± 0.35 ND
3 6 3.12 2.03 ± 0.72 ND
4 7 4.10 2.82 ± 0.59 ND
5 11 3.80 3.62 ± 1.65 ND
6 12 1.23 0.81 ± 0.23 3
7 14 3.60 3.28 ± 1.80 ND
8 19 1.10 1.02 ± 0.37 ND
9 27 4.78 2.34 ± 0.93 2
10 47 3.52 2.37 ± 0.53 6
11 51 1.12 0.75 ± 0.23 2
12 53 2.03 1.19 ± 0.31 ND
13 57 8.82 3.05 ± 2.44 4
14 58 2.36 2.07 ± 0.32 ND
15 60 1.61 1.24 ± 0.43 3
16 61 6.81 3.4 ± 2.06 2
17 65 1.59 1.28 ± 0.22 ND
18 66 2.04 1.83 ± 0.32 ND
19 68 1.57 1.25 ± 0.28 ND
20 69 2.98 2.10 ± 0.52 ND
21 78 2.84 1.95 ± 0.60 1
22 WT 2.05 1.23 ± 0.37 0
ND: not-determined
WT: non-transgenic maize B73 inbred
a: One unit o f enzyme is defined as 1 micromole glucose liberated per minute under assay conditions.
b: SD is standard deviation of the mean of four determinations
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Table 2. APU purification and enterokinase cleavage  
 
 
 
 
Table 3. Direct bioethanol production from TrAPU maize 
 
 
 
  
 
 
 
 
 
 
 
 
Samples Yield 
(%)
Glucose 
(mM) 
Unita Specific activity 
(unit/µg TSP) 
Crude extract 100 21.84 728.03 11.03
Flow  through 90 10.33 344.24 5.74
FLAG-APU 6.4 13.29 443.07 105.5
APU after FLAG removal - 12.81 427 101.65
FLAG elution - - - - 
WT - 1.36 45.2 1.03
Positive control* - 5.02 167.4 3.28
a: One unit o f enzyme is defined as 1 micromole glucose liberated per minute under assay conditions. 
* Pullulanase purchased from Sigma was used as positive contro l.
Samples 
Starch content 
(%) 
Reducing sugars
(mg/100 mg) 
Ethanol yield 
(g/100 g) 
Conversion efficiency e
(%) 
WT 66.1 ± 0.50 8.1 ± 0.07a 0.02 ± 0.01a 0.8 ± 0.29a
WT + 3u AMG 66.1 ± 0.50 64.1 ± 0.13c 32.7 ± 0.52c 87.2 ± 1.62c
TrAPU maize 64.5 ± 0.39 29.6 ± 0.26b 14.7 ± 0.90b 40.2 ± 2.63b
TrAPU maize + 3u AMG 64.5 ± 0.39 64.3 ± 0.15c 33.1 ± 0.66c 90.5 ± 1.69d
The values with different superscripts within a column are significantly different (P < 0.05) by Duncan’s multiple range test.
e: Conversion efficiency (%) = 100 × ethanol yield/ starch content/ theoretical yield of ethanol (56.73)
WT: wild type Hi II maize
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Figure 1. Schematic diagram of T-DNA region in vector pNAP03. Codon-optimized 
TrAPU gene driven by 27 gamma zein promoter (P27γz) was transformed into maize immature 
embryo via Agrobacterium-mediated transformation. zSP, maize γ-zein signal peptide; 
FLAG, epitope-tag; SEKDEL, endoplasmic reticulum retention signal; TVSP, soybean 
vegetative storage protein gene terminator; bar: bialaphos resistance gene; P35S, the 
cauliflower mosaic virus 35S promoter; LB: Agrobacterium T-DNA Left border; RB, 
Agrobacterium T-DNA right border; Pst I, Hind III, and Sac I, restriction enzymes; kb, 
kilobases.  
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Figure 2. Southern blot analysis of TrAPU transgenic maize (lines 12, 27, 47, 51, 60, 61, 
78, and 57). Genomic DNA (10 µg) from eight bialaphos resistance lines and 75 pg of pNAP03 
were digested with Hind III and separated on 0.8 % agarose gel. Digestion products were 
transferred into nitrocellulose membrane before being hybridized with TrAPU probe. pNAP03, 
TrAPU construct plasmid as positive control; WT, non-transgenic B73 inbred line as negative 
control; kb, kilobases. 
  
kb 
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Figure 3. Reverse transcriptase PCR analysis of two TrAPU transgenic maize (lines 27 
and 61) at different developmental stages (a) and different organs (b). RNA was extracted 
from 1 to 2 samples of immature seeds (10 and 20 DAP), mature seeds (Mature), leaves or 
roots. Actin primer is utilized as internal control. MW, molecular weight marker; ddH2O, 
distilled water as template of negative control; pNAP03, TrAPU construct plasmid control; 
WT, mature seed of non-transgenic maize inbred B73; DAP, days after pollination.  
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Figure 4. Immunoblotting analysis of TrAPU transgenic maize (lines 27, 57, and 61). Two 
single kernels were analyzed from each line. Total protein (20 µg) extracted from single mature 
kernel was loaded into each well. APU protein was detected using anti-DYKDDDDK tag 
antibody. kDa, kilodalton; WT, B73 non-transgenic maize inbred.  
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Figure 5. APU enzyme specific activity of TrAPU transgenic maize (lines 27, 57, and 61). 
Three ears from each line were analyzed. Each ear represents a pool of at least 8 T3 
generation transgenic seeds. WT, non-transgenic maize B73 inbred. Protein extract mixed with 
1.25% pullulan substrate was incubated at 85 °C for 30 minutes. One unit of enzyme is defined 
as 1 micromole of glucose liberated per minute under assay conditions. Asterisk (*) indicate 
statistically different at (P < 0.05). Error bars represent standard deviation of mean from 3 
technical determinations.  
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Figure 6. Accumulations of TrAPU enzyme in endosperm and embryo of mature seed 
from three transgenic maize lines (27, 57, and 61). WT, pool of non-transgenic segregant 
maize seeds from lines (27, 57, and 61); TSP, total soluble protein. Error bars represent 
standard deviation of mean from 3 technical determinations. 
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Figure 7. Western analysis of TrAPU purified by FLAG-epitope based 
immunoprecipitation using anti-FLAG antibody. Lane M01, A 52-kDa multiple tagged 
fusion protein (arrow head) as positive control (M0101, Genscript, Piscataway, NJ); Lane 1, 
protein extract of non-transgenic B73 inbred; Lane 2, recovered liquid sample (flow through) 
passing through the FLAG column; Lane 3, crude protein extract of TrAPU seeds; Lane 4, 
FLAG column purified protein sample digested with enterokinase; Lane 5, FLAG column 
elution sample after enterokinase cleavage; Lane 6, FLAG column purified protein; Lane 7, 
recovered liquid sample passing through FLAG column after FLAG removal with 
enterokinase. kDa, kilodalton.  
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Figure 8. Scanning electron micrograph of starch granules isolated from maize mature 
seeds. Non-transgenic maize starch samples were treated at room temperature (A), or at 85 °C 
(B and C) and TrAPU maize starch samples at room temperature (D) or at 85°C (E and F). 
Scale bar 50 µm (1500 X) for panels A, B, D and E; 10 µm (5000 X) for panels C and F.  
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Figure 9. TLC analysis of TrAPU maize hydrolysis products.  1% of wild type (WT) maize 
and TrAPU maize slurry was used in the experiment.  Lane S, standard; Lane 1, WT plus α-
amylase, 80 °C, 4 hr; Lane 2, WT plus α-amylase (80 °C, 4 hr) and AMG (60 °C, 2 hr); Lane 
3, TrAPU, 80 °C , 1 hr;  Lane 4, TrAPU, 80 °C, 3 hr;  Lane 5, TrAPU, 80 °C, 4 hr;  Lane 6, 
TrAPU,  80 °C, 4 hr, then 30 °C,  72 hr;  Lane 7, TrAPU, 30 °C, 4 hr; Lane 8, WT, 80 °C, 4 
hr. G1, glucose; G2, maltose; G3, maltotriose; G4, maltotetraose; G5, maltopentaose; G6, 
maltohexaose; G7, maltoheptaose.  
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CHAPTER 3: EXPRESSION OF H3N2 NUCLEOPROTEIN IN MAIZE SEEDS AND 
IMMUNOGENICITY IN MICE 
 
Modified from a paper published in Plant Cell Reports (2015) 34:969-980 
 
Hartinio N Nahampun, Brad Bosworth, Joan Cunnick, Mark Mogler, Kan Wang 
 
Key message: Oral administration of maize-expressed H3N2 nucleoprotein induced antibody 
responses in mice showing the immunogenicity of plant-derived antigen and its potential to be 
utilized as a universal flu vaccine. 
 
Abstract  
Influenza A viruses causes influenza epidemics that are devastating to humans and livestock. 
The vaccine for influenza needs to be reformulated every year to match the circulating strains 
due to virus mutation. Influenza virus nucleoprotein (NP) is a multifunctional RNA-binding 
protein that is highly conserved among strains, making it a potential candidate for a universal 
vaccine. In this study, the NP gene of H3N2 swine origin influenza virus was expressed in 
maize endosperm. Twelve transgenic maize lines were generated and analyzed for 
recombinant NP (rNP) expression. Transcript analysis showed the main accumulation of rNP 
in seed. Protein level of rNP in T1 transgenic maize seeds ranged from 8.0 – 35 µg of NP/g of 
corn seed. The level increased up to 70 µg of NP/g in T3 seeds. A mouse study was performed 
to test the immunogenicity of one line of maize-derived rNP (MNP). Mice were immunized 
with MNP in a prime-boost design. Oral gavage administration showed a humoral immune 
response was elicited in the mice treated with MNP indicating the immunogenicity of MNP. 
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NP-specific antibody responses in the MNP group showed comparable antibody titer with the 
groups receiving positive controls such as Vero cell-derived NP (VNP) or alphavirus replicon 
particle-derived NP (ANP). Cytokine analysis showed antigen specific stimulation of IL-4 
cytokine elicited in spleenocytes from mice treated with MNP further confirming a TH2 
humoral immune response induced by MNP administration.  
Keywords: nucleoprotein, H3N2, plant-based vaccine, antigens, transgenic maize  
 
Introduction 
Influenza A viruses are the causal agent of influenza epidemics that results in millions 
of dollars of economic loss and provoke serious health impacts due to morbidity to mortality. 
These viruses are found in many host organisms including birds (ducks and chickens), pigs, 
dogs and humans (Medina and García-Sastre 2011). Influenza A virus is a negative-sense RNA 
virus consisting of eight single stranded RNA fragments that encode for 11 or 12 viral proteins 
(Portela and Digard 2002; Hutchinson et al. 2010; Medina and García-Sastre 2011). Influenza 
A viruses are classified into subtypes based on the amino acid sequence of the hemaglutinin 
(HA) and neuraminidase (NA) glycoproteins. Currently, there are 16 HA subtypes and 9 NA 
subtypes of influenza viruses circulating in birds, while two strains H1N1 and H3N2 
commonly circulate in humans (Medina and García-Sastre 2011).  
The current practice of influenza vaccination is based on the surface antigens HA 
(Crawford et al. 1999; Steel et al. 2010; Kodihalli et al. 1999) and NA (Chen et al. 2000; Brett 
and Johansson 2005), which are the major proteins involved in the receptor binding to the host 
cells and release of progeny virions from host cells, respectively (Medina and García-Sastre 
2011; Chen et al. 2009). However, these glycoproteins are prone to mutation due to antigenic 
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shift and antigenic drift (Luo et al. 2012; Medina and García-Sastre 2011). These mechanisms 
have allowed the virus to develop into a new strain that may or may not result in cross-species 
transmission (Kuiken et al. 2006). For example, the swine origin 2009 H1N1 virus caused 
pandemic in humans (Medina and García-Sastre 2011; Garten et al. 2009). Consequently, the 
human influenza vaccine has to be reformulated each year to match the current circulating 
strain, because previous vaccines may not be effective for the new strain.  
Many studies have focused on the development of a universal vaccine based on 
conserved proteins such as the extracellular matrix protein (M2e), HA and nucleoprotein (NP). 
Conserved proteins are less likely to undergo mutation and thus, the vaccine does not need to 
be changed each year (Du et al. 2010). The purpose of a universal vaccine is to provide broad 
protection against heterosubtypic strains of influenza virus. This is important due to the fact 
that the development of strain specific vaccines can take months. Therefore, the universal 
vaccine can prevent or reduce the effects of an epidemic before the strain specific vaccine 
becomes available (Zheng et al. 2014).  
The sequence of the NP gene is 90 % conserved among influenza virus strains and 
types (Portela and Digard 2002; Epstein et al. 2005). This protein plays a role in virus genome 
transcription and replication (Turrell et al. 2013). Previous studies showed that NP protein is 
the major target for cross-reactive immune responses and a potential candidate for a universal 
vaccine (Yewdell et al. 1985; Townsend et al. 1985). Vaccination with NP protein (Wraith et 
al. 1987) or NP DNA (Luo et al. 2012; Epstein et al. 2002) in mice led to generation of NP 
specific cytotoxic T cells and virus clearance. Recombinant NP (rNP) has been expressed using 
different systems such as animal cells (Townsend et al. 1984), bacteria (Eschericia coli, 
Salmonella typhimurium) (Huang et al. 2012; Ashraf et al. 2011) and virus vectors (Crawford 
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et al. 1999; Epstein et al. 2005). However, there are limited studies related to immunogenicity 
of NP protein produced in plants.  
Plant molecular farming is considered as a feasible and relatively inexpensive system 
for large-scale production of pharmaceuticals (Ma et al. 2003). Transgenic plants are favorable 
over animals systems due to properties of scalability, speed, quality, and freedom from animal 
pathogens (Perea Arango et al. 2008; Rybicki 2010; Rosales-Mendoza and Salazar-Gonzalez 
2014). The attempts and success of pharmaceutical protein production such as antibodies, 
enzymes, antigens, subunit vaccines and epitope peptides in plants have been reviewed 
elsewhere (Daniell et al. 2001; Ma et al. 2003; Daniell et al. 2009; Stoger et al. 2014). Several 
plant-made pharmaceutical products have gone through clinical trials and released to the 
market. For example, carrot-derived Elelyso™ (taliglucerase alfa) (http://www.elelyso.com/), 
a medicine for Type 1 Gaucher disease, was approved by FDA and marketed in the U.S by 
Pfizer Company in 2012 (Stoger et al. 2014). A tobacco-derived humanized antibody cocktail 
ZMapp has been successfully used for the treatment of Ebola virus infected humans in the 
2014 West Africa Ebola outbreak (Geisbert 2014; Qiu et al. 2014).   
In this study, the rNP gene of H3N2 swine influenza virus was expressed in maize seed 
using a maize endosperm-specific promoter. Maize seed was chosen because it is one of the 
components of swine feed. Maize seed is also a stable organ for protein storage. Previous work 
has shown that maize-derived antigens could elicit an immune response and protect animals 
from diseases (Chikwamba et al. 2002). We generated 12 transgenic maize lines expressing 
rNP in seeds. Enzyme-linked immunosorbent assay (ELISA) of the T1 seeds showed that the 
accumulation of NP protein ranged from 8.0 – 35 µg of NP/g of maize seed. Oral 
administration of maize-derived rNP (MNP) elicited NP-specific antibodies in mice. The 
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antibody titer induced in the group receiving MNP was comparable to the control groups 
receiving Vero cell-derived NP (VNP) or alphavirus replicon particle-derived NP (ANP), 
suggesting that MNP is immunogenic. Our study shows that the plant is a good system to 
produce vaccines. 
     
Materials and Methods 
DNA Construct  
The nucleoprotein (NP) gene of Influenza A Virus H3N2 (gene bank accession CY157826.1) 
was codon optimized and synthesized by GeneArt® (Life Technologies, Grand Island, NY). 
The endosperm specific promoter of the maize 27-kDa γ-zein gene was chosen to drive the 
expression of NP protein in transgenic maize seeds. The vector construct of rNP expression in 
maize seed endosperm is depicted in Figure 1. Maize γ-zein signal peptide (Marks et al. 1985) 
was added upstream of the NP gene. C-terminal SEKDEL (ER-retention signal) (Munro and 
Pelham 1987) and VSP (soybean vegetative storage protein) terminator (Mason et al. 1993) 
were added downstream of the NP gene, respectively. A complete NP DNA cassette with PstI-
EcoRI sites was inserted in multiple cloning sites of a binary vector pTF101.1 (Paz et al. 2004), 
resulting in construct pHN05 (Fig. 1a). The binary vector pTF101.1 contains an herbicide 
resistant gene (bar) that can be used as selectable marker for maize transformation. The 
construct pHN05 was transferred into Agrobacterium tumefaciens strain EHA101 (Hood et al. 
1986) prior to maize transformation. 
 
Maize transformation 
Agrobacterium-mediated plant transformation was conducted by the Plant Transformation 
Facility of Iowa State University. Maize Hi-II immature embryos were infected with A. 
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tumefaciens EHA101 (Frame et al. 2002) harboring the pHN05 plasmid. Screening of the 
putative transgenic events was performed using the herbicide, Bialaphos. Transgenic plants 
were generated and advanced in the greenhouse to obtain T1 seeds. NP transgenic maize was 
self-pollinated or cross-pollinated with B73 for seed propagation.  
 
Southern blot analysis  
Southern blot analysis was carried out to estimate copy numbers of the NP transgene 
integration in the transgenic maize plant genome. Genomic DNA (10 µg) isolated from young 
leaves of T1 plants (Doyle and Doyle 1990) was digested overnight with HindIII enzyme. The 
digestion products were fractionated in 0.8 % agarose gel then cross-linked into a membrane 
(Ambion® BrightStar®-Plus Positively Charged Nylon Membrane) using a cross-linker 
apparatus. The membrane was pre-hybridized in Church’s buffer for 2 hours at 65 °C before 
adding the probe. An NP specific probe was amplified from pHN05 plasmid by PCR using 
forward (5’ CGTCTCGGTGGCATAAGAAC 3’) and reverse (5’ 
AAGGGCAAGTTCCAGACAGC 3’) primer pair (Figure 1) then labeled with 32P dCTP. The 
probe was purified then denatured at 90 °C for 10 minutes prior to overnight membrane 
hybridization at 65 °C. The membrane was washed 4 times with high stringency washing 
solution (0.2 X SSC/saline-sodium citrate buffer, 0.1 % SDS/sodium dodecyl sulfate). The 
film was developed after 16 hours exposure at 80 °C. 
 
RNA isolation and RT-PCR 
Transcription level of the NP gene was analyzed using the reverse-transcriptase PCR (RT-
PCR) method. Total RNA (from maize leaf, seed, silk, husk) was extracted using Qiagen 
RNeasy Plant Mini kit (Qiagen Inc, Valencia, CA) following supplier’s instructions. An 
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aliquot (1 µg) of the total RNA was used as template to synthesize complementary DNA 
(cDNA) using SuperSCript™ II reverse transcriptase (Invitrogen, Grand Island, NY) in a total 
reaction of 20 µl. NP transcripts (± 723 bp) were amplified from 2 µl of cDNA (100 ng) using 
the same primer pair utilized for Southern blot analysis. Actin primers forward (5’ 
ATTCAGGTGATGGTGTGAGCCACAC 3’) and reverse (5’ 
GCCACCGATCCAGACACTGTACTTCC 3’) were used to amplify actin as internal control 
of housekeeping gene. Equal amounts of PCR product were loaded into each well and 
transcription level was determined semi-quantitatively. 
 
Protein extraction and protein concentration determination 
Total soluble protein was extracted from maize kernels for NP protein expression analysis. A 
single maize kernel was ground into powder using the Genogrinder 2000 operated at 550 
stroke/ min for 90 seconds at the Iowa State University Plant Tissue and Seed Grinding 
Facility. The sample was homogenized in 10 µl of sodium phosphate buffer (pH 6.6) 
supplemented with a cocktail of protease inhibitors per mg of maize powder as described 
(Moeller et al. 2009). The sample was incubated with shaking at 37 °C, 250 rpm for 2 hours 
then centrifuged in a tabletop microcentrifuge at 13,000 rpm for 20 minutes. The supernatant 
was transferred into a new tube. Total soluble protein (TSP) concentration was quantified with 
the Bradford method (Bradford 1976) using BSA (bovine serum albumin) as standard. The 
protein extract was used for NP quantification by ELISA (Enzyme-linked immunosorbent 
assay), Western blot and for animal experiments. 
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Western blot 
Maize protein extract (20 µg) was boiled for 5 minutes then directly put on ice (Laemmli 1970). 
Samples were loaded into a 4-15 % SDS gel (Bio-Rad, Hercules, CA) run at 110 volts for 90 
minutes. Western blot was carried out at room temperature unless otherwise stated. The gel 
was transferred onto a 0.2 μm nitrocellulose membrane using a semi-dry blot transfer apparatus 
(Bio-Rad, Hercules, CA) following the manufacturer’s instructions. Non-specific binding was 
blocked by incubating the membrane with 5 % non-fat dry milk in 1X phosphate buffered 
saline [1X PBS: 137 mM NaCl, 10 mM Na2HPO4, 1.76 mM KH2PO4, pH 7.4] for 2 hours. The 
membrane was washed 4 times with 1X PBST [PBS-0.05 % Tween-20 (v/v)] then incubated 
with a 1:1,000 dilution of mouse anti-NP monoclonal antibody (Milipore, Billerica, MA). 
Secondary antibody goat-anti-mouse-IgG conjugated with horseradish peroxide (HRP) (Sigma 
Aldrich, St. Louis, MO) in a 1:5,000, dilution was added to the membrane followed by 4 times 
washing with 1X PBST. The membrane was incubated with Sure Blue 3,3,5,5’-
tetramethylbenzidine (TMB) substrate (KPL, Gaithersburg, MD) for 20 minutes at room 
temperature for protein visualization. 
 
NP quantification 
NP antigen concentration in transgenic maize seed was quantified using an ELISA method. 
Eight PCR positive seeds from each transgenic line were tested. Total protein extracts (50 
µl/well) diluted in 1X PBS buffer were added into a 96-well plate. Serial dilution of pure 
recombinant NP (NBP2-26531, Imgenex, San Diego, CA) was used as a standard. Analysis of 
samples and standards was carried out in duplicate. The plate was incubated overnight at 4 °C 
followed by 3 times washing with 1X PBST buffer. Blocking solution (5 % non-fat dry milk 
in 1X PBS) was added to each well to remove non-specific binding then the plate was 
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incubated at 37 °C for an hour. After washing 3 times using 1X PBST, samples were incubated 
with mouse anti-NP antibody (1:1000) at 37 °C for one hour. After washing, samples were 
incubated with the goat anti-mouse secondary antibody (1:5000, 50 µl/ well) at 37 °C for one 
hour. TMB substrate was added to each well. And absorbance was measured using a plate 
reader at 405 nm. NP concentration was determined based on known concentration of 
standards.  
 
Pig study 
Four experimental crossbred pigs (approximately 7 weeks old) were obtained from a 
commercial herd (Wilson’s Prairie View Farms, Burlington, WI) with no serological evidence 
of influenza infection, and were randomly assigned into two groups consisting of two pigs per 
group. Animals were immunized with 16 µg MNP or non-transgenic maize (NTM) extract. 
Protein extract was mixed with adjuvant (Benchmark BioLabs item #70101) at a 4:1 ratio in a 
5 ml final volume. Immunization (5 ml) was administered intramuscularly in the neck. Each 
pig received prime and boost immunization at days 0 and 21, respectively. Sera samples were 
collected at the day of prime (day 0), day of boost (day 21) and 6 days after boost immunization 
(day 27) for NP-specific antibody detection. The pig study was approved by the Institutional 
Animal Care and Use Committee of Harrisvaccines, Inc.   
 
Mouse study 
Female BALB/c mice (6-8 weeks old) were purchased from Charles River Laboratories 
International Inc. (Willmington, MA). The experiments were approved by the Institutional 
Animal Care and Use Committee (IACUC) of Iowa State University. All mice were 
maintained in the Iowa State University animal facility. Mice were housed in plastic cages (4 
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mice per cage) at 20 °C with reverse 12 h light/dark cycle. The animals were allowed to a 2-
week acclimation before the experiment started. Bedding was changed twice per week and 
mice had ad-libitum access to feed and water. Body weight was recorded every week.  
Mouse immunization   
Three groups consisting of 8 mice per group were vaccinated with 20 µg of MNP, VNP 
(NP expressed in Vero cells), or non-transgenic maize protein extracts. For positive control, 4 
mice per group received ANP (alphavirus replicon particles expressing NP) at a dosage 5x106 
of replicon particles (RP)/100 µl; for negative control, the same number of mice received the 
same volume and concentration of AGFP (alphavirus replicon particles expressing green 
fluorescent protein) (Vander Veen et al. 2013). All animals received three immunizations that 
were given in prime-boost design as summarized in Table 1. During prime immunization (day 
0), immunogens (except groups receiving ANP and AGFP) were administered subcutaneously 
with the adjuvant Imject Alum (Pierce, Rockford, IL) in 1:1 (v:v) ratio. Boost immunizations 
(days 21 and 42) were administered orally through gavage without adjuvant. Prime and boost 
immunizations of groups receiving ANP and AGFP were administered subcutaneously without 
adjuvant. Mice were fasted 12 hours prior to oral boost until 30 minutes after immunization.  
Mouse specimen collection   
Blood and fecal pellets were collected one day prior and one week after each prime or 
boost immunization. Serum was separated from other blood cellular components by 
centrifugation at 12,000 rpm and stored at 20°C until the day of analysis. Fecal pellets were 
frozen and lyophilized for 48 hours prior to antibody analysis. One week after the last boost, 
mice were euthanized and blood and spleens were collected. Spleens were dissociated to a 
single cell suspension in Roswell Park Memorial Institute (RPMI) 1640 complete media 
102 
 
(GIBCO, Grand Island, NY) supplemented with 2 mM glutamine, 25 mM of 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, 50 μg/ml gentamicin, and 
10% heated-inactivated fetal bovine serum (FBS) (Zhai et al. 2007).  
Antibody detection   
Antibodies specific to NP were analyzed by an NP ELISA (IDEXX Laboratories, Inc, 
Westbrook, Maine) that is based on a competitive ELISA (Ciacci-Zanella et al. 2010). The test 
was performed by the Veterinary Diagnostic Laboratory of Iowa State University. The mouse 
serum sample was added onto an NP-coated plate followed by washing. A known horseradish 
peroxidase-conjugated antibody specific for NP was added followed by washing. TMB 
substrate was added and the absorbance was measured. The amount of antibodies presence in 
the unknown sample is inversely proportional to the absorbance reading, due to competitive 
inhibition of known conjugate binding. Test results are presented as S/N values (sample to 
negative control ratio). The cut off value for positive samples in mouse is S/N ≤ 0.67 while the 
cut-off value for swine sample is S/N ≤ 0.70. Serum and fecal samples were analyzed for 
antibody isotypes using ELISA. Fecal extraction was conducted by adding 10 µl 1X PBS 
supplemented with protease inhibitor cocktail (Sigma Aldrich, St. Louis, MO) per mg of dry 
fecal sample. Samples were incubated with vigorous shaking at 9 °C overnight then 
centrifuged at 12,000 rpm for 15 minutes. A 96-well ELISA plate was coated with 10 µg/ml 
rNP (Imgenex, San Diego, CA) in carbonate buffer pH 9.6 and incubated overnight at 4 °C. 
After washing with 1X PBST, the plate was blocked with 5 % bovine serum albumin (BSA) 
in 1X PBS then washed. A serum sample diluted 1:50 was added to each well and the plate 
was incubated at 37 °C for 2 hours followed by washing with 1X PBST. Goat anti-mouse (IgA, 
IgG, IgG1, or IgG2a) peroxidase conjugated antibody was added and incubated at 37 °C for 1 
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hour followed by washing. TMB substrate was added for color development. Reaction was 
stopped by adding 1 N HCl then the absorbance was read at 450 nm. 
Enzyme-linked immunospot (ELISPOT)   
Red blood cells in mouse spleenocytes were lysed by adding 1X flow cytometry mouse 
lyse buffer (R&D Systems, Inc., Minneapolis, MN). Samples were submitted to the Cell 
Hybridoma Facility of Iowa State University for cell counting using flow cytometry. Cells 
were used to measure mouse NP antigen specific IL-4 and interferon gamma production using 
ELISPOT. Spleenocytes cells (1x106/ml) were added to each well in a 96-well plate. The 
procedure was performed following manufacturer’s instruction (R&D Systems, Inc., 
Minneapolis, MN). Cells were stimulated with two swine influenza virus strains (2009 
pandemic strain H1N1 and H3N2) overnight at 37 °C in a CO2 incubator. After washing with 
1X PBST, biotinylated antibody specific to IL-4 or IFN-γ was added subsequently. The plates 
were incubated overnight at 4 °C followed by washing three times with 1X PBST. 
Streptavidin-AP was added to the well after incubation and washing, 5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt (BCIP)/nitro-blue tetrazolium chloride (NBT) chromogenic 
substrate was added for development of spots. Chromogen solution was discarded and 
microplates were dried completely before counting ELISpots under the microscope.  
 
Statistical analysis 
Statistical analysis was performed using JMP 10 software (SAS Institute Inc., Cary, NC, USA). 
Data were analyzed using analysis of variance. Significance was set at P-value ≤ 0.05. 
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Results and Discussion 
Stable expression of rNP in transgenic maize plants 
In this study, the H3N2 Nucleoprotein gene (referred to as rNP) expression was driven 
by the maize endosperm-specific promoter, 27-kDa γ-zein (Marks et al. 1985) that facilitates 
the accumulation of protein in seed endosperm. This strategy was chosen to confine the 
transgene expression to a specific compartment and thus prevent proteolytic degradation (Lee 
et al. 2014). Seed expression can also reduce the risk of contamination of the environment 
compared to the expression in leaves or roots (Ou et al. 2014). An endoplasmic reticulum (ER) 
targeting signal, SEKDEL was fused in the C-terminus of the rNP gene that functions to retain 
the translated proteins inside the ER (Ellgaard and Helenius 2003).  
The NP gene used in this study was codon optimized and synthesized for mammalian 
cell expression (matched the sequence expressed by Vero cell, kindly provided by Dr. Ryan 
Vander Veen). The GC percentage of this gene is around 63 %. We reasoned that this version 
would be appropriate for maize expression since maize has high GC percentage (around 55 %) 
(http://www.kazusa.or.jp/codon/). Construct pHN05 containing the codon-optimized rNP and 
selectable marker bar genes (Fig.1a) was transformed into the maize genome through 
Agrobacterium-mediated transformation. Twelve transgenic lines were generated then 
subjected to Southern blot assay for gene integration and copy number analysis. Genomic 
DNA was digested with HindIII enzyme that recognized one site in the promoter region of the 
pHN05 construct. The number of bands appearing on the hybridization film suggests copy 
number of rNP genes that are integrated into the maize genome. The intact NP gene will 
demonstrate a band size larger than 2.8 Kb and bands of lower molecular weights are likely 
partial integration of the NP construct into maize genome. Eight out of 12 lines (lines 4, 13, 
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18, 28, 29, 32, 35, and 38) had multiple copies of rNP genes as shown by the presence of 
multiple bands (Fig.1b) and four lines (1, 16, 17 and 37) showed one hybridization band, 
indicating a single integration of the rNP gene. Those twelve lines were evaluated for rNP 
protein accumulation. Three events with the highest rNP accumulation were advanced for 
seeds production for five generations (T5). Transgenic plants showed similar phenotype 
compared to wild type plants and no abnormal growth.  
 
Analysis of rNP protein accumulation in transgenic maize seeds 
First generation (T1) transgenic maize seed was analyzed for rNP protein accumulation 
with an end-point ELISA assay. The concentration of rNP protein was determined against 
known concentrations of purified commercial NP protein (Imgenex, San Diego, CA). This 
experiment was carried out to screen lines that have high expression of NP protein. The 
accumulation of rNP protein in the T1 transgenic maize seeds ranged between 8.0 and 35 µg/g 
corn seed (Fig. 2). Lines 1, 16 and 18 showed high rNP protein accumulation with the 
concentration 35.0, 32.7 and 29.2 µg/g corn seed, respectively. Those lines were advanced in 
the green house for seed productions. Analysis of NP expression in T3 seeds of Line 1 that had 
a single copy of rNP showed an increase of NP accumulation up to 70 µg/g of corn seed. 
The rNP protein accumulation did not appear to correlate with the transgene copy 
number. In this study, Lines 1 and 16 had high rNP expression levels of 35.0 and 32.7 µg/g, 
respectively. However, single copy events 17 and 37 showed low (9.7 µg/g) and moderate 
(18.7 µg/g) rNP expression, respectively (Fig. 2). On the other hand, multiple copies event 18 
has similar high gene expression (29.2 µg/g) compared to the single copy Line 1. Multiple 
copy numbers of transgenes could lead to the increase of gene expression but it could also 
result in gene silencing (Flavell 1994; Stam et al. 1997; Hood et al. 2003; Schubert et al. 2004).   
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Seed-specific expression of rNP transgenic maize 
Molecular analysis was performed to confirm rNP expression in transgenic maize 
seeds. Different tissues such as leaf, husk, silk and seed were collected from transgenic Line 
1. PCR analysis showed amplification of both rNP and bar genes in transgenic maize (Fig. 3a). 
Reverse-transcriptase PCR (RT-PCR) analysis showed that rNP transcripts were mainly 
accumulated in seed and the level increased as the seed matured (Fig. 3b). The rNP gene was 
driven by the maize 27-kDa γ-zein promoter, and this transcription level pattern is in agreement 
with the pattern of maize zein transcript accumulation during maize seed development where 
transcripts reach their peak during 15-25 days after pollination. Transcripts decrease when 
seeds reach the mature stage (Russell and Fromm 1997).  
High accumulation of rNP in the seed indicates proper activity of the endosperm-
specific promoter and suggests that a tissue-specific promoter is an efficient strategy for 
recombinant protein accumulation. Seed is a stable organ for recombinant protein 
accumulation and it is a natural component of animal feed (Ma et al. 2003; Giddings et al. 
2000). Proteins accumulated in seed are still functional and available even years after 
harvesting (Giddings et al. 2000; Ma et al. 2003; Moravec et al. 2007; Wu et al. 2007).   
NP protein is a non-glycosylated protein (Townsend et al. 1985) and prediction with 
NetNGlyc 1.0 server showed that no potential glycosylation site was found in the rNP sequence 
(http://www.cbs.dtu.dk/services/NetNGlyc/) (Gupta et al. 2004). Glycosylation should be 
considered before expressing antigens or antibodies in plants. This is important due to different 
glycosylation patterns between animal and plant cells. Improper glycosylation patterns may 
lead to incorrect protein folding that could result in a non-functional or unstable protein 
(Twyman et al. 2012).  
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Western blot analysis of maize-derived rNP was carried out to confirm a correctly 
folded protein was accumulated in the transgenic plants. Membrane visualization showed 
similar banding pattern of 55 kDa between pure NP protein, VNP and MNP (Fig. 3c). This 
result indicates that proper NP protein was expressed in maize seeds. The highest rNP 
expression observed in this study was about 0.06 % TSP (total soluble protein). A previous 
study showed similar results in which highest expression of LT-B vaccine driven by maize 27-
kDa γ-zein promoter was 0.07 % (Chikwamba et al. 2002). A recent study showed high 
accumulation of the hepatitis B surface antigen (HBsAg) in maize seed driven by an improved 
version of globulin 1 promoter showing a production level of 0.51 % TSP (Hayden et al. 2012). 
Strategies are important when designing construct to express foreign protein in seed. The 
choice of promoter, signal sequence for organelle targeting, and terminator can contribute to 
the expression level of the transgene (Orellana-Escobedo et al. 2014). 
 
Animal study 
In an attempt to prove that maize-derived NP is immunogenic, we conducted a 
preliminary study in pigs. Sera samples collected during the experiment were sent to the 
Veterinary Diagnostic Laboratory of Iowa State University for NP-specific antibody analysis. 
As can be seen in Figure 4, there was no NP-specific antibody detected in all experimental 
pigs prior to prime immunization (day 0) and 21 days after the first vaccination (day of boost). 
Significant immune response was induced by MNP administration (intramuscular injection) 6 
days after boost immunization (day 27) (Fig. 4). NP-specific antibody analysis showed positive 
response only in the group receiving MNP while the negative control group remained 
seronegative during the entire experiment, suggesting that maize-derived NP is immunogenic.  
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Our goal was to develop an orally-delivered vaccine for influenza. Due to resource 
limitations, further studies were performed using laboratory mice as a model. A mouse study 
was designed to evaluate MNP as an orally fed vaccine for Influenza A Virus (IAV). In a 
preliminary study, mice were fed maize pellets containing 20 µg of MNP, 20 µg of VNP mixed 
with non-transgenic maize powder, or non-transgenic maize (NTM). Maize pellets in the MNP 
and VNP groups were supplemented with or without 20 µg of MLTB (maize-derived LT-B) 
as adjuvant (Chikwamba et al. 2002). A positive control group was administered a 
subcutaneous injection of 20 µg VNP. A negative control group was immunized 
subcutaneously with phosphate buffered saline. Oral feeding was administered 3 times at 3 
week intervals. Sera and fecal analyses to detect NP-specific antibodies did not show an 
immune response induced by NP oral feeding. Sera analysis showed positive result only in the 
positive control group that received the subcutaneous injection of VNP (Fig. S1, supplemental 
materials). We speculated that oral feeding was not an effective route for vaccine 
administration.  
To investigate whether the negative immune response was due to ineffectiveness of 
MNP or the delivery method, we carried out a second mouse study in which MNP was 
administered orally through gavage and subcutaneously. In this study, immunization was 
conducted in a prime-boost design, in which immunizations were 3 weeks apart. Prime 
immunization was administered subcutaneously with adjuvant at a ratio of 1:1 (v/v). Each 
mouse then received two boost vaccinations that were administered through gavage (except 
boosts to ANP and AGFP groups were administered subcutaneously). As can be seen in Figure 
5, NP-specific antibody in MNP fed group showed a high antibody titer that is comparable to 
the VNP group and positive control ANP group. Specific antibodies were detected after boost 
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vaccination and remained high until the day of termination. This result suggested that maize-
derived rNP (MNP) was able to induce equivalent humoral immune response compared to 
animal-derived rNP (VNP or ANP). Our result is in agreement with observations reported by 
Huang et al (2012), in which comparable humoral immune response could be induced by rNP 
expressed in both prokaryotic and eukaryotic systems. 
Further antibody analyses (IgG and IgA) were performed to detect immune responses 
elicited by MNP oral administration in mouse. As shown in Fig. 6a, similar levels of IgG can 
be detected from the mice groups treated with MNP, VNP or ANP. Antibody isotype analyses 
showed that IgG2a antibody titer was higher than IgG1, suggesting that IgG2a was highly 
induced in this experiment (Fig. 6b & c). Production of IgG2a is stimulated by interferon 
gamma (IFN-γ), which indicates cell mediated immunity (Pertmer et al. 1996). In this study, 
we performed oral gavage administration with an attempt to induce a mucosal immune 
response. However, no notable increase of IgA in any group could be detected in our study, 
suggesting poor mucosal immune response to the NP regardless of the source of production.  
To further confirm immune responses induced by MNP oral administration, cytokine 
analysis using the ELISPOT assay was performed. Both interleukin-4 (IL-4) and interferon 
gamma (IFN-γ) cytokines that indicate TH2 and TH1 mediated immune responses, 
respectively, were analyzed. Spleenocytes were stimulated against two influenza virus strains 
(H1N1 and H3N2) to test heterosubtypic responses induced by MNP. The results are 
summarized in Table 2. Cytokine IL-4 was highly induced in the groups that received VNP 
and ANP, which is significantly different compared to other groups (P < 0.05). A moderate 
IL-4 response was detected in the MNP group, although not as high as the positive control 
groups (VNP and ANP) (P < 0.05). However, the result showed that the MNP group is 
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significantly different compared to the negative groups that received non-transgenic corn 
(NTM) and AGFP (P < 0.05), both of which had undetectable IL-4. The numbers of IL-4 spots 
induced by pandemic H1N1 and H3N2 in all groups were similar (P < 0.05). This result 
confirmed that MNP induces a humoral response against different strains of influenza viruses, 
suggesting that NP is a conserved protein. Interestingly, we could not detect a cytokine IFN-γ 
response in any groups except for the ANP group (too many to count) using the ELISPOT 
assay despite previous result that showed IgG2a antibody was highly induced. This 
discrepancy could be caused by the IFN-γ independent production of IgG2a (Markine-
Goriaynoff et al. 2000). ANP was shown previously (Vander Veen et al. 2013) to induce TH2 
and TH1 mediated immune responses. Alphavirus replicon particle vaccine mimics the wild 
type virus infection, except it does not have the structural protein that can cause systemic 
infection. It is possible that the dose of rNP used in this study was too low to induce the 
production of IFN-γ. A study by Huang et al. (2012) showed that intramuscular injection of E. 
coli-derived NP induced the production of IFN-γ in mice that were administered with 90 µg of 
NP but not in the groups receiving 10 or 30 µg of NP. Further study testing different doses of 
MNP will confirm this speculation.  
An ideal vaccine should be immunogenic, inducing both humoral, mucosal and cell 
mediated immune (CMI) responses. Our study showed that the amount of MNP used induced 
a humoral, but not a TH1 CMI response. Various forms of NP vaccinations and their immune 
responses have been reported. They include live attenuated Salmonella vaccine, DNA, virus 
vector or purified protein (Ashraf et al. 2011; Pertmer et al. 1996; Kim et al. 2013; Huang et 
al. 2012) in which both humoral and CMI responses were induced. DNA or virus-based vector 
vaccinations are considered to mimic live virus infection that can induce the major 
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histocompatibility complex class I presentation (Cohen et al. 1998; Lambert and Fauci 2010). 
A mucosal immune response is also an important factor for vaccine design as the first defense 
against viral infection that relies on the route of vaccination (Rose et al. 2012). Intramuscular 
immunization of NP protein did not induce a mucosal response (Sanchez et al. 2014), but 
intranasal administration was able to induce mucosal immunity (Luo et al. 2012). Furthermore, 
adjuvant is also important to elicit both humoral and CMI responses of NP-based vaccine 
(Sanchez et al. 2014; Wang et al. 2014).  
In the current study, we did not observe a CMI response. The relative importance of 
CMI or antibody to NP in protection is somewhat controversial. CMI to NP is thought to be 
important because protection is possibly conferred via CD8+ T cells (Epstein et al. 2005; 
Jimenez et al. 2007; Kreijtz et al. 2008; Zhou et al. 2010). Others have suggested that 
antibodies against NP are important for protection and that immune serum alone can transfer 
protection (Carragher et al. 2008; Eliasson et al. 2008; LaMere et al. 2011a; Lamere et al. 
2011b).  
 
Conclusion 
Influenza A virus infection causes severe respiratory disease. However, the 
development of a vaccine for this disease is a complex process due to the antigenic shift and 
drift of the virus. This leads to a desired universal vaccine that is based on conserved proteins. 
A universal vaccine is expected to provide some level of protection against influenza virus 
infection before the strain specific vaccine is produced and administered. 
Our study provides evidence of the accumulation of a universal vaccine protein 
candidate in a plant. Oral administration of plant-derived rNP induced antibody production but 
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not cell-mediated immunity in mice. Few factors such as route of delivery, dose and adjuvant 
are important for the immune response induction. Further study combining these factors will 
be useful for the improvement of NP vaccine efficacy as a universal influenza vaccine.  
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Table 1. Design of Immunization
route dose route dose
MNP 8 subcutaneous 20 µg gavage 20 µg
VNP 8 subcutaneous 20 µg gavage 20 µg
NTM 8 subcutaneous 20 µg gavage 20 µg
ANP 4 subcutaneous** 5 x 10
6
 RP subcutaneous 5 x 10
6
 RP
AGFP 4 subcutaneous** 5 x 10
6
 RP subcutaneous 5 x 10
6
 RP
**Prime immunization w as administered w ithout adjuvant
RP: replicon particles
*Adjuvant (aluminum hydroxide) w as added in 1:1 ratio respective to the volume of immunogen
Immunogens (Immunogen + adjuvant*) (without adjuvant)
Prime/Day 0 Boost/ Day 21 & 42
# mouse
Table 2. Cytokine IL-4 production in orally immunized mice*
Groups H1N1 H3N2
MNP 12.75 ± 7.67a 12.13 ± 6.47a
VNP 31.19 ± 13.48b 34.31 ± 14.20b
ANP 30.25 ± 7.60b 28.63 ± 6.29b
NTM   3.11 ± 1.19c   3.17 ± 1.30c
AGFP   3.88 ± 1.11c   5.25 ± 0.96c
*Mean IL-4 secreting cells per 1x 106 mouse spleenocytes at day 56. The values w ith
different superscripts w ithin a column are signif icantly different (P < 0.05) by Student's t
test
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Figure 1. (A) Schematic diagram of the T-DNA region in vector pHN05. The codon-
optimized rNP gene driven by the 27-kDa γ-zein promoter (P27γz) was transformed into maize 
immature embryos via Agrobacterium-mediated transformation. γSP, maize γ-zein signal 
peptide; SEKDEL, endoplasmic reticulum retention signal; TVSP, soybean vegetative storage 
protein gene terminator; bar, bialaphos resistance gene; P35S, the cauliflower mosaic virus 
35S promoter; LB: Agrobacterium T-DNA Left border; RB, Agrobacterium T-DNA right 
border; HindIII, restriction enzymes; kb, kilobases. (B) Southern blot analysis of twelve rNP 
transgenic maize lines. Genomic DNA was digested with HindIII, separated, and then 
transferred onto a nitrocellulose membrane before being hybridized with an rNP probe. 
pHN05, rNP construct plasmid as positive control; WT, non-transgenic B73 inbred line as 
negative control; kb, kilobases. 
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Figure 2. rNP accumulation in T1 transgenic maize. Eight PCR positive seeds from each 
line were analyzed by ELISA. Three lines (1, 16, and 18) were advanced in the green house 
for seed production. Error bars represent the standard deviation of eight biological replicates.  
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Figure 3. rNP expression analysis in transgenic maize (Line 1). (A) PCR analysis for NP 
gene detection; (B) RT-PCR analysis for RNA detection; (C) Western blot analysis for maize-
derived rNP protein detection. Bar gene primers are used as a positive control for PCR analysis. 
Actin gene primers are utilized as a positive control for transcript analysis. rNP (NBP2-26531) 
from Imgenex is used as positive control for protein analysis. MW, molecular weight marker; 
WT, wild type B73 maize; pHN05, rNP construct plasmid control; DAP, days after pollination. 
rNP, recombinant NP; VNP, Vero cell-derived NP; MNP, maize-derived rNP; NTM, non-
transgenic maize. 
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Figure 4. Anti-NP antibody serum analysis in experimental pigs after MNP 
administration. Two pigs were injected with 16 µg of MNP or NTM extract. Day 0, prime 
immunization; day 21, booster vaccination; day 27, 6 days post booster vaccination. NTM, 
non-transgenic maize; MNP, maize-derived rNP. S/N (Sample/Negative) response is the ratio 
of the sample optical density (OD650) reading to the kit negative control OD reading. Asterisk 
(*) indicates significantly different (P < 0.05) by Student’s t test. Error bars represent the 
standard deviation of the mean of biological replicates. 
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Figure 5. Oral administration of MNP induces NP specific antibodies in experimental 
mouse serum. MNP, maize-derived rNP; VNP, Vero cell-derived NP; ANP, alphavirus 
replicon particle-derived NP; NTM, non-transgenic maize and AGFP, alphavirus replicon 
particles expressing green fluorescent protein. S/N (Sample/Negative) response is the ratio of 
the sample optical density (OD650) reading to the kit negative control OD reading. The values 
with different superscripts are significantly different (P < 0.05) by Student’s t test. Error bars 
represent the standard deviation of mean of biological replicates. Asterisk (*) indicates the day 
before boost immunization. 
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Figure 6. Immunoglobulin (IgG) antibody analysis in orally immunized mice. (A) anti-NP 
IgG levels; (B) anti-NP IgG1 levels; (C) anti-NP IgG2a levels in mouse sera after MNP oral 
administration. MNP, maize-derived rNP; VNP, Vero cell-derived NP; ANP, alphavirus 
replicon particle-derived NP; NTM, non-transgenic maize and AGFP, alphavirus replicon 
particles expressing green fluorescent protein. Error bars represent the standard deviation of 
the mean of biological replicates (see Table 1 for # of replications). Arrow indicates the day 
of boost immunizations (day 21 and day 42).  
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Supplemental Materials 
Maize-derived NP (MNP) oral feeding experiment 
Female BALB/c mice (6-8 weeks old) were purchased from Charles River Laboratories 
International Inc. (Willmington, MA). The experiments were approved by Institutional Animal 
Care and Use Committee (IACUC) of Iowa State University. All mice were maintained under 
pathogen-free conditions and treated humanely. Mice were housed in plastic cage (3 mice per 
cage) at 20°C with reverse 12 h light/dark cycle. The animals were allowed to 2 weeks 
adjustment before the experiment started. Bedding was changed twice per week and mice had 
ad-libitum access to feed and water. Body weight was recorded every week. Unless otherwise 
stated, specimen collection, antibody analysis and ELISPOT was conducted in the same 
manner of MNP oral administration study.  
 
Immunization 
The mouse oral feeding experiment on MNP was conducted as follow. Six groups consisted 
of 6 mice per group were fed with three doses of maize pellet (except group 5 that received 
VNP subcutaneously) in prime-boost design (Day 0, 21 and 42) as summarized in Table S1. 
In the groups receiving MNP and VNP, maize pellets were adjuvanted with or without MLB 
(maize derived LT-B). Mice were fasted 12 hours before immunization, normal feeding was 
taken away except water. During the day of immunization, each mouse was put in a single 
container and one maize pellet was given. Mice receiving subcutaneous injection accepted the 
same treatment as well. Mouse was let to finish the pellet for 1 hour then all mice were put 
back in their cage and normal feed and water was put back.    
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Table S1. MNP oral feeding experiment in mouse 
Groups # mouse Immunogens Prime/boost 
1 6 MNP pellet 20 µg 
2 6 MNP + MLB pellet 20 µg 
3 6 VNP + NTM pellet 20 µg 
4 6 VNP + MLB pellet 20 µg 
5 6 VNP subcutaneous 20 µg 
6 6 NTM pellet 20 µg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. NP specific antibody in experimental mouse serum and fecal after oral feeding 
experiment with MNP 
  
S/N (Sample/Negative) response is the ratio of the sample optical density (OD) reading to the kit negative 
control OD reading. Statistical analysis using JMP10 (SAS Inc), Turkey’s test (α < 0.05) 
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Abstract 
The dsRNA molecules can be designed specifically to target genes that are controlling 
virus, pest pathogens and to treat disease. Transgenic plants have been extensively studied as 
the production system for recombinant proteins. However, production of therapeutics dsRNAs 
in transgenic plants is still a limited area of research. Plant expressed therapeutics dsRNAs 
could open new avenue of vaccine oral delivery. In this study, production of dsRNAs specific 
to infectious myonecrosis virus (IMNV) and white spot syndrome virus (WSSV) shrimp viral 
pathogens in soybean and maize were evaluated. Hairpin RNA (hpRNA) constructs expressing 
dsRNA308 specific to IMNV and dsRNA381 specific to WSSV were introduced into maize 
and soybean genomes. Molecular analyses showed the accumulation of full length dsRNA308 
and dsRNA381 in transgenic plants. Our result showed low levels accumulation of dsRNA308 
and dsRNA381 in transgenic maize and soybean. Shrimp bioassay was carried out to test the 
efficacy of plant-derived dsRNA as vaccine for shrimp. Total RNA isolated from transgenic 
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soybean seeds expressing dsRNA308 was injected into shrimp followed by challenge with 
WSSV. Shrimp bioassay analysis showed moderate protection of plant-derived dsRNA308 
against lethal challenge to WSSV due to low level of dsRNA308 presence in the total RNA. 
This study provides useful information of plant system for the accumulation of dsRNA for 
shrimp vaccine.  
Keywords double stranded RNA, WSSV, RNAi, transgenic plants 
 
Introduction 
Shrimp aquaculture is a multibillion dollar industry worldwide (Johnson et al., 2008). 
However, viral pathogens attack has caused great economic losses on shrimp farming 
worldwide. White spot syndrome virus (WSSV) and infectious myonecrosis virus (IMNV) are 
major viral pathogens in shrimp aquaculture. Infection of WSSV was first emerged in 1992 
and can cause 100% mortality within 7-10 days post infection (Kumar et al., 2015; lightner, 
1996). On the other hand, IMNV was first observed in 2002 (Walker and Mohan, 2009) has 
caused major infection resulted in mortality. Practices to prevent virus contamination in shrimp 
farming include vaccination with recombinant proteins and health management practices are 
urgent matter (Johnson et al., 2008). Many recombinant proteins such as viral capsid protein, 
envelope protein and viral antibodies (Kim et al., 2004; Li et al., 2005; S and Kwang, 2011) 
have been utilized as a vaccine to alleviate WSSV infection. For example, VP19 and VP28 
protein has been studied in numerous reports as an efficient subunit vaccine for WSSV 
(Caipang et al., 2008; Witteveldt et al., 2004a; Witteveldt et al., 2004b).  
Recent practice showed antiviral mechanism mediated by RNAi pathway upon 
application of double stranded RNA (dsRNA) (Killiny et al., 2014; Kumar et al., 2015). In this 
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mechanism, the introduced long dsRNA is cleaved into 20-24 nucleotides (nt) small interfering 
RNAs (siRNAs) by DICER (RNase III) enzyme. One of the siRNA strands is loaded into an 
RNA-induced silencing complex (RISC) and recognizes complementary messenger RNA 
(mRNA) that leads to the degradation or transcription inhibition of mRNA target (Baulcombe, 
2004; Fire et al., 1998). RNAi also can be mediated by virus-induced gene silencing (VIGS), 
microRNA (miRNA), and hairpin RNA (hpRNA) to target specific mRNA (Caplen et al., 
2001; Heinemann et al., 2013).  
Study by Elbashir et al. (2001) reported the application of synthetic siRNA led to 
sequence specific degradation of mRNA target. These finding indicates that siRNA can be 
designed to target specific mRNA, such as mRNA associated with disease thus allowing the 
potential application of dsRNA as a therapeutic molecule (Zhou et al., 2004). Injection of 
dsRNA specific to IMNV provided 95% protection against the virus in tiger shrimp (Loy et 
al., 2012). Currently, most therapeutics RNA is synthetically produced or expressed using a 
virus vector (Castanotto and Rossi, 2009). Several reports showed plant fed dsRNA as strategy 
to control pest pathogens (Baum et al., 2007; Mao et al., 2011; Pitino et al., 2011). Expression 
of dsRNA targeting V-ATPase gene of insect in transgenic maize reduced root damage by the 
coleopteran corn rootworm (Baum et al., 2007). Plant-expressed dsRNA was reported to be 
taken up by the digestive system in insect and worm (Gordon and Waterhouse, 2007; Mao et 
al., 2007). This result suggested the promising application of plant-produced dsRNA to control 
pathogens. 
Transgenic plants have been extensively studied for molecular farming purpose for the 
production of recombinant proteins such as industrial enzymes, pharmaceuticals and vaccines 
(Ramessar et al., 2008). Maize and soybean offers advantages for the accumulation of foreign 
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proteins. Maize and soybean are the most produced crops annually (Lobell et al., 2011). Both 
crops offer advantages for the production of recombinant proteins, high protein seed content 
and non-toxic (Herman and Schmidt, 2015; Twyman et al., 2003). Furthermore, soybean meal 
is natural component of shrimp diet (Bautista-Teruel et al., 2003). Expression of dsRNA in 
soybean offers an advantage of oral delivery application to control shrimp viral pathogen.  
In this study, dsRNA308 encoding VP19 region of WSSV and dsRNA381 specific to 
IMNV were expressed in transgenic maize and soybean. Various promoters, constitutive and 
seed-specific were utilized to drive the expression of these dsRNAs. Our study demonstrated 
that activity of plant virus promoter CaMV 35S caused negative effects from gene silencing 
and lethality to plants. The activity of plant endogenous promoters (constitutive and seed 
specific) led to the accumulation of full length dsRNA308 and dsRNA381 in soybean and 
maize. However, the dsRNA308 and dsRNA381 was accumulated at low levels in both 
soybean and maize. A bioassay experiment was performed to confirm the activity of plant-
derived dsRNA as shrimp vaccine by injecting soybean-derived dsRNA308 to shrimp. Our 
study showed moderate protection provided by soybean dsRNA308 against lethal challenge of 
WSSV due to low level of dsRNA308 available in total RNA. Our study showed that 
transgenic plants could accumulate dsRNAs specific to shrimp viral pathogens. Improvement 
is needed to increase accumulation levels of vaccine dsRNAs. 
 
Material and Methods 
Vector Construct 
Two dsRNA fragments namely dsRNA308 and dsRNA381 were designed specific to 
IMNV and WSSV, respectively. The sequence information of dsRNA308 and dsRNA381 
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were kindly provided by Dr. Mark Mogler and Jill Gander (Harris Vaccines). The dsRNA308 
corresponds to 308 bp of VP19 gene of WSSV (GenBank: AY220744.1) (van Hulten et al., 
2002) while the dsRNA381 corresponds to 285 bp region of IMNV genome. Both dsRNAs 
fragments for plants expression were synthesized by GenScript (Piscataway, NJ). Constitutive 
and seed-specific promoters were utilized to drive the expression of dsRNA308 and 
dsRNA381. Four promoters CaMV 35S (Odell et al., 1985), maize ubi-1 (Christensen et al., 
1992), maize U3 (Leader et al., 1994) were used for the constitutive expression of dsRNAs. 
Endosperm specific promoters, β-conglycinin (Beachy et al., 1985) and 27 kDa γ-zein (Marks 
et al., 1985) were used for seed-specific expression in soybean and maize, respectively. In 
total, nine T-DNA constructs for constitutive and seed-specific expression of dsRNA308 and 
dsRNA381 in maize and soybean were generated (Figure 1). One T-DNA construct for the 
accumulation of dsRNA381 driven by CaMV 35S (Odell et al., 1985) promoter was 
transformed into maize and soybean (ST171/A455). The complete dsRNAs expression 
cassette was cloned into binary vector PTF101.1 (Paz et al., 2004) containing expression 
cassette of herbicide resistance bar gene (selectable marker for plant transformation) then 
transformed into Agrobacterium tumefaciens EHA101 (Hood et al., 1986).  
 
Plant Transformation 
Plant transformation experiment was performed by Plant Transformation Facility of 
Iowa State University. Two DNA constructs namely ST171 and ST181 driven by Cauliflower 
mosaic virus (CaMV) 35S and β-conglycinin promoters, respectively were transformed into 
soybean William 82 mature seeds (Luth et al., 2015). Four DNA constructs of dsRNA308 
(A543, A547, A558, and A559) and 4 constructs of dsRNA381 (A455, A544, A560, and 
A561) were transformed into maize Hi II immature embryos (Frame et al., 2011). The 
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construct carrying expression cassette of CaMV35S-dsRNA381 that was transformed into 
maize and soybean were assigned as A455 and ST171, respectively. Four constructs ST181, 
A455, A543, and A544 were regenerated into plantlet and advanced in the green house for 
seed production. The other six constructs were carried out into transgenic callus culture. 
Summary of all constructs is presented in Table 1. 
 
Molecular Analysis 
All transgenic events were analyzed with DNA PCR to confirm the presence of dsRNA 
and bar transgenes. DNA was isolated from callus, leaf or seed using CTAB protocol (Doyle 
and Doyle, 1987). The dsRNA308 fragment (226 bp) was amplified using primer pair forward 
(5’-CTTGAAGGCTCCATGTCTAT-3’) and reverse (5’-CGGACCCAGCCAGAAGCATC-
3’). The dsRNA381 fragment (220 bp) was amplified using primer pair forward (5’-
CGCCCTTCCTCCTCTTGG-3’) and reverse (5’-CCTAAAGGTGGCAGGTGTCC-3’). PCR 
product was analyzed with agarose gel electrophoresis. 
Reverse transcriptase PCR (RT-PCR) was performed to analyze the expression of 
dsRNA in transgenic plants. Total RNA from callus and seeds were extracted using protocol 
as described by (Li and Trick, 2005). An aliquot (1 µg) of the total RNA was used as template 
to synthesize complementary DNA (cDNA) using ThermoScript™ reverse transcriptase 
(Invitrogen, Grand Island, NY) in a total reaction of 20 µl. The cDNA was prepared using gene 
specific primers (GSP) (5’-CGAACACGAATGCACGAGAGGCCACCACGACTAAC-3’) 
for dsRNA308 and (5’-
ACCAGAACACGAACAAGCGAGATAGAGCGAGAAAAACAGA-3’) for dsRNA381. 
Transcript of dsRNA308 (226 bp) was amplified from 2 µl of cDNA template (100 ng) using 
primer pairs forward (5’-CGAACACGAATGCACGAGAG-3’) and reverse (5’-
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CGGACCCAGCCAGAAGCATC-3’). The dsRNA381 transcript (220 bp) was amplified 
from 100 ng cDNA template using primers forward (5’-ACCAGAACACGAACAAGCG-3’) 
and reverse (5’-AACTCAACCAATACAGTCC-3’). Actin gene was utilized as internal 
control and amplified with primers forward (5’-ATTCAGGTGATGGTGTGAGCCACAC-3’) 
and reverse (5’GCCACCGATCCAGACACTGTACTTCC-3’). PCR product was analyzed 
with agarose gel electrophoresis. Equal amounts of PCR product were loaded into each well 
and transcription level was determined semi-quantitatively. 
Expression level of dsRNA308 and dsRNA381 in transgenic plants was analyzed 
quantitatively by qPCR. E.coli expressed dsRNA308 and dsRNA381 were kindly provided by 
Patrick Jennings (Harris Vaccines, Ames, Iowa) and utilized as positive control. Several 
dilution of known concentration dsRNAs positive control were prepared to establish standard 
curve for the determination of dsRNAs transcript levels in transgenic plants. The dsRNAs in 
transgenic plant samples were amplified using the same primer pairs utilized in the reverse 
transcriptase analysis. The transgenic plant cDNA was utilized as template and added into a 
reaction containing QuantiTect SYBR green master mix (Qiagen, Valencia, CA). Transcript 
level was determined against standard curve established for dsRNA308 and dsRNA381 
control.  
 
Northern blot 
Northern blot was performed to analyze full length dsRNAs transcript (dsRNA308 and 
dsRNA381) in transgenic plants. Total RNA from soybean seeds (ST181), maize callus (A547, 
A560 and A561) were analyzed. Total RNA isolated from non-transgenic soybean William 82 
seed and maize Hi II callus were used as negative control. Escherichia coli expressed 
dsRNA308 and dsRNA381 was utilized as positive control. Total RNA sample (10 µg) was 
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loaded into denaturing 1% glyoxal agarose gel followed by transfer into positively charged 
nylon membrane (Ambion® BrightStar® plus membrane, Thermo Fisher Scientific, Waltham, 
MA). The membrane was pre-hybridized in ULTRAhyb® ultrasensitive hybridization buffer 
(Thermo Fisher Scientific, Waltham, MA) for 2 hours at 65°C. The dsRNAs probes were 
prepared from dsRNAs positive control and labeled with 32P dATP. The membrane was 
hybridized overnight at 65°C followed by 2 times washing with NorthernMax® high 
stringency washing solution (Thermo Fisher Scientific, Waltham, MA). The film was 
developed after 16 hours of exposure at -80°C.  
 
Next Gene Sequencing 
Total RNA of soybean seeds (ST181) and maize callus (A547 and A455) were used in 
the assay. Total RNA isolated from soybean seeds was prepared from a pool of 20 PCR 
positive transgenic seeds. Transcript was purified from total RNA using RiboMinus™ 
(Thermo Fisher Scientific, Waltham, MA) following the manufacturer’s instruction. RNA 
quality was assessed using Agilent 2100 Bioanalyzer at the DNA Facility of Iowa State 
University to ensure that sample was free of ribosomal RNAs. Transcript samples were 
submitted to the DNA Facility of Iowa State University for the paired ends sequencing analysis 
in duplicate using Illumina HiSeq 2500 (Illumina, San Diego, CA). The next gene sequencing 
data were analyzed using NextGene software (SoftGenetics, LLC., State College, PA). 
Transcripts were analyzed against dsRNAs sequence and reference genome of maize (B73 
RefGen_v1) (Schnable et al., 2009) and soybean William 82.    
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Shrimp bioassay 
Shrimp bioassay was performed to test activity of plant-derived dsRNA. Specific 
pathogen free shrimp (10 juveniles/tank) was acclimatized in a tank containing 200 L synthetic 
seawater and an oyster shell airlift biofilter for 2 weeks. Tanks were maintained at 28 ppt 
salinity and 28 °C. Six groups were injected intramuscularly with total RNA of soybean ST181 
(GDS), E.coli expressed dsRNA308 (EDR), E.coli expressed dsRNA308 spiked with non-
transgenic soybean RNA (EDS), non-transgenic soybean RNA (NT), or RNase-free water 
(NC). Shrimp bioassay experiment is presented in Table 2. Animals were challenged with 
WSSV or with RNase-free water (Group CH) intramuscularly into the third abdominal 
segment 72 hours post vaccination. Animals were monitored and counted daily for mortality 
then terminated at the end of experiment.  
 
Results 
Transgenic soybean expressing dsRNA308 and dsRNA381  
Two DNA constructs were transformed into soybean genome for the accumulation of 
dsRNA308 and dsRNA381. The first construct ST171 was designed for the constitutive 
expression of dsRNA381 driven by CaMV 35S promoter (Figure 1). Detrimental effect was 
observed in this construct as shown by the damage tissue appearance (Figure 2A) and no 
transgenic events were recovered from this construct. We speculated that strong activity of this 
promoter might cause such effect. Negative effects of transgene expression driven by 
CaMV35S promoter have been reported before (Clough et al., 2006; Hood et al., 2003). The 
expression of dsRNA381 specific to shrimp virus might also interfere with plant growth 
especially in the early stage of the development. Sequence alignment analysis against soybean 
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genome was performed to find any possible targets of dsRNA381 in soybean. BLAST analysis 
showed the possibility of dsRNA381 targeting genes related to germination in soybean. Further 
analyses should be performed to verify this speculation. 
In the second construct, a tissue specific promoter was preferred to drive the expression 
of dsRNA. This strategy was aimed to confine gene expression in specific tissue and expect to 
minimize detrimental effect that might be caused by strong activity of constitutive promoter. 
For this purpose, a T-DNA construct carrying expression cassette of dsRNA308 driven by 
soybean seed specific β-conglycinin promoter was transformed into William 82 seeds (Figure 
1). Unlike the ST171 construct, 8 transgenic events were generated in ST181 construct (Table 
1). Transgenic soybean plants showed similar phenotype compared to wild type plants. Seeds 
were produced in the green house until fourth generation and analyzed for the dsRNA308 
accumulation.  
 
Transgenic maize expressing dsRNA308 and dsRNA381 
Ectopic expression of dsRNAs specific to shrimp viral pathogens was further evaluated 
in maize. Various promoters were tested to assess the effect of promoter on dsRNA 
accumulation in transgenic plant. The promoters are categorized into constitutive and seed-
specific promoter. The constitutive promoters are further divided into two subcategories which 
are plant virus-derived (CaMV 35S) and endogenous promoters (maize ubi-1 and U3). The 
maize endosperm-specific 27 kDa γ-zein promoter was utilized to drive the dsRNAs 
expression in seed. Summary of all constructs are summarized in Figure 1. In total, 8 DNA 
constructs were designed for the expression of dsRNA308 and dsRNA381 in maize. 
Constitutive expression constructs of dsRNA308 (A547, A558, and A559) and dsRNA381 
(A561 and A560) were regenerated into transgenic callus culture. Constitutive construct A455 
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were regenerated into both callus culture and seed production in the greenhouse. Constructs 
driven by seed-specific 27 kDa γ-zein promoter (A543 and A544) were advanced in the 
greenhouse for T1 seed production (Table 1).  
Four constructs (A543, A547, A558, and A559) expressing dsRNA308 specific to 
WSSV were transformed into maize Hi II immature embryos (Figure 1). A total of 14 events 
were generated in the construct A547 expressing dsRNA308 driven by maize ubi-1 promoter. 
Constitutive expression of dsRNA308 driven by maize U3 promoter (construct A559) resulted 
in 12 transgenic events generated. Ten transgenic events were generated in A543 construct 
carrying seed-expression of dsRNA308 (Table 1). Similar to the observation in soybean 
ST171, the A558 construct expressing dsRNA308 driven by CaMV35S promoter showed 
growth inhibition (Figure 2B). Transgenic callus events of A558 construct showed poor callus 
growth and performance compared to the routinely observed callus for typical Hi II 
transformation (Figure 2D). The embryogenic callus in A558 were non-regenerable, 
consequently no transgenic events were recovered from this construct (Table 1). 
Four constructs expressing dsRNA381 specific to IMNV were also tested in maize. A 
total of 12 events were obtained in A560 construct and 10 events were generated in A561 
construct. Twelve transgenic lines expressing dsRNA381 in seeds were obtained from A544 
construct. In contrast to the observation in soybean (ST171), 10 transgenic events were 
generated in A455 construct expressing dsRNA381 driven by CaMV 35S promoter (Table 1). 
Most of the transgenic callus events of A455 construct showed normal morphology (similar to 
the routinely observed, Figure 2D). However, several events of A455 construct showed small 
callus size (Figure 2C). Nonetheless, all of the transgenic callus events were regenerable into 
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T0 plants. There was no abnormality observed in the T0 plants of A455 construct and transgenic 
plants were able to produce T1 seeds. 
 
Molecular analyses of plant-expressed dsRNA308 and dsRNA381 
 DNA PCR analysis was assayed to confirm the presence of dsRNA and selectable 
marker bar genes in transgenic callus and plants. All transgenic events generated in this study 
were both positive for the presence of dsRNA and bar gene (data not shown). Reverse 
transcriptase (RT) PCR was performed to analyze dsRNAs expression in transgenic maize and 
soybean. This assay was also used to screen transgenic lines with high expression of dsRNAs. 
Three events with high dsRNAs expression from each construct were chosen for further 
analysis.  
Representative gene expression analysis of dsRNA308 and dsRNA381 in transgenic 
soybean and maize is presented in Figure 3. Three transgenic events (event no 7, 12, and 14) 
from soybean ST181 were analyzed for dsRNA308 gene expression. Each event represented a 
pool of total RNA isolated from 15 transgenic seeds.  RT-PCR analysis showed the expression 
of 226 bp dsRNA308 in transgenic soybean seeds of ST181 (Figure 3A). Ten transgenic callus 
events from A547 construct were also analyzed for the expression of dsRNA308. As shown in 
Figure 3B, the 226 bp transcript were observed in all events indicating the expression of full 
length dsRNA308. Analysis of 12 transgenic callus events from A561 construct expressing 
dsRNA381 driven by maize U3 promoter showed the accumulation of 220 bp transcript 
(Figure 3C). These results suggest that transgenic plants could accumulate long dsRNAs 
specific to shrimp viral pathogens. 
An interesting observation was shown in the construct A455 expressing dsRNA381 
driven by CaMV 35S promoter. DNA PCR analysis of 10 transgenic callus events showed the 
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presence of dsRNA381 and bar genes (Figure 4A). Representative gene expression analysis 
of A455 construct is presented in Figure 4B. Three transgenic lines from construct A455 were 
analyzed for transcript analysis of dsRNA381 and bar. Bar transcript could be detected in 
A455 transgenic plants indicating gene expression activity. However, dsRNA381 transcript 
was undetectable in all samples.  As mentioned in the previous section, the same T-DNA 
construct caused lethality when transformed into soybean (ST171).  
The accumulation of dsRNA308 and dsRNA381 transcript was further analyzed with 
Northern blot assay. Three transgenic events with high expression of dsRNA were tested. Total 
RNA isolated from non-transgenic soybean seed and maize callus were utilized as negative 
control. The E.coli-expressed dsRNAs spiked with non-transgenic total RNA was used as 
positive control.  Three events from construct ST181 (event no 12, 14, and 32) and A547 (event 
no 10, 14 and 19) were analyzed for the accumulation of dsRNA308 transcript. Northern blot 
analysis showed dsRNA308 transcript in all samples (Figure 5A). Three events from construct 
A560 (event no 1, 2, and 3) and A561 (event no 9, 22, and 23) were analyzed for dsRNA381 
transcript. Northern blot analysis also showed the expression of dsRNA381 in both constructs 
A560 and A561 (Figure 5B).  
 
Expression level of dsRNA308 and dsRNA381 in transgenic plants 
Transcript levels of dsRNA308 and dsRNA381 in soybean and maize were determined 
with quantitative PCR. The dsRNA308 accumulation was analyzed in the ST181, A543, A547 
and A559 constructs. The A547 construct expressing dsRNA308 driven by maize ubi-1 
promoter showed highest dsRNA308 transcript level (Figure 6A). Highest accumulation level 
of dsRNA308 in construct A547 was about ±0.0023% total RNA. Constructs A543, A560, and 
A561 were analyzed for the accumulation of dsRNA381. The A561 construct expressing 
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dsRNA381 driven by maize U3 promoter showed highest accumulation of the dsRNA381 
(Figure 6B). However, expression levels of dsRNA381 were lower than dsRNA308. Highest 
accumulation of dsRNA381 in construct A561 was ±0.0006% of total RNA. 
Transcript reading analysis of constructs ST181 and A547 showed full length reading 
of the sense and antisense strands of dsRNA308 in soybean and maize. This result further 
confirmed that full length dsRNA308 in double stranded form was expressed in soybean and 
maize. Transcript reading analysis indicated higher expression of dsRNA308 in maize A547 
compared to soybean ST181. Accumulation of dsRNA308 in maize construct A547 was 
approximately 4 folds higher compared to soybean ST181 (Figure 7). This result is in 
agreement with the quantitative PCR analysis (Figure 6).  However, the number of reading of 
dsRNA308 transcript was low compared to total transcripts of soybean and maize. Highest 
accumulation of dsRNA308 was ±0.002% of total transcript. This result further confirmed low 
accumulation of dsRNA308 in transgenic soybean and maize. Analysis of construct A455 
showed undetectable level of dsRNA381 transcript while bar transcript was presence in all 
samples. This result further confirmed that dsRNA381 was possibly silenced. 
 
Next gene sequencing analysis 
Transcriptome analysis was performed against reference genome of soybean (William 
82) and maize (B73) to analyze the differentially expressed genes due to the ectopic expression 
of dsRNAs specific to shrimp viral pathogens. Three events with high dsRNA308 expression 
from soybean ST181 construct (event no 12, 14, and 32) and maize A547 (event no 10, 14, 
and 19) were analyzed. Three events from maize construct A455 (event no 2, 4 and 8) that 
showed undetectable expression of dsRNA381 were also included in the analysis. Non-
transgenic soybean William 82 and maize Hi II were used as negative controls. Soybean data 
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reflects transcriptome of soybean seed. Sequencing data of maize samples reflect 
transcriptome of maize Hi II callus. 
Sequencing data of transgenic soybean ST181 (event no 12, 14 and 32) was mapped to 
a total of 88,647 genes. The data was further narrowed down into 250 genes that were 
differentially expressed between transgenic and non-transgenic plants (Table S1). Among 
these transcripts, genes related with late embryogenesis abundant (LEA) proteins were down-
regulated (3-5 fold) in the transgenic samples. Seed maturation proteins, plant seed protein, 
and senescence associated proteins were also down-regulated in transgenic samples. On the 
other hand, protein synthesis elongation factor Tu (EF-Tu) and ABA-responsive protein-
related were upregulated in the transgenic samples. 
Sequencing data of transgenic maize samples (A455and A547) showed expression of 
260,000 genes. Transcriptome analysis showed differentially expressed genes between 
transgenic maize compared to wild type Hi II maize. Data was further narrowed down into 250 
transcripts that were differentially expressed between transgenic and non-transgenic samples 
(Table S2). Glycine rich protein and membrane protein complex were down-regulated in both 
maize A455 and A547 compared to non-transgenic sample. Several genes such as heat shock 
protein 70 (hsp70), ATP-synthase, cysteine and serine-protease superfamily related genes were 
highly upregulated in the A455 sample compared to A547.  
 
Shrimp bioassay 
Shrimp bioassay was performed to test the activity of plant-derived dsRNA as antiviral 
agent for shrimp. Shrimp was injected with total RNA of soybean ST181 seed expressing 
dsRNA308 (Group GDS). Group GDS that received 250 µg of transgenic soybean RNA was 
compared to positive control groups (Groups EDR and EDS) that received E.coli expressed 
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dsRNA308. Two negative control groups received 250 µg of non-transgenic soybean RNA 
(Group NT) or RNase-free water (Group NC) were also included in the experiment. A sham 
group (CH) was injected and infected with RNase free water. All groups except CH was 
challenged with WSSV 72 hours post injection. The survival of shrimp was monitored daily 
in a period of 16 days post infection (dpi) (Figure 8). At 8 dpi, 50% of the shrimp in the Group 
GDS that received soybean-dsRNA308 were able to survive while the negative control groups 
injected with non-transgenic RNA (Group NT) or water (Group NC) showed below 20% 
survival. The 40% of shrimp in the group GDS could survive until 11 dpi and at 14 dpi no 
survival was observed in this group. Positive control groups receiving 1 µg E.coli expressed 
dsRNA308 or non-challenged group showed more than 95% survival until the end of 
experiment. A sham control group (CH) that was injected and challenge with RNase free water 
showed > 95% survival until the end of experiment. 
 
Discussion 
RNAi pathway is a mechanism to regulate gene expression, harmful or aberrant 
mRNAs, and activate host-pathogens interaction pathway (Baulcombe, 2004). Recent studies 
showed that this pathway also activates interferon as antiviral mechanism (Kumar et al., 2015; 
Robalino et al., 2007). The potential of therapeutics RNA emerged because RNAi acts in a 
sequence specific manner that leads to the degradation of mRNA target (Sioud, 2004). A recent 
study showed injection of in-vitro expressed dsRNA specific to viral pathogen IMNV in 
shrimp provided 95% protection against lethal challenge of the virus (Loy et al., 2012). This 
result indicates the potential of dsRNA as vaccines for infectious viral pathogens.  
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Transgenic plants have been utilized as host for the accumulation of recombinant 
proteins (Fischer et al., 2004). This system offers a relatively cheap system for the 
accumulation of valuable products. In this study, plants were utilized as a platform for the 
accumulation of therapeutic RNA to explore the feasibility of plant system not only for 
recombinant proteins production but also to accumulate valuable molecules. This work 
demonstrates an attempt to accumulate dsRNA as vaccine for shrimp viral pathogens in 
transgenic soybean and maize. Soybean and maize are major crops produced annually 
providing grains for food and feed. Expression of dsRNA in soybean seed for shrimp vaccine 
could benefit the application of edible vaccine.  
Constitutive and seed-specific promoters were utilized to drive the expression of 
dsRNAs in maize and soybean. The CaMV 35S promoter is a constitutive promoter derived 
from plant virus and has been extensively studied to enhance gene expression. In the present 
work, negative effects were shown in the constructs driven by the CaMV 35S promoter 
regardless of the dsRNA being expressed. A T-DNA construct carrying expression cassette of 
dsRNA381 driven by the CaMV 35S caused detrimental effect in soybean ST171 and silencing 
in maize A455. On the other hand, expression of dsRNA308 driven by the CaMV 35S 
suppressed maize callus growth that eventually led to lethality in the construct A558. The 
CaMV 35S has been shown to cause negative effects such as silencing and interfere with plant 
growth (Flavell, 1994; Matzke and Matzke, 1995; Potenza et al., 2004).  
Silencing effect of CaMV 35S might be caused by the fact that this promoter is derived 
from plant virus and plant endogenous promoter is preferable to minimize this effect (Potenza 
et al., 2004). In this work, maize endogenous constitutive promoter ubi-1 and U3 were tested 
to drive the expression of dsRNA308 and dsRNA381. Multiple transgenic events were 
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recovered from constructs driven by these promoters. Our data showed that highest expression 
of the dsRNA308 was shown in the construct A457 driven by maize ubi-1 promoter. On the 
other hand, highest expression of the dsRNA381 was shown in the construct A560 driven by 
maize U3 promoter. Maize ubi-1 is strong constitutive promoter that has been reported to lead 
to high accumulation of recombinant proteins (Lu et al., 2015). Our results showed that 
endogenous promoters could minimize negative effects and resulted in higher dsRNAs levels 
compared to the CaMV 35S.  
We also tested seed-specific promoter in order to confine gene expression and 
minimize the negative effects that might interfere with plant growth and thus promote 
transgenic event recovery. Seed specific promoters the β-conglycinin and 27 kDa γ-zein were 
used in soybean and maize, respectively. Multiple transgenic events were generated in these 
constructs and transgenic plants showed normal phenotype suggesting that confinement of 
gene expression could minimize negative effects. Gene expression analysis showed the 
accumulation of full length dsRNAs (dsRNA308 and dsRNA381) in maize and soybean seeds.  
However the accumulation of dsRNAs was low compared to the constructs driven by 
constitutive promoters (maize ubi-1 and U3). This might be caused by the fact that seed is an 
organ for protein storage. Nevertheless, our study demonstrated that dsRNA specific to shrimp 
viral pathogens can be expressed in seed (soybean and maize) although improvement is needed 
to increase the accumulation level of dsRNA.  
Next gene sequencing analysis showed differential expressed genes of transgenic 
plants expressing dsRNA specific to WSSV and IMNV compared to wild type. It is interesting 
to note that late embryogenesis abundant (LEA)-related proteins were down-regulated in the 
soybean ST181 expressing dsRNA specific to WSSV in seed. Several other genes related to 
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seed maturation proteins, plant seed protein, and senescence associated proteins were also 
down-regulated in the transgenic samples. In the present work, only a brief summary of the 
next gene sequencing result is presented. In depth analysis of the sequencing data is part of the 
future work.  
In all attempts of using different promoters, ectopic expression of dsRNAs specific to 
shrimp viral pathogens were favorable under the activity of plant endogenous promoters. 
Accumulation levels of dsRNAs in soybean and maize were low indicating that transgenic 
plants were not efficient as platform for the accumulation of dsRNA vaccine. Addition of 
elements in the DNA construct expression cassette such as silencing suppressor gene might 
enhance the dsRNA levels. It has been reported that polyadenylation (Poly A) tail contributes 
to the mRNA stability and reduce degradation or RNA turnover. The stability depends on the 
length of Poly A. This application has been applied for example in guide RNA (gRNA) of the 
CRISPR. It could be that by adding poly A tail in the DNA construct might increase the 
accumulation of dsRNA although further study should be performed to verify this speculation. 
It has been reported that the expression of silencing suppressor such as P1/Hc-Pro lead to 
expression of mRNA target beyond its limit expression levels (Anandalakshmi et al., 1998; 
Mallory et al., 2002). Expression this protein along with dsRNA expression cassette might 
improve dsRNA expression. Further experiments are needed to unravel function of each 
element and confirm this hypothesis. 
The efficacy of dsRNA delivery into target animals is also determined by the chemical 
and physical barriers. These barriers are known to limit the uptake of dsRNA by cells which 
is important for relaying the immunity mechanism. Recent report highlighting the possibility 
of dietary micro RNA (miRNA) in regulating metabolic processes (Snow et al., 2013) which 
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showed the potential of horizontal delivery of micro RNA through diet and emphasize the 
feasibility of exogenous dsRNA application as oral therapeutics. However, question remains 
whether exogenous dsRNA can survive gastrointestinal (GI) tract. There is discrepancy 
towards the result that this delivery system could be ineffective (Dickinson et al., 2013). An 
assessment of orally-delivered miRNA in mice demonstrated that exogenous miRNA could 
survive GI track.  However, only a small percentage of miRNA was able to travel through 
bloodstream (Zhang et al., 2012).  
Antiviral response triggered by siRNA is affected by the length of dsRNA (Reynolds 
et al., 2006). Preliminary result showed that injection of long dsRNA was more efficient in 
providing protection against WSSV in shrimp. In this study, full length of the dsRNA308 and 
dsRNA381 were detected in transgenic soybean and maize. Due to potential application of 
soybean-derived dsRNA as shrimp oral vaccine, soybean-derived dsRNA308 was used in the 
shrimp bioassay study. Injection of total RNA isolated from transgenic soybean seeds 
expressing dsRNA308 into shrimp resulted in moderate protection against lethal challenge of 
WSSV. This result suggested the activity of plant-derived dsRNA308 against WSSV. Since, 
total RNA was vaccinated into shrimp; it means that only low level of specific dsRNA308 was 
delivered into shrimp consequently moderate protection was observed in this study. The 
specific dsRNA308 can be enriched from the total RNA by size specific purification. However, 
this preparation is laborious and expensive. Furthermore, large transgenic materials are needed 
to achieve efficient level of dsRNAs for vaccination.  
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Table 1. Vector constructs of dsRNA308 and dsRNA381 expression in transgenic maize and soybean
No crops construct ID promoter
type of 
expression
tissue 
transformed
transgenic 
materials 
generated
#event
1 A543 27-gamma zein seed specif ic immature embryo seeds 10
2 A547 maize ubi-1 constitutive immature embryo callus 14
3 A558 35 S constitutive immature embryo not regenerable not regenerable
4 A559 U3 constitutive immature embryo  callus 12
5 A455 35S constitutive immature embryo callus and seeds 10
6 A544 27 gamma zein seed specif ic immature embryo seeds 12
7 A560 maize ubi-1 constitutive immature embryo  callus 12
8 A561 U3 constitutive immature embryo callus 10
9 dsRNA381 ST-171 35 S constitutive mature seed not regenerable not regenerable
10 dsRNA308 ST-181 beta conglycinin seed specif ic mature seed seeds 8
maize
dsRNA308
dsRNA381
soybean
Table 2. Shrimp bioassay of soybean-expressed dsRNA308
No Groups RNA #animals dose* challenge
1 GDS soybean derived dsRNA308 30 250 µg WSSV
2 NT non-transgenic soybean 20 250 µg WSSV
3 EDR E.coli expressed dsRNA308 20 1 µg dsRNA308 WSSV
4 EDS E.coli expressed dsRNA308 spiked w ith non-transgenic soybean 20 1 µg dsRNA308 + 249 µg non-transgenic soybean RNA WSSV
5 NC negative control 20 RNase free w ater WSSV
6 CH sham 20 RNase free w ater Rnase free w ater
*Each animal received intramuscular injection in a total volume of 100 µl 
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Figure 1. T-DNA expression cassettes of dsRNA308 and dsRNA381 transformed into 
maize and soybean. Constitutive promoters: Cauliflower mosaic virus (CaMV) 35S; maize 
ubiquitin (zm ubi-1); maize U3 (zm U3); seed-specific promoters: maize 27 kDa γ-zein (27 
kD γ-zein) and soybean β-conglycinin were utilized to drive the expression of hairpin construct 
dsRNA308 and dsRNA381. s308, sense strand dsRNA308; as308, antisense strand dsRNA30; 
s381, sense strand dsRNA381; as381, antisense strand dsRNA381; L, loop; 3’UTR’ 3’ 
untranslated region. 
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Figure 2. Morphologies of soybean and maize tissues transformed with construct 
expressing dsRNAs driven by CaMV 35S promoter. (A) Transformation of T-DNA 
construct expressing CaMV35S-dsRNA381 caused detrimental effect in soybean William 82 
(ST171). (B) Transformation of CaMV35S-dsRNA308 into maize Hi II (A558) resulted in 
poor callus growth and non-regenerable. (C) Several transgenic maize callus expression 
CaMV35S-dsRNA381 (A455) showed poor callus growth. (D) Normal morphology of maize 
Hi II callus in the Agrobacterium-mediated transformation. 
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Figure 3. Transcript analyses of dsRNA308 and dsRN381 in transgenic soybean and 
maize. (A) Seed-specific expression of dsRNA308 in transgenic soybean ST181 line 7, 12 and 
14. (B) Constitutive expression of dsRNA308 driven by maize ubi-1 promoter (A547) in 10 
transgenic maize lines. (C) Expression analysis of dsRNA308 driven by maize U3 promoter 
(A561) in 12 transgenic maize lines. M, 100 bp DNA ladder; P, plasmid expressing dsRNA308 
or dsRNA381 as positive control; WT, non-transgenic Hi II maize as negative control. 
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Figure 4. Molecular analyses of transgenic maize A455 expressing dsRNA381 driven by 
CaMV 35S. (A) DNA PCR analysis of ten transgenic maize lines A455 showed the presence 
of dsRNA381 and selectable marker bar gene. (B) Transcript analysis of 3 transgenic maize 
lines showed the expression of bar gene but the expression of dsRNA381 was undetectable. 
M, 100 bp DNA ladder; P, plasmid expressing dsRNA381 as positive control; WT, non-
transgenic maize Hi II as negative control; actin, housekeeping gene as internal control. 
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Figure 5. Northern blot analysis of dsRNA308 and dsRNA381 in transgenic maize and 
soybean. (A) Expression of dsRNA308 in transgenic soybean ST181 and maize callus A547. 
(B) Expression of dsRNA381 transgenic maize callus A560 and A561. Three transgenic lines 
were tested from each construct. E.coli expressed dsRNA308 (E308) and dsRNA381 (E381) 
were utilized as positive control and spiked with non-transgenic Hi II maize RN. MWT, total 
RNA of non-transgenic maize; SWT, total RNA of non-transgenic soybean William 82 seeds.  
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Figure 6. Relative expression level of dsRNA308 (A) and dsRNA381 (B) in transgenic 
maize and soybean.  
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Figure 7. Next generation sequencing analysis of dsRNA308 transcript in maize A547 
and soybean ST181. 
 
  
164 
 
 
 
 
Figure 8. Shrimp bioassay of soybean-derived dsRNA308 for WSSV vaccine. GDS, group 
injected with ST181 total RNA; EDR, group injected with E.coli expressed dsRNA308; EDS, 
group injected with E.coli expressed dsRNA308 spiked with non-transgenic RNA; NT, group 
received non-transgenic RNA; CH, group injected with RNase free water; NC, group injected 
with RNase free water. Groups GDS, EDR, EDS, NT and NC were challenged with virus 
WSSV 72. CH was challenged with RNase free water. Shrimp survival was monitored daily.  
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Table S1. Differentially expressed genes in transgenis soybean ST181 expressing dsRNA308     
Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID 
Glyma.10G000100.1 Glyma.10G055300.1 Glyma.10G174400.2 Glyma.10G262400.1 Glyma.17G059900.1 Glyma.17G245100.2 Glyma.09G191200.1 Glyma.04G028100.1 
Glyma.10G003500.1 Glyma.10G064400.1 Glyma.10G179000.1 Glyma.10G277800.1 Glyma.17G062000.1 Glyma.17G245600.2 Glyma.09G199000.1 Glyma.04G042300.1 
Glyma.10G006200.1 Glyma.10G067600.1 Glyma.10G179600.1 Glyma.10G287400.1 Glyma.17G062600.2 Glyma.17G247000.1 Glyma.09G235500.1 Glyma.04G061800.1 
Glyma.10G009200.1 Glyma.10G068800.1 Glyma.10G180600.1 Glyma.U025900.2 Glyma.17G062600.1 Glyma.17G251900.1 Glyma.04G009900.1 Glyma.04G063000.1 
Glyma.10G012600.1 Glyma.10G078900.1 Glyma.10G180600.2 Glyma.U025900.1 Glyma.17G063400.1 Glyma.17G255600.1 Glyma.04G009400.1 Glyma.04G065400.1 
Glyma.10G014200.1 Glyma.10G081100.1 Glyma.10G180600.3 Glyma.U040900.1 Glyma.17G072400.1 Glyma.09G008100.1 Glyma.04G018700.1 Glyma.04G065500.1 
Glyma.10G014200.3 Glyma.10G082100.1 Glyma.10G189900.1 Glyma.U007300.1 Glyma.17G075800.1 Glyma.09G011600.1 Glyma.04G019600.2 Glyma.04G073900.3 
Glyma.10G014200.2 Glyma.10G082300.1 Glyma.10G192900.1 Glyma.U007400.1 Glyma.17G092200.2 Glyma.09G035400.1 Glyma.04G019600.1 Glyma.04G073900.2 
Glyma.10G014400.2 Glyma.10G094400.1 Glyma.10G193900.1 Glyma.17G016300.1 Glyma.17G092200.1 Glyma.09G041500.1 Glyma.04G223500.1 Glyma.09G183300.1 
Glyma.10G014400.1 Glyma.10G098500.1 Glyma.10G205900.1 Glyma.17G020600.1 Glyma.17G092800.1 Glyma.09G046100.1 Glyma.04G226500.1 Glyma.09G185500.1 
Glyma.10G019000.1 Glyma.10G099200.1 Glyma.10G205900.2 Glyma.17G022300.3 Glyma.17G092800.2 Glyma.09G058100.1 Glyma.04G229800.1 Glyma.07G029500.3 
Glyma.10G019000.2 Glyma.10G099200.2 Glyma.10G207100.1 Glyma.17G022300.2 Glyma.17G137800.1 Glyma.09G069800.1 Glyma.04G240900.1 Glyma.07G029900.1 
Glyma.10G022900.1 Glyma.10G099200.3 Glyma.10G211300.1 Glyma.17G026300.1 Glyma.17G155000.1 Glyma.09G072100.1 Glyma.U041400.1 Glyma.07G043600.1 
Glyma.10G024300.4 Glyma.10G103000.1 Glyma.10G212600.1 Glyma.17G027400.1 Glyma.17G164200.1 Glyma.09G072100.2 Glyma.U041500.1 Glyma.07G055900.2 
Glyma.10G024300.2 Glyma.10G103000.2 Glyma.10G212600.2 Glyma.17G029000.1 Glyma.17G185500.1 Glyma.09G078400.1 Glyma.07G017700.1 Glyma.07G058700.1 
Glyma.10G024300.3 Glyma.10G124700.1 Glyma.10G212600.3 Glyma.17G029600.2 Glyma.17G185600.1 Glyma.09G081400.1 Glyma.07G019100.1 Glyma.07G070900.1 
Glyma.10G024300.1 Glyma.10G124700.3 Glyma.10G214200.1 Glyma.17G029600.1 Glyma.17G185800.1 Glyma.09G081600.2 Glyma.07G019100.2 Glyma.07G073100.1 
Glyma.10G025000.1 Glyma.10G124700.2 Glyma.10G214500.1 Glyma.17G032700.2 Glyma.17G186100.1 Glyma.09G090100.1 Glyma.07G023500.1 Glyma.07G078300.6 
Glyma.10G027600.2 Glyma.10G124800.1 Glyma.10G223400.1 Glyma.17G032700.1 Glyma.17G186600.1 Glyma.09G098900.1 Glyma.07G028200.1 Glyma.07G078300.2 
Glyma.10G027600.1 Glyma.10G132300.1 Glyma.10G225300.1 Glyma.17G032800.1 Glyma.17G187600.1 Glyma.09G111600.1 Glyma.07G028300.4 Glyma.07G078300.3 
Glyma.10G037100.1 Glyma.10G145300.3 Glyma.10G226400.1 Glyma.17G038400.2 Glyma.17G187600.2 Glyma.09G112100.1 Glyma.07G029500.1 Glyma.07G078300.1 
Glyma.10G038600.1 Glyma.10G145300.2 Glyma.10G232100.1 Glyma.17G038400.1 Glyma.17G202700.2 Glyma.09G123800.2 Glyma.04G170400.1 Glyma.07G078300.4 
Glyma.10G040600.1 Glyma.10G145300.1 Glyma.10G233300.1 Glyma.17G039000.1 Glyma.17G202700.3 Glyma.09G131500.1 Glyma.04G182000.1 Glyma.07G078300.5 
Glyma.10G040700.1 Glyma.10G147700.1 Glyma.10G235100.1 Glyma.17G039100.1 Glyma.17G202700.4 Glyma.09G133900.1 Glyma.04G191500.2 Glyma.07G079100.1 
Glyma.10G044200.1 Glyma.10G149200.1 Glyma.10G236000.1 Glyma.17G039200.8 Glyma.17G202700.1 Glyma.09G139600.1 Glyma.04G191500.1 Glyma.07G079200.1 
Glyma.10G044200.2 Glyma.10G149200.2 Glyma.10G238400.1 Glyma.17G039400.1 Glyma.17G202700.5 Glyma.09G158600.1 Glyma.04G194100.1 Glyma.07G079300.1 
Glyma.10G044200.3 Glyma.10G151900.1 Glyma.10G239100.3 Glyma.17G040600.1 Glyma.17G211000.1 Glyma.09G160500.1 Glyma.04G194800.1 Glyma.07G090400.1 
Glyma.10G047700.1 Glyma.10G155000.1 Glyma.10G244100.1 Glyma.17G040800.1 Glyma.17G218500.1 Glyma.09G164000.1 Glyma.04G217400.1 Glyma.07G091800.1 
Glyma.10G047700.2 Glyma.10G155300.1 Glyma.10G247500.1 Glyma.17G047600.4 Glyma.17G223300.1 Glyma.09G168300.1 Glyma.04G217400.2 Glyma.07G098000.1 
Glyma.10G048100.1 Glyma.10G161600.1 Glyma.10G250400.2 Glyma.17G047600.5 Glyma.17G242300.1 Glyma.09G178600.1 Glyma.04G218900.1 Glyma.07G104500.2 
Glyma.10G050500.1 Glyma.10G174400.1 Glyma.10G251900.3 Glyma.17G053700.1 Glyma.17G242900.3 Glyma.09G183300.2 Glyma.04G219800.1 Glyma.07G104500.1 
 
  
1
6
5
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Table S2. Differentially expressed genes in transgenic maize callus expressing dsRNA308 and dsRNA381 
Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID Gene ID 
GRMZM2G104553 GRMZM2G333069  GRMZM2G028870  GRMZM2G077769  GRMZM2G325462  GRMZM2G113239  GRMZM2G333777  GRMZM2G015804  
GRMZM2G059865 GRMZM2G032104  GRMZM2G120584  GRMZM2G426802  GRMZM2G319022  GRMZM2G332548  GRMZM5G849989  GRMZM2G103079  
AC177838 GRMZM2G032104  GRMZM2G035377  GRMZM2G055880  GRMZM2G428184  GRMZM2G092578  AC196215  GRMZM2G173067  
GRMZM2G093395 GRMZM2G399700  GRMZM2G085691  GRMZM5G863796  GRMZM2G105571  GRMZM5G859683  GRMZM2G119852  GRMZM2G078898  
GRMZM2G093399 AC191595  GRMZM2G535510  GRMZM2G062210  GRMZM2G180951  GRMZM2G703491  GRMZM2G445602  GRMZM2G365544  
GRMZM5G809743 GRMZM2G374812  GRMZM2G085827  GRMZM2G030173  GRMZM2G180951  GRMZM5G859683  GRMZM2G315321  GRMZM2G163129  
GRMZM5G833153 AC191595  GRMZM2G041881  GRMZM2G085909  GRMZM2G180951  GRMZM2G703490  GRMZM2G410704  GRMZM2G163154  
AC177838 GRMZM5G834145  GRMZM5G802392  GRMZM2G008327  GRMZM2G180951  GRMZM2G144558  GRMZM2G385605  GRMZM2G462885  
AC177838 GRMZM2G483779  GRMZM2G006673  GRMZM2G008327  GRMZM2G057778  GRMZM2G140339  GRMZM2G053627  AC208897  
GRMZM2G104553  GRMZM2G002167  GRMZM2G007025  GRMZM2G387837  GRMZM2G057727  GRMZM5G813886  GRMZM2G006676  GRMZM5G892535  
GRMZM2G104491  GRMZM2G002121  GRMZM2G015384  GRMZM2G013634  GRMZM2G358187  GRMZM2G300800  GRMZM2G164539  GRMZM5G892535  
GRMZM5G822187  GRMZM2G026639  GRMZM2G137366  GRMZM2G013986  GRMZM2G058301  GRMZM2G472236  GRMZM2G432557  AC208897  
GRMZM2G023647  GRMZM2G521058  GRMZM2G137236  GRMZM5G829371  GRMZM5G841360  GRMZM2G038982  GRMZM2G002002  GRMZM5G879116  
GRMZM5G815900  GRMZM2G065130  GRMZM2G436226  GRMZM2G014382  GRMZM2G008053  GRMZM2G453001  GRMZM5G880508  GRMZM5G891739  
GRMZM2G493774  GRMZM2G474194  GRMZM5G881380  GRMZM2G114934  GRMZM2G137312  GRMZM2G056231  GRMZM2G006977  GRMZM2G134251  
GRMZM2G131672  GRMZM2G161560  GRMZM2G092232  GRMZM2G453794  GRMZM2G392956  GRMZM2G136081  GRMZM5G827194  GRMZM2G134251  
GRMZM2G560476  GRMZM2G461427  GRMZM2G393083  GRMZM2G453794  GRMZM2G075701  GRMZM2G008550  GRMZM2G457178  GRMZM2G157580  
GRMZM2G560484  GRMZM2G579667  GRMZM2G393062  GRMZM2G453794  GRMZM2G475059  GRMZM2G314133  GRMZM5G863656  GRMZM2G407287  
GRMZM2G581519  GRMZM5G826836  GRMZM5G804870  GRMZM2G136859  GRMZM2G176155  GRMZM2G556515  GRMZM2G013457  AC197545  
GRMZM2G137648  GRMZM2G060296  GRMZM2G124550  GRMZM2G437776  GRMZM2G171181  GRMZM2G124051  GRMZM2G035217  GRMZM2G411653  
GRMZM2G137697  GRMZM2G164696  GRMZM2G144197  GRMZM2G341934  GRMZM2G171324  GRMZM2G124143  GRMZM2G005624  GRMZM2G040121  
GRMZM2G408834  GRMZM5G831937  GRMZM5G830509  GRMZM2G040762  GRMZM2G046932  GRMZM2G063287  GRMZM5G812298  GRMZM2G040503  
GRMZM2G330431  GRMZM2G114459  GRMZM2G144101  GRMZM2G070047  GRMZM2G149257  GRMZM2G362942  GRMZM2G155242  GRMZM2G024435  
GRMZM2G500797  GRMZM5G855560  GRMZM2G077669  GRMZM2G159427  GRMZM5G823004  GRMZM2G035243  GRMZM2G091563  GRMZM2G440164  
GRMZM2G032104  GRMZM2G028826  GRMZM2G077760  GRMZM2G476107  GRMZM5G820122  GRMZM2G333756  GRMZM2G015741  GRMZM2G099860  
GRMZM2G081343  GRMZM2G040638  GRMZM2G084733  GRMZM2G152877  GRMZM2G003530  GRMZM2G120587  GRMZM2G347808  GRMZM5G838788  
AC216849  GRMZM2G168073  GRMZM5G835736  GRMZM2G107473  GRMZM2G077897  GRMZM2G464575  GRMZM2G049070  GRMZM2G048324  
GRMZM2G156827  GRMZM2G024234  GRMZM2G311036  GRMZM2G410479  GRMZM2G347583  GRMZM2G130121  GRMZM2G111208  AC177908  
GRMZM2G108416  GRMZM2G326248  AC202066  GRMZM5G842143  GRMZM2G173030  GRMZM2G304442  GRMZM2G111208  GRMZM2G117930  
GRMZM2G040669  GRMZM2G092888  GRMZM2G113139  GRMZM5G885169  GRMZM2G477869  GRMZM2G030805  GRMZM2G117513  GRMZM2G104983  
GRMZM2G389194  GRMZM2G338924  GRMZM2G025107  GRMZM2G025190  GRMZM2G119766  GRMZM2G528636  GRMZM2G071172  GRMZM2G176595  
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Key Message 
An alternative selection system utilizing a bacterial phosphite oxidoreductase gene as the 
selectable marker was evaluated in Agrobacterium-mediated maize transformation and 
resulted in positive selection of transgenic events on the media containing phosphite as the 
selective agent. 
 
Abstract 
Application of phosphite (Phi) on plants can interfere plant metabolic system leading to 
stunted growth and lethality. On the other hand, ectopic expression of the ptxD gene in tobacco 
and Arabidopsis allowed plants to grow in media with Phi as the sole phosphorous source. The 
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phosphite oxidoreductase (PTXD) enzyme catalyzes the conversion of Phi into phosphate (Pi) 
that can then be metabolized by plants and utilized as their essential phosphorous source. Here 
we assess an alternative selectable marker based on a bacterial ptxD gene for Agrobacterium-
mediated maize transformation. We compared the transformation frequencies of maize using 
either the ptxD/Phi selection system or a standard herbicide bar/bialaphos selection system. 
Two maize genotypes, a transformation amenable hybrid Hi II and an inbred B104, were 
tested. Transgene presence, insertion copy numbers, and ptxD transcript levels were analyzed 
and compared. This work demonstrates that the ptxD/Phi selection system can be used for 
Agrobacterium-mediated maize transformation of both type I and type II callus culture and 
achieve a comparable frequency as the herbicide bar/bialaphos selection system.  
Keywords: Agrobacterium-mediated transformation, maize, phosphite, ptxD gene, phosphite 
oxidoreductase 
 
Introduction 
Global maize production is increasing annually and reached about 1 billion metric tons 
in 2013 (http://faostat3.fao.org/). Because of its importance as a crop for food, feed, fiber and 
fuel, the improvement of maize agronomic traits such as yield and pathogen resistance is an 
important aspect to ensuring the productivity of this crop. Crop improvement has been 
accomplished by using conventional breeding, which can take several decades to establish a 
new variety or by genetic engineering. Genetic transformation has been utilized as a method 
for targeted crop improvement allowing specific traits to be introduced into the maize genome 
(Moose and Mumm 2008). Agrobacterium-mediated transformation is a tool that has been 
developed for more than 25 years offers advantages compared to any other genetic 
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transformation method in terms of transgene stability, low copy transgene integration, and the 
length of the DNA segments that can be introduced into the plant genome (Frame et al. 2002; 
Ishida et al. 2007).  
During genetic transformation, plant tissues are grown on media containing a selection 
agent that kills non-transformed cells, allowing only transformed cells to survive (Miki and 
McHugh 2004). Choice of selectable marker is a key factor in the successful production of 
transgenic plants. Typically the selectable marker gene is placed along with the gene of interest 
in the DNA vector construct. Antibiotic (hygromycin and kanamycin) and herbicide (bialaphos 
and glyphosate) resistance genes have been widely utilized as selectable markers (Block et al. 
1987; Gordon-Kamm et al. 1990; van den Elzen et al. 1985). However, some plant species 
have natural resistance to antibiotics. For example, orchids are naturally resistant to 
hygromycin and kanamycin (Knapp et al. 2000). On the other hand, many plant species are 
sensitive to herbicides such as bialaphos or glyphosate. In fact a number of commercial 
genetically modified (GM) crops are either bialaphos resistant (LibertyLink®) or glyphosate 
resistant (Roundup Ready®) (Breyer et al. 2014). Although herbicide resistant genes are 
effective in achieving plant transformation, intellectual property restrictions can limit the 
utilization of such genes by the public sector. Recently, concern over possible horizontal gene 
transfer of herbicide resistance traits to wild relative species has also encouraged researchers 
to seek alternatives (Ramessar et al. 2007). 
One of the systems that has been developed is positive selection in which the selectable 
marker supports growth of transformed cells instead of killing non-transformed cells. The 
positive selection system based on E. coli phosphomannose isomerase (PMI) has been reported 
in a number of plants including maize, rice, tobacco, and cabbage (Joersbo and Okkels 1996; 
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Lucca et al. 2001; Min et al. 2007). The PMI enzyme reversibly converts mannose-6-phosphate 
to fructose-6-phosphate allowing the identification of transgenic events on media containing 
mannose (Negrotto et al. 2000; Reed et al. 2001). Higher transformation frequency compared 
to antibiotic selection using this system has been reported (Joersbo and Okkels 1996; Min et 
al. 2007).  
A recent study showed the utilization of phosphite oxidoreductase (ptxD) gene derived 
from Pseudomonas stutzeri WM88 as a positive selectable marker for plant transformation 
(López-Arredondo and Herrera-Estrella 2013). The PTXD catalyzes the conversion of 
phosphite (Phi), a non-metabolizable form of phosphorus (P), into inorganic phosphate (Pi) 
that can be readily used by plant cells as P source. Phi is a structural analogue of Pi and has 
been reported to act as an alternative fungicide that can inhibit the growth of oomycete 
(McDonald et al. 2001). Plants can only metabolize Pi. Selection of transgenic events using 
the ptxD gene allows transformed cells to utilize Phi as a phosphorous (P) source and survive 
on media containing Phi. A selectable marker system based on ptxD/Phi has been reported in 
tobacco and Arabidopsis (López-Arredondo and Herrera-Estrella 2013) and more recently in 
yeast transformation (Kanda et al. 2014) with some advantages in term of cost and safety 
compared to antibiotic selection.  
In this current study, PTXD was utilized as a selectable marker for Agrobacterium-
mediated maize transformation. Maize Hi II hybrid genotype and B104 inbred line have been 
shown to be amenable for the routine Agrobacterium-mediated transformation protocol (Frame 
et al. 2006; Frame et al. 2002; Zhao et al. 2002). Selection of transformed cells was performed 
on media containing monopotassium phosphite (KH2PO3) and compared to bialaphos 
selection. The bar/bialaphos is a selection system routinely used for maize transformation. The 
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ptxD/Phi system resulted in positive selection of transgenic events from Hi II and B104. 
Molecular analyses further confirmed the expression of ptxD gene in all transgenic events 
selected with Phi. Our results indicate that ptxD/Phi system can be effectively used for 
Agrobacterium-mediated maize transformation.  
 
Materials and methods 
DNA Construct  
The T-DNA region harboring the A522 plasmid containing both the ptxD (Lopez-Arredondo 
and Herrera-Estrella 2012) and the bar (White et al. 1990) genes was used in the experiment 
as shown in Figure 1. The plasmid is based on the Gateway binary vector pB7WG2 (Karimi 
et al. 2002), that contains the bar gene under the control of the nos promoter and terminator 
(Bevan et al. 1983) as selectable marker and the spectinomycin resistance (Sm/SpR) gene for 
selection in Agrobacterium and E. coli. The ptxD gene was codon optimized to be expressed 
in maize and regulated by the maize ubiquitin gene ubi1 promoter with its intron (Christensen 
et al. 1992) and the CaMV 35S terminator (Odell et al. 1985). The DNA construct was 
transformed into Agrobacterium tumefasciens EHA101 (Hood et al. 1986) and utilized to 
infect maize immature embryos. 
 
Plant Material 
Maize Hi II hybrid (Armstrong et al. 1991) and B104 inbred (Hallauer et al. 1997) genotypes 
were used in the experiments. Greenhouse grown maize ears were kindly provided by the Plant 
Transformation Facility of Iowa State University. Immature zygotic embryos (1.5-2.0 mm and 
1.8-2.0 mm) were dissected from Hi II and B104 maize ears, respectively.  
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Media preparation 
N6-based (Chu 1975) and MS-based (Murashige and Skoog 1962) media for Hi II and B104, 
respectively, were prepared as previously described by Frame et al. (2011). The media 
formulations for infection, resting and co-cultivation were the same between treatment and 
control groups. Detailed media compositions including different selective agents is described 
in Table 1 and Table S1. For Phi selection media preparation, basal salts of N6 and MS with 
no P were specially formulated by PhytoTechnology Laboratories (Overland Park, KS). 
Monopotassium phosphite (KH2PO3, CAS No. 13977-65-6) was purchased from Wanjie 
International (ZheJiang, China) while monopotassium phosphate (KH2PO4) was obtained from 
Sigma. Regeneration media for somatic embryo maturation and germination for Hi II and B104 
were prepared using MS salts (Murashige and Skoog 1962). 
 
Maize transformation 
Agrobacterium-mediated maize transformation was conducted following protocols described 
by Frame et al. (2011). Immature zygotic embryos of Hi II and B104 were infected with A. 
tumefaciens EHA101 (Hood et al. 1986) harboring the A522 plasmid expressing the ptxD gene, 
then transferred to cocultivation media, and kept in the dark at 20°C for three days. Immature 
embryos were subcultured onto resting media and kept in dark at 28°C for seven days before 
being transferred onto selection media. Unless otherwise stated, all tissue culture plates were 
maintained in dark at 28°C from this step forward. Embryos were transferred onto different 
selection media containing Phi or bialaphos as summarized in Table 1. The difference in the 
selection between Hi II and B104 is described as follows. 
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Selection of transgenic events for Hi II transformation 
Responding embryos were cultured on Selection 1 (S1) media (Table S1) in the dark (25oC) 
for two weeks. The media used for Phi selection treatment groups were depleted with P as 
described above. After two weeks, calli proliferating on the S1 media were subcultured onto 
Selection 2 (S2) media (Table S1). Subculture duration for S2 stage was 3 weeks for Phi and 
2 weeks for the bialaphos selection groups, respectively. Putative transgenic events forming 
Type II calli that survived the S2 selection stage were subcultured for another round of S2 
before being transferred onto pre-regeneration media for two weeks. Embryogenic calli were 
transferred onto Regeneration 1 (R1) media (Table S1) for 2 weeks for somatic embryo 
maturation and then subcultured to Regeneration 2 (R2) media (Table S1) and germinated in 
the light (25oC, 80 – 100 µE/m2/s, 16:8 photoperiod) for 7-10 days. Transgenic Hi II plantlets 
were advanced in the greenhouse to obtain flowering T0 plants.  
Selection of transgenic events for B104 transformation 
B104 embryos were cultured on B104 S1 media in the dark (25oC) for two weeks, and then 
subcultured onto S2 media (Table S1). As for Hi II transformation, the media used for Phi 
selection were depleted with P. Duration for the S2 stage were 4 weeks on Phi selection 
(freshly subcultured into new media every 2 weeks) and 2 weeks on bialaphos selection group. 
Putative transgenic Type I calli were subcultured on S2 media for two more rounds before 
being transferred onto R1 media for 2 weeks (Table S1). Mature somatic embryos were then 
subcultured to R2 media (Table S1) in the light (25oC, 80 – 100 µE/m2/s, 16:8 photoperiod) 
for 7-10 days for germination. 
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Molecular analyses 
Putative transgenic calli were subjected to molecular analysis to confirm the presence of the 
ptxD gene. Polymerase Chain Reaction (PCR) was used for DNA analysis. DNA from calli 
were extracted using cetyltrimethylammonium bromide (CTAB) protocol (Doyle and Doyle, 
1987) and utilized as a PCR template to amplify the ptxD gene (±1 Kb) using primer forward 
5´-GGTGTTACTTCTGCAGATGC-3´ and reverse 5-GAGAGATAGATTTGTAGAGA-3´. 
The PCR product was analyzed with agarose gel electrophoresis.  
Quantitative real time PCR (qPCR) was used to estimate copy number of ptxD in T0 
Hi II plants. Template genomic DNA (20 ng) was added in a reaction containing QuantiTect 
SYBR Green PCR master mix (Qiagen) following the manufacturer’s instruction. Each sample 
was analyzed in duplicate. Copy number estimation was determined against a known 
concentration of the plasmid A522 DNA control (Gadaleta et al. 2011; Song et al. 2002). 
The ptxD transcription level was analyzed using reverse-transcriptase PCR (RT-PCR) 
method. Total RNA was extracted from T0 Hi II plants using Qiagen RNeasy Plant Mini kit 
(Qiagen Inc, Valencia, CA) following the supplier’s instructions. Complementary DNA 
(cDNA) was synthesized from 1 µg of the total RNA using SuperSCript™ III reverse 
transcriptase (Invitrogen, Grand Island, NY) in a total volume of 20 µl. An aliquot of 2 µl 
cDNA (100 ng) was used as template for PCR to amplify approximately 300 bp fragment of 
ptxD gene using primer pair forward (5-TGAGCTGCTCGCACTCGTTA-3’) and reverse (5´-
AGTGCTCGCCGGGGCGAGAC-3). A housekeeping gene, actin, was used here as an 
internal control. An approximately 500 bp actin fragment was amplified using the following 
primers, forward (5´-ATTCAGGTGATGGTGTGAGCCACAC-3´) and reverse (5´-
GCCACCGATCCAGACACTGTACTTCC-3´). Equal amounts of PCR product were 
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analyzed by agarose gel electrophoresis and transcription level was determined semi-
quantitatively. Quantitative real time PCR (qPCR) was used to analyze the relative gene 
expression level of ptxD in T0 Hi II plants. Template cDNA was added in a reaction containing 
QuantiTect SYBR Green PCR master mix (Qiagen) following the manufacturer’s instructions. 
Each sample was analyzed in duplicate. Relative ptxD gene expression was determined using 
the ΔΔct method and normalized against the actin housekeeping gene. 
 
Results and discussion 
Phosphite selection kill curve establishment 
In previous work on tobacco transformation using the ptxD/Phi system as selection, it was 
established that 1 mM of Phi in regeneration media was adequate to select for transgenic events 
(López-Arredondo and Herrera-Estrella 2013). To determine the Phi selection level for maize 
transformation, we first evaluated a number of Phi concentrations (kill curve) for their effect 
on embryogenic callus induction for both maize Hi II and B104 genotypes. Maize immature 
zygotic embryos (IZEs) were aseptically dissected from ears of Hi II and B104. Approximately 
25 IZEs/plate were cultured in Pi-free media but containing different concentrations of Phi 
(from 0 to 3.5 mM). One control plate (standard N6S for Hi II and MSS for B104) was 
included. Due to limited explant sources, the evaluation was repeated only twice.  
Visual examination suggested that all Phi concentrations including 0 mM Phi 
suppressed callus formation and development regardless of callus types (Type II callus for Hi 
II and Type I callus for B104, Figure S1). It is likely that the lack of Pi in the callus induction 
media severely affected the callus formation. Based on these initials observations, we designed 
treatment groups as shown in Table 1. We used 0.5 and 1.25 mM Phi for S1 and S2, 
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respectively, in Hi II transformation (groups B and C); and 1.25 mM Phi for S1 and either 1.25 
or 2 mM Phi for S2 in B104 transformation (groups E-H). Because of the poor callus induction 
responses in the absence of Pi, we also included treatment groups (groups C, F and H) in which 
a low concentration of Pi (50 µM KH2PO4) was included in the S1 media to favor callus 
initiation and proliferation.   
 
Hi II transformation with phosphite selection 
In total, over 1,600 Hi II maize IZEs were infected with A. tumefasciens EHA101 carrying the 
A522 plasmid expressing both bar and ptxD genes in three independent experiments (Table 
2). As shown in Figure 1, this construct carries the bar gene under a constitutive CaMV 35S 
promoter and the ptxD gene under another constitutive and strong maize ubiquitin gene 
promoter. After co-cultivation, the infected embryos were divided into two or three selection 
groups for either bialaphos or Phi selection. In the first Hi II transformation experiment maize 
embryos selected with Phi were grown on S1 media containing 0.5 mM Phi for two weeks 
then transferred onto S2 containing 1.25 mM Phi for three weeks (Table 1). Control embryos 
were grown on S1 containing 1.5 mg/L bialaphos for 2 weeks then transferred to S2 containing 
3 mg/L bialaphos for another 2 weeks (Frame et al., 2011). Callus initiation from IZEs cultured 
on Phi-containing media was considerably slower than for the control IZEs on bialaphos 
selection. Embryogenic Type II callus emerged approximately three weeks after IZEs were 
transferred onto S2 media under Phi selection, while callus from the control group emerged as 
early as two weeks after being sub-cultured on S2. This delayed callus response on Phi-
containing media may be attributed to the fact that under Phi selection, plants have first to 
convert Phi into Pi before it can be metabolized.  
177 
 
In the subsequent Hi II transformation experiments (experiment 2 and 3), an additional 
Phi selection group (group C) was included whereby the S1 media was supplemented with 50 
µM Pi in addition to the 0.5 mM Phi selective agent. The small amount of Pi supplementation 
was intended to support immature embryo response in the early stage of development and 
improve the recovery of transformed cells. Interestingly, there was no noticeable difference in 
terms of callus growth and transgenic events recovery between group B and C (Table 2). 
Slower callus growth was also observed in the group C.  
To increase the likelihood that emerging calli were indeed transgenic events, they were 
transferred to S2 media for another round of selection before regeneration. All Hi II putative 
events identified from either bialaphos or Phi selection were regenerable (Figure 2). No 
morphological differences were observed from T0 plants regenerated from either selection 
system.  
 
B104 transformation under phosphite selection 
The B104 maize genotype is a better suited inbred for functional genomic studies compared to 
the hybrid genotype Hi II. It is one of the few inbred lines that are amenable for Agrobacterium-
mediated method using the bar/bialaphos selection system, and as such it was also tested in 
this study. Four independent experiments were conducted using maize B104 IZEs for 
transformation with the A522 construct. Based on observations from the kill curve 
experiments, the nature of B104 callus (Type I), and our experience in Hi II and B104 
transformation using bialaphos as a selective agent (Frame et al., 2011), we used 1.25 mM Phi 
in the S1 stage for B104 transformation. This was higher than the Phi concentration (0.5 mM) 
that was used for Hi II selection (Type II callus) at the same stage (Table 1). As we did for Hi 
II transformation, supplementation with 50 µM Pi (group F) or without Pi (group E) in Phi 
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selection were compared. Similar to what was observed in Hi II transformation, slower callus 
initiation was observed in both B104 Phi selection treatments (groups E and F) when compared 
to control embryos on the bialaphos selection media. In fact, callus initiation for B104 was 
even slower than that for Hi II. Type I embryogenic calli formation was apparent four weeks 
after sub-cultured onto Phi-containing S2 media, while Type I callus initiation for the 
bialaphos selection control group (group D) was observed 2 weeks after being subcultured 
onto S2 media.  
Unlike Type II callus of Hi II genotype that is friable and relatively homogenous, Type 
I callus of B104 is often compact and heterogeneous. Resistant calli generated from the 
infected embryos may contain a mixture of transformed and non-transformed cells. Therefore, 
resistant callus of B104 were further selected with another 2 rounds on S2 media. Each 
subculture of B104 was performed by cutting callus clump into small pieces and placing them 
onto fresh S2 media containing 2 mM Phi (groups E and F, Table 2). However, no putative 
embryogenic callus events survived after 2 weeks on S2 Phi selection media in the experiments 
1 and 2. In contrast, a total of 13 bialaphos resistant putative callus events (7 and 6 events from 
experiment 1 and 2, respectively) were recovered from the bialaphos selection control group 
(Table 2).  
A slight modification in the Phi selection media was made for B104 transformation 
experiments 3 and 4 (Table 2) whereby the concentration of Phi in S2 media was at 1.25 mM 
(group G and H) throughout selection. Slow emergence of Type I callus was also observed in 
groups G and H. However, after another two rounds in 1.25 mM Phi selection on S2, some 
putative transgenic calli could be identified. From these two independent experiments, a total 
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of six putative events from Phi selection (two events in group G, four events in group H) and 
15 putative events from the bialaphos selection (group D) were recovered (Table 2).  
 
Transformation frequencies 
A summary of transformation frequencies (TF) for Hi II and B104 with the treatment 
regimens described in Table 2 is presented in Figure 3. Due to limited resources including 
plant materials and person power, only three independent experiments for Hi II and four 
independent experiments for B104 were performed. Nevertheless, in each experiment, similar 
numbers of embryos were treated to evaluate the Phi selection.  
In general, Phi selection resulted in lower TF compared than bialaphos selection in 
both Hi II and B104. Based on 3 independent experiments in Hi II, the TF with ptxD/Phi 
selection (group B) ranging from 1.3 to 2% (Table 2) with an average of 1.5±0.4% (Figure 3). 
The inclusion of Pi in S1 media (group C) did not enhance TF (ranging from 1.3-1.7% with an 
average of 1.5±0.3%). On the other hand, in the control group (group A) selected with 
bialaphos, TF ranged between 2.4-5.1% with an average of 4.0±1.4%. It is worth noting that 
the TF of Hi II using the bar/bialaphos selection was below the TF previously reported using 
this protocol (Frame et al. 2011). This could be attributed to a number of reasons including 
sub-optimal ear quality and less experienced researchers.  
TF for B104 using ptxD/Phi selection was lower than for Hi II. The high Phi 
concentration (2 mM) in S2 media groups E and F did not support callus growth. Reduction of 
the Phi concentration to 1.25 mM resulted in a TF of 0.4%±0% (group G) while Pi 
supplementation (group H) resulted in TF between 0.4-1.1% with an average of 0.75±0.5% 
(Figure 3). Similar to Hi II transformation, higher TF was achieved for B104 using the 
bar/bialaphos for selection (4.7 ± 0.4%). However, it must be stated that due to limited 
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resources, the small number of experiments did not allow the optimization of ptxD/Phi 
transformation and most likely this could be significantly improved with further experiments. 
 
Effect of phosphite selection on callus growth  
In order to use ptxD/Phi as a selection system, plant materials have to be cultured on 
growth media that lacks Pi. If the ptxD gene is transformed and integrated into the genome and 
expressed, the transformed cells will be able to convert the non-metabolizable Phi into 
metabolizable Pi and thus survive and thrive on the media minus Pi. Lack of Pi in plant growth 
media severely inhibits maize callus growth as shown in the Phi kill curve experiments (Figure 
S1).  
In embryos infected with the ptxD carrying construct and selected on Phi, slower 
emergence of embryogenic callus was observed both in Hi II and B104 under Phi selection as 
compared to the control groups that were selected on bialaphos. Phi selection also affected 
embryogenic callus end-point size wherein smaller callus were observed for Hi II (Figure S2) 
and B104 (Figure S3) when compared with eventual callus size for the bialaphos selected 
explants. In the case of B104, further delay in the development of Type I callus compared to 
the Type II callus of Hi II in the experiments was observed. This may be due to the fact that a 
higher concentration of Phi (1.25 mM) was used in S1 for B104 compared to 0.5 mM Phi used 
for Hi II. To enhance callus initiation at the early embryo development stage, low 
concentration of metabolizable Pi was supplemented in the media to overcome the total lack 
of P at the S1 stage. However, this attempt did not improve callus growth or transgenic event 
recovery for Hi II or B104.  
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The concentration of Phi in S1, S2 and regeneration media should be optimized for 
future Hi II and B104 transformation. In addition, supplementation of Pi in the early callus 
initiation stage can be fine-tuned to further improve the overall transformation frequencies.    
 
Transgene co-presence and copy number analyses 
Resistant events generated in the transformation experiments were subjected to 
molecular analyses to confirm the presence of the ptxD gene. In total, 32 Hi II and 34 B104 
putative events were analyzed using the polymerase chain reaction (PCR) to detect the ptxD 
gene. Analysis results are summarized in Table 2 and representative events are presented in 
Figure S4. For Hi II, 14 events were generated from group A, 10 events from group B and 8 
events from group C. All events, regardless whether they were selected from the bialaphos 
system (group A) or the Phi system (groups B and C), contained the intact copy of the ptxD 
and bar gene fragments (Figure S4A). For B104, all events generated from Phi selection (2 
from group G and 4 from group H) were positive for the ptxD and bar genes (Figure S4B). 
These results indicate that both selection systems can also deliver an accompanying gene of 
interest for both maize Hi II and B104 transformed in this study.  
To evaluate whether different selection systems have any effect on copy number of the 
ptxD gene, we performed quantitative PCR (qPCR) on T0 plants of Hi II events (Figure 4A). 
Plasmid A522 was utilized as a control to establish a standard curve for copy number 
estimation (Figure S5). Analysis of transgene copy number using qPCR has been reported in 
numerous studies as a reliable and fast method that is comparable to Southern blot 
hybridization (Gadaleta et al. 2011; Ingham et al. 2001; Song et al. 2002), especially in 
laboratories with resource constraints. Due to large genome size of maize, Southern blot 
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hybridization can present technical difficulty for laboratories that do not perform this technique 
regularly.  
Both single and multiple-copy insertions are observed in the events analyzed (Figure 
4A). Seven out of 22 events carry a single copy of ptxD. Six of the eight events tested were 
from the bialaphos selection (group A) and the remaining one event was from the Phi selection 
(group B). Group A (bialaphos selection) generated 67% (6/9) single copy events, 11% (1/9) 
low copy (2-4 copies) events, and 22% (2/9) high copy (>5 copies) events. Group B (Phi 
selection) generated 14% (1/7) single copy events, 86% (6/7) low copy events and no high 
copy event. Group C (Phi+Pi selection) generated no single copy event, 67% low copy events 
and 33% high copy events.  
The Agrobacterium-mediated maize transformation method is reported to generate 
transgenic events with single and low copy insertions (Ishida et al. 1996). Our work here, using 
either bialaphos or Phi selection, is in agreement with previous observations. It appears that a 
higher percentage of single copy events was obtained from the bialaphos selection group. 
However, the number of events obtained from each treatment groups are too low to be 
conclusive.  
The reason why some constructs or transformation procedures generate a higher 
percentage of single or multiple copy insertions remains a topic of discussion. Expression 
strength of a selectable marker gene expression may attribute to the copy number of an inserted 
marker gene (Gendloff et al. 1990; Hobbs et al. 1993). In this study, a single construct A522 
carrying both selectable marker gene, the bar and ptxD genes; the bar gene was driven by 
CaMV 35S promoter and the ptxD was driven by a maize ubiquitin promoter. Agrobacterium-
A522 strain was used for maize embryo infection and cocultivation. The infected embryos 
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were divided into 2 or 3 groups, either plated on media for bialaphos or for Phi selection. For 
future Phi selection optimization, different promoters could be evaluated to determine whether 
copy number insertions could be reduced to improve transgenic event quality.  
 
Transgene expression and phosphite tolerance tests  
The ptxD gene expression analysis was performed using reverse transcript (RT-PCR). 
Semi quantitative RT-PCR analysis detected the ptxD transcript in all T0 Hi II plants (Figure 
S6). Quantitative PCR analysis further verified relative expression level (low to high) of ptxD 
gene in T0 Hi plants (Figure 4B). Not surprisingly, medium to high ptxD gene expression was 
generally observed in transgenic events selected on Phi (group B and C). It is worth noting that 
almost all high expressers were the events that also carried high copy number inserts (Figure 
4A vs 4B). For example, the highest expression event C-1 carried 9 copies of the insert from 
the Phi selection group C. All single copy events, whether selected on bialaphos media (group 
A) or Phi media (group B), displayed low ptxD gene expression.  
The ability of Hi II transgenic maize expressing the ptxD gene to utilize Phi as a P 
source and tolerate Phi was confirmed by performing a Phi tolerance test. Two transgenic 
callus events each from group A (A-1 and A-6), group B (B-1 and B-4), and group C (C-4 and 
C-6) were grown on media containing three different levels of Phi (Figure 5). Their growth 
was compared with non-transgenic Hi II callus. Figure 5A compares the growth of one Phi-
positive event (B-1) and non-transgenic Hi II callus on three different media. On regular media 
(N6S) without any selective agents, both the transgenic and non-transgenic calli grow equally 
well. On N6S media containing 1.5 mg/L bialaphos only transgenic callus thrived while the 
non-transgenic callus growth was inhibited. This result also indicates that transgenic events 
generated in Phi selection were also resistant to bialaphos. Callus growth for both transgenic 
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and non-transgenic events was severely inhibited when cultured on media containing no Phi 
and Pi (the bottom panel in Figure 5A). This growth inhibition is due to the complete lack of 
a P source necessary for cell growth in the cell media. 
Figure 5B-D illustrates the growth of the six transgenic callus lines subcultured on 
media containing 1.25-5 mM of Phi. Event A-1 was a single copy but low expression ptxD 
event (Figure 4). This event could only grow on media containing 1.25 mM Phi but not on the 
media containing 2.5 and 5 mM Phi. Events B-1 and C6 both had 2-copies of the ptxD 
transgene and were medium expressors (Figure 4). These two events were able to grow on 
both 1.25 mM and 2.5 mM Phi-containing media, while their growth was slightly suppressed 
on 5 mM Phi-containing media. Events A-6, B-4 and C-4 were multiple copy number events 
(> 4) and were high expressors (Figure 4). Events B-4 and C-4 were able to grow on all media 
including 5 mM Phi; however, event A-6 grew well on the two low Phi media but had slight 
growth inhibition when cultured in 5 mM Phi media.  
The phenotypic performance observed from the selected transgenic callus lines 
correlates positively with their genotypic data, that is, the higher the ptxD gene expression, the 
better the callus grows on increasing concentration of Phi in the culture media. These results 
suggested that transgenic callus could metabolize Phi as P source and the ability of transgenic 
events to metabolize Phi depend on the level of gene expression. Although the high expressors 
identified in this work all possessed higher transgene copy number, it is worth noting that these 
tests were performed on T0 transgenic callus lines due resource constraints. Multiple-copy 
transgene insertions often cause more genome disruption than that of single-copy insertions. 
Multiple-copy insertion events also have high probability for transgene instability and reduced 
transgene expression in subsequent generations (Shou et al. 2004; Zhong et al. 1999).  
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Conclusion 
We have demonstrated that a bacterial gene encoding a phosphite oxidoreductase, 
PTXD, can be used as a selectable marker gene for Agrobacterium-mediated maize 
transformation. This system allows transformed cells expressing the ptxD gene to grow in the 
presence of Phi as a sole P source while non-transformed cells cannot. Since ptxD/Phi is not 
an antibiotic or herbicide resistance based selection system, it is less likely to cause resistance 
that commonly raise concern in the selectable system. Furthermore, Phi has been used as a 
biopesticide that does not pose harm to human health or the environment based on US 
environmental Protection Agency classification.  
It has been reported that the ptxD/Phi selection system can be used for tobacco and 
Arabidopsis transformation (López-Arredondo and Herrera-Estrella 2013). Here we confirm 
that it can be used effectively as a positive selectable marker system for the transformation of 
a major crop, maize. Despite the apparently lower transformation frequencies and the lack of 
progeny test due to limited resources in this assessment study, the fact that Phi resistant 
transgenic lines were recovered from two maize genotypes, could be readily generated by 
researchers with little transformation skills is evidence of the robustness of this selection 
system. Further improvements, including optimization of Phi concentrations in selection media 
will be needed to enhance the quantity and quality of transgenic events. It is also important to 
mention that the cost of Phi is significantly lower and more stable than herbicides or 
antibiotics, making it more amenable for the development of transformation systems of other 
crop plants. 
186 
 
Author contribution statement 
KW and LHE conceptualized the research, XX designed and performed kill curve experiment, 
HN designed and performed all experiments. LHE and DLA provided materials and expertise. 
HN and KW analyzed data and wrote manuscript. All the authors read and approved the 
manuscript. 
 
Acknowledgements 
HN and KW thank Bronwyn Frame for her expertise in the scientific discussion of 
transformation and critical review of the manuscript. This work was supported in part by the 
U.S. Department of Agriculture National Institute of Food and Agriculture (Hatch Project No. 
IOW05162 to KW), the Iowa State University Crop Bioengineering Consortium (KW) and 
Charoen Pokphand Indonesia (HN).  
 
Conflict of interest 
HN, XX and KW declare that they have no conflict of interest. DLA and LHE are employees 
of StelaGenomics México, which provided materials and expertise for the work. However, this 
does not alter the authors’ adherence to all the Plant Cell Reports policies on sharing data and 
materials. 
 
References 
Armstrong CL, Green CE, Phillips RL (1991) Development and availability of germplasm 
with high Type II culture formation response. Maize Genetics Cooperative Newsletter 
65:92-93 
 
 
187 
 
Bevan M, Barnes WM, Chilton MD (1983) Structure and transcription of the nopaline synthase 
gene region of T-DNA. Nucleic Acids Research 11(2):369-385 
 
 
Block MD et al. (1987) Engineering herbicide resistance in plants by expression of a 
detoxifying enzyme. The EMBO Journal 6(9):2513-2518 
 
 
Breyer D, Kopertekh L, Reheul D (2014) Alternatives to Antibiotic Resistance Marker Genes 
for In Vitro Selection of Genetically Modified Plants – Scientific Developments, 
Current Use, Operational Access and Biosafety Considerations. Critical Reviews in 
Plant Sciences 33(4):286-330  
 
 
Christensen A, Sharrock R, Quail P (1992) Maize polyubiquitin genes: structure, thermal 
perturbation of expression and transcript splicing, and promoter activity following 
transfer to protoplasts by electroporation. Plant Mol Biol 18(4):675-689  
 
 
Chu CC (1975) Establishment of an efficient medium for anther culture of rice through 
comparative experiments on the nitrogen sources. Scientia Sinica 18:659-668 
 
 
Frame B, Main M, Schick R, Wang K (2011) Genetic transformation using maize immature 
zygotic embryos. Methods in Molecular Biology (Clifton, NJ) 710:327-341  
 
 
Frame BR et al. (2006) Improved Agrobacterium-mediated transformation of three maize 
inbred lines using MS salts. Plant Cell Reports 25(10):1024-1034  
 
 
Frame BR et al. (2002) Agrobacterium tumefaciens-Mediated Transformation of Maize 
Embryos Using a Standard Binary Vector System. Plant Physiology 129(1):13-22  
 
 
Gadaleta A, Giancaspro A, Cardone MF, Blanco A (2011) Real-time PCR for the detection of 
precise transgene copy number in durum wheat. Cellular & molecular biology letters 
16(4):652-668  
 
Gendloff E, Bowen B, Buchholz W (1990) Quantitation of chloramphenicol acetyl transferase 
in transgenic tobacco plants by ELISA and correlation with gene copy number. Plant 
Mol Biol 14(4):575-583  
 
 
188 
 
Gordon-Kamm WJ et al. (1990) Transformation of Maize Cells and Regeneration of Fertile 
Transgenic Plants. The Plant Cell 2(7):603-618  
 
 
Hallauer AR, Lamkey KR, White PR (1997) Registration of five inbred lines of maize: B102, 
B103, B104, B105, and B106. Crop Science:1405-1406 
 
 
Hobbs SA, Warkentin T, DeLong CO (1993) Transgene copy number can be positively or 
negatively associated with transgene expression. Plant Mol Biol 21(1):17-26  
 
 
Hood EE, Helmer GL, Fraley RT, Chilton MD (1986) The hypervirulence of Agrobacterium 
tumefaciens A281 is encoded in a region of pTiBo542 outside of T-DNA. Journal of 
Bacteriology 168(3):1291-1301 
 
 
Ingham DJ, Beer S, Money S, Hansen G (2001) Quantitative real-time PCR assay for 
determining transgene copy number in transformed plants. BioTechniques 31(1):132-
134, 136-140 
 
 
Ishida Y, Hiei Y, Komari T (2007) Agrobacterium-mediated transformation of maize Nat 
Protocols 2(7):1614-1621 
 
 
Ishida Y, Saito H, Ohta S, Hiei Y, Komari T, Kumashiro T (1996) High efficiency 
transformation of maize (Zea mays L.) mediated by Agrobacterium tumefaciens. 
Nature Biotechnology 14(6):745-750  
 
 
Joersbo M, Okkels FT (1996) A novel principle for selection of transgenic plant cells: positive 
selection. Plant Cell Reports 16(3-4):219-221  
 
 
Kanda K et al. (2014) Application of a phosphite dehydrogenase gene as a novel dominant 
selection marker for yeasts. Journal of Biotechnology 182–183:68-73  
 
 
Karimi M, Inze D, Depicker A (2002) GATEWAY vectors for Agrobacterium-mediated plant 
transformation. Trends in Plant Science 7(5):193-195 
 
Knapp JE, Kausch AP, Chandlee JM (2000) Transformation of three genera of orchid using 
the bar gene as a selectable marker. Plant Cell Reports 19(9):893-898  
 
189 
 
Lopez-Arredondo DL, Herrera-Estrella L (2012) Engineering phosphorus metabolism in 
plants to produce a dual fertilization and weed control system Nature Biotechnology 
30(9):889-893  
 
 
López-Arredondo DL, Herrera-Estrella L (2013) A novel dominant selectable system for the 
selection of transgenic plants under in vitro and greenhouse conditions based on 
phosphite metabolism. Plant Biotechnology Journal 11(4):516-525  
 
 
Lucca P, Ye X, Potrykus I (2001) Effective selection and regeneration of transgenic rice plants 
with mannose as selective agent. Molecular Breeding 7(1):43-49  
 
 
McDonald AE, Grant BR, Plaxton WC (2001) Phosphite (Phosphorous Acid): its relevance in 
the environment and agriculture and influence on plant phosphate starvation response 
Journal of Plant Nutrition 24(10):1505-1519  
 
 
Miki B, McHugh S (2004) Selectable marker genes in transgenic plants: applications, 
alternatives and biosafety Journal of Biotechnology 107(3):193-232  
 
 
Min BW et al. (2007) Successful genetic transformation of Chinese cabbage using 
phosphomannose isomerase as a selection marker. Plant Cell Reports 26(3):337-344  
 
 
Moose SP, Mumm RH (2008) Molecular Plant Breeding as the Foundation for 21st Century 
Crop Improvement. Plant Physiology 147(3):969-977  
 
 
Murashige T, Skoog F (1962) A Revised Medium for Rapid Growth and Bio Assays with 
Tobacco Tissue Cultures. Physiologia Plantarum 15(3):473-497  
 
Negrotto D, Jolley M, Beer S, Wenck AR, Hansen G (2000) The use of phosphomannose-
isomerase as a selectable marker to recover transgenic maize plants (Zea mays L.) via 
Agrobacterium transformation. Plant Cell Reports 19(8):798-803  
 
 
Odell JT, Nagy F, Chua N-H (1985) Identification of DNA sequences required for activity of 
the cauliflower mosaic virus 35S promoter. Nature 313(6005):810-812 
 
Ramessar K et al. (2007) Biosafety and risk assessment framework for selectable marker genes 
in transgenic crop plants: a case of the science not supporting the politics. Transgenic 
Res 16(3):261-280  
190 
 
Reed J et al. (2001) Phosphomannose isomerase: An efficient selectable marker for plant 
transformation. In Vitro CellDevBiol-Plant 37(2):127-132  
 
 
Shou H, Frame B, Whitham S, Wang K (2004) Assessment of transgenic maize events 
produced by particle bombardment or Agrobacterium-mediated transformation 
Molecular Breeding 13(2):201-208  
 
 
Song P, Cai C, Skokut M, Kosegi B, Petolino J (2002) Quantitative real-time PCR as a 
screening tool for estimating transgene copy number in WHISKERS™-derived 
transgenic maize Plant Cell Reports 20(10):948-954  
 
 
van den Elzen PM, Townsend J, Lee K, Bedbrook J (1985) A chimaeric hygromycin resistance 
gene as a selectable marker in plant cells. Plant Mol Biol 5(5):299-302  
 
 
White J, Chang SY, Bibb MJ, Bibb MJ (1990) A cassette containing the bar gene of 
Streptomyces hygroscopicus: a selectable marker for plant transformation. Nucleic 
Acids Res 18(4):1062 
 
 
Zhao Z-y et al. (2002) High throughput genetic transformation mediated by Agrobacterium 
tumefaciens in maize. Molecular Breeding 8(4):323-333  
 
 
Zhong G-Y et al. (1999) Commercial production of aprotinin in transgenic maize seeds. 
Molecular Breeding 5(4):345-356  
  
191 
 
 
 
 
 
  
Table 1. Selective agent treatment groups
Genotypes Groups Selection 1 Selection 2 & Regeneration
A 1.5 mg/L bialaphos 3 mg/L bialaphos
B 0.5 mM Phi 1.25 mM Phi
C 0.5 mM Phi + 0.05 mM Pi 1.25 mM Phi
D 2 mg/L bialaphos 6 mg/L bialaphos
E 1.25 mM Phi 2 mM Phi
F 1.25 mM Phi + 0.05 mM Pi 2 mM Phi
G 1.25 mM Phi 1.25 mM Phi
H 1.25 mM Phi + 0.05 mM Pi 1.25 mM Phi
Phi: Monopotassium phosphite, KH2PO3
Pi: monopotassium phosphate, KH2PO4
B104
Hi-II
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Table 2. Hi II and B104 transformation summary
Genotypes Experiment 
#
Embryo size 
(mm)
# Embryos Treatment 
groups*
# Resistant & ptxd 
PCR+ events
Transformation 
frequency (%)
117 A 6 5.1
151 B 3 2.0
136 A 6 4.4
240 B 3 1.3
239 C 4 1.7
126 A 3 2.4
309 B 4 1.3
311 C 4 1.3
TOTAL 1629
117 D 6 5.1
235 E 0 0.0
235 F 0 0.0
138 D 7 5.1
271 E 0 0.0
271 F 0 0.0
141 D 6 4.3
285 G 1 0.4
285 H 1 0.4
136 D 6 4.4
270 G 1 0.4
270 H 3 1.1
TOTAL 2654
* Treatment description is listed in Table 1.
1.8
1.8-2.0
1.8
1.5-1.8
B104
1
2
3
4
Hi-II
1 1.2-1.8
2 1.5-1.8
3 1.5-1.8
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Figure 1. T-DNA region of A522 construct expressing the ptxD gene. P ubi1, maize ubi-1 
promoter; T35S, CaMV 35S terminator; P35S-bar-tvsp, bar gene expression cassette of driven 
by CaMV 35S promoter (P35S); Tvsp, soybean vegetative storage protein terminator; LB, 
Agrobacterium T-DNA left border; RB, Agrobacterium T-DNA right border; Hind III, 
restriction enzyme; kb, kilobases.  
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Figure 2. Overview of Hi II transformation at different developmental stage (1) resting, 
(2) Type II embryogenic callus, (3) somatic embryo maturation, (4) germination, and (5) T0 
plants. 
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Figure 3. Comparison of Hi II and B104 transformation frequencies under different 
selection systems. Infected embryos were cultured onto three different selection media 
(bialaphos, Phi, or Phi+Pi). Hi II transformation experiments were divided into three groups 
(A, B, and C). B104 transformation experiments were divided into five groups (D, E, F, G and 
H). 
  
196 
 
 
 
 
Figure 4. Copy number and gene expression analyses of the ptxD gene in T0 Hi II 
transgenic plants. (A) Copy number estimation of the ptxD gene determined by quantitative 
PCR, (B) relative ptxd gene expression normalized to actin housekeeping gene. Data from 
twenty two representative transgenic callus events generated from different selection systems: 
bialaphos (Group A), Phi (Group B), and Phi+Pi (Group C); WT, non-transgenic Hi II maize 
as negative control. 
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Figure 5. Phi tolerance test of transgenic Hi II callus. (A) Comparison of event B-1 callus 
generated from Phi selection and non-transgenic Hi II callus on media (N6S) without selective 
agents, N6S containing 1.5 mg/L bialaphos, or N6S without Phi and Pi. The ability of 
transgenic Hi II callus to utilize and tolerate Phi in the media containing different concentration 
of Phi (B) 1.25 mM; (C) 2.5 and (D) 5 mM Phi. Two transgenic Hi II events generated from 
bialaphos (A-1 and A-6), Phi (B-1 and B-4), and Phi+Pi (C-4 and C-6) selection groups were 
compared to non-transgenic Hi II callus. 
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Supplemental Materials 
Media composition 
Media composition for maize transformation was prepared as described by Frame, et al. (2011) 
with a slight modifications for phosphite (Phi) selection, whereby N6 and MS salts for Phi 
selection did not contain phosphate (Pi) as specially formulated by PhytoTechnology 
Laboratories (Overland Park, KS).  Complete media formulation of media for Hi II and B104 
are presented in Table S1.  
Basic media composition is as follow: 
N6S: 4 g/L N6 salts; 1 mL/L N6 vitamin stock; 1.5 mg/L 2, 4-D; 0.7 g/L L-proline; 30 g/L 
sucrose; 0.5 g/L 2-(4-morpholino)-ethanesulfonic acid (MES);  5 mM silver nitrate; 100 mg/L 
cefotaxime; 100 mg/L vancomycin; 8 g/L purified agar; pH 5.8. 
N6S-P: 3.59 g/L N6 salts without phosphate; 1 mL/L N6 vitamin stock; 1.5 mg/L 2,4-D; 0.7 
g/L L-proline; 30 g/L sucrose; 0.5 g/L MES; 0.5 mM potassium phosphite; 100 mg/L 
cefotaxime; 100 mg/L vancomycin; 5 mM silver nitrate; 8 g/L purified agar; pH 5.8. 
MSS: 4.43 g/L MS salts; 1 mL/L modified MS vitamin stock; 0.5 mL/L dicamba; 0.7 g/L L-
proline; 0.5 g/L MES; 100 mg/L casein hydrolysate; 100 mg/L myo-inositol; 30 g/L sucrose; 
2.3 g/L Gelrite; 2 mg/L bialaphos; 88 mM silver nitrate; 250 mg/L carbenicillin; pH 5.8. 
MS-P: 4.3 g/L MS salts without phosphate; 1 mL/L modified MS vitamin stock; 0.5 mL/L 
dicamba; 0.7 g/L L-proline; 0.5 g/L MES; 100 mg/L casein hydrolysate; 100 mg/L myo-
inositol; 30 g/L sucrose; 2.3 g/L Gelrite; 88 mM silver nitrate; 250 mg/L carbenicillin; pH 5.8. 
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Hi II and B104 kill curve 
A kill curve experiment was designed to determine the optimal Phi concentration to 
use for selection to develop a transformation system using the ptxD selectable marker gene. 
Maize immature zygotic embryos (IZEs) were aseptically dissected from ears of Hi II and 
B104. Approximately 25 IZEs/plate were cultured on the media without Pi and containing 
different concentrations of Phi. One control plate (N6S or MSS media) was prepared for each 
genotype. Hi II IZEs were grown on the N6S media without Pi (Table S1) containing 0, 0.25, 
0.5, 1, 1.5, or 2 mM of Phi.  IZEs of B104 were grown in the MSS media without Pi and 
containing 0, 0.5, 1.5, 2.5, 3 or 3.5 mM of Phi. Plates were cultured in dark at 28°C for 2-4 
weeks and callus initiation and growth was observed. 
 
Phi tolerance test 
Two events of transgenic Hi II callus were chosen from group A, B and C. Non-
transgenic Hi II callus was used as control. Calli were subcultured on six different media: N6S 
media; N6S with 1.5 mg/L bialaphos; N6S without Pi (N6S-P) with 0 mM Phi; 1.25 mM Phi; 
2.5 mM Phi; and 5 mM Phi. Plates were cultured in the dark at 28°C for 2 weeks and callus 
initiation and growth was observed. 
 
Supplemental Results 
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Table S1. Media composition for maize Hi II and B104 transformation using bialaphos or Phi as selective agents (modified based on Frame et al., 2011).
Geno types
Select ion 
t reat ment  g roups
M edia Ingredients
A, B, C
Infection liquid
(Hinf)
4 g/L N6 salts, 1 ml/L N6 vitamin stock, 1.5 mg/L 2,4-D, 0.7 g/L L-pro line, 68.4 g/L sucrose, 36 g/L glucose, pH 5.2. Add 100 µM  acetosyringone after autoclaving. 
A, B, C
Cocultivation
(Hcc)
4 g/L N6 salts, 1 mL/L N6 vitamin stock, 1.5 mg/L 2, 4-D, 0.7 g/L L-pro line, 30 g/L sucrose, pH 5.8, 3 g/L Gelrite. Add 5 mM  silver nitrate, 100 mM  acetosyringone and 300 mg/L L-
cysteine after autoclaving.
A, B, C
Resting
(N6S)
4 g/L N6 salts, 1 mL/L N6 vitamin stock, 1.5 mg/L 2, 4-D, 0.7 g/L L-pro line, 30 g/L sucrose, 0.5 g/L 2-(4-morpholino)-ethanesulfonic acid (M ES), pH 5.8,  8 g/L purified agar. Add 5 
mM  silver nitrate, 100 mg/L cefotaxime, 100 mg/L vancomycin after autoclaving.
A
Selection 1 
(HS1A)
N6S, 1.5 mg/L bialaphos
B
Selection 1 
(HS1B-P)
N6S-P (3.59 g/L N6 salts minus phosphorus) and no bialaphos, 0.5 mM  KH 2PO3
C
Selection 1 
(HS1C-P)
N6S-P (3.59 g/L N6 salts minus phosphorus) and no bialaphos, 0.5 mM  KH 2PO3, 0.05 mM  KH2PO4
A
Selection 2 
(HS2A)
N6S, 3 mg/L bialaphos
B, C
Selection 2 
(HS2BC)
N6S-P (3.59 g/L N6 salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
A
Pre-regeneration
(PR)
4.43 g/L M S Salts, 1 mL/L M S* vitamin stock, 100 mg/L myo-inosito l, 0.25 mL/L 2,4-D, 30 g/L sucrose, pH 5.8, 3 g/L gelrite. Add 2 mg/L bialaphos and 100 mg/L cefotaxime after 
autoclaving.
B, C
Pre-regeneration
(PR-P)
PR-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
A
Regeneration 1 
(R1)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 100 mg/L myo-inosito l, 60 g/L sucrose, pH 5.8, 3 g/L Gelrite. Add 3 mg/L bialaphos and 100 mg/L cefotaxime after autoclaving.
B, C
Regeneration 1 
(R1-P)
R1 (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
A, B, C
Regeneration 2
(R2)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 100 mg/L myo-inosito l, 30 g/L sucrose, pH 5.8, 3 g/L Gelrite.  Add 100 mg/L cefotaxime after autoclaving.
A, B, C
Infection
(Binf)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 0.5 mL/L dicamba, 0.7 g/L L-pro line, 68.4 g/L sucrose, 36 g/L glucose, pH 5.2. Add 100 mM  acetosyringone after autoclaving.
A, B, C
Cocultivation
(Bcc)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 0.5 mL/L dicamba, 0.7 g/L L-pro line, 100 mg/L casein hydro lysate, 100 mg/L myoinosito l, 30 g/L sucrose, pH 5.8, 2.3 g/L Gelrite.  
Add 88 mM  silver nitrate, 100 mM  acetosyringone, and 300 mg/L L-cysteine after autoclaving.
A, B, C
Resting
(M SS)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 0.5 mL/L dicamba, 0.7 g/L L-pro line, 0.5 g/L M ES, 100 mg/L casein hydro lysate, 100 mg/L myo-inosito l, 30 g/L sucrose, pH 5.8, 2.3 
g/L Gelrite. Add 2 mg/L bialaphos, 88 mM  silver nitrate, and 250 mg/L carbenicillin after autoclaving.
D
Selection 1 
(BS1D)
M SS, 2 mg/L bialaphos
E, G
Selection 1 
(BS1EG-P)
M SS-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
F, H
Selection 1 
(BS1FH-P)
M SS-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3, 0.05 mM  KH2PO4
D
Selection 2 
(BS2A)
M SS, 6 mg/L bialaphos
E, F
Selection 2 
(BS2EF-P)
M SS-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 2 mM  KH 2PO3
G, H
Selection 2 
(BS2GH-P)
M SS-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
D
Regeneration 1 
(R1)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 100 mg/L myo-inosito l, 60 g/L sucrose, pH 5.8, 3 g/L Gelrite. Add 3 mg/L bialaphos and 100 mg/L cefotaxime after autoclaving.
G, H
Regeneration 1 
(R1-P)
R1-P (4.3 g/L M S salts minus phosphorus) and no bialaphos, 1.25 mM  KH 2PO3
A, B, C
Regeneration 2
(R2)
4.43 g/L M S salts, 1 mL/L M S* vitamin stock, 100 mg/L myo-inosito l, 30 g/L sucrose, pH 5.8, 3 g/L Gelrite.  Add 100 mg/L cefotaxime after autoclaving.
M S* vitamin stock:  modified M S vitamins contain higher thiamine HCl and lower nicotinic acid concentrations compared to  the standard M S vitamins (Frame et al., 2011).
Hi II
B104
2
0
0
 
1
6
5
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Figure S1. Kill curve for Hi-II maize and B104 on media containing varying 
concentrations of Phi. Immature zygotic embryos (IZEs) were cultured on media without 
phosphate and containing varying concentrations of Phi (A) Hi II IZEs on 0-2 mM Phi, (B) 
B104 IZEs on 0-3.5 mM Phi, C: control IZEs on media containing phosphate, 0 Phi. 
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Figure S2. Morphology of Hi II embryogenic type II callus on media containing different 
selection agents. Putative transgenic callus were transferred onto first selection 2 (S2) media 
for 2 weeks. (A) Two putative transgenic events (A7 and A8) selected on bialaphos; (B) three 
putative transgenic events (B5, B6, and B7) selected on Phi; (C) three putative transgenic 
events (C4, C5 and C6) selected on Phi+Pi. 
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Figure S3. Morphology of B104 embryogenic type I callus on media containing different 
selection agents. (A) Putative transgenic callus selected on bialaphos after 2 weeks transfer 
onto the first selection 2 (S2) media; putative transgenic callus selected on (B) Phi and (C) 
Phi+Pi after 4 weeks transfer onto the first S2 media. Red circle indicates Type I callus. 
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Figure S4. DNA PCR analysis of Hi II and B104 putative transgenic callus events. (A) Hi 
II putative transgenic events selected on media containing bialaphos (Group A), phosphite 
(Group B), and phosphite supplemented with phosphate (Group C). Twenty two representative 
events were analyzed for the presence of the ptxD (1 Kb) and bar (400 bp) genes. (B) B104 
putative transgenic events generated from bialaphos (Group D), Phi (Group G) or Phi+Pi 
(Group H) selection systems. Data from 34 putative transgenic events. M: 100 bp ladder, p: 
plasmid expressing PTXD, WT: non-transgenic B73 maize, (-): H2O    
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Figure S5. Standard curve for qPCR 
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Figure S6. Transcript analysis of the ptxD gene expression in T0 transgenic Hi-II maize 
plants. Reverse transcriptase analysis showed the ptxD gene expression in all transgenic events 
selected with bialaphos (Group A), Phi (Group B), and Phi+Pi (Groups C). Actin gene is 
housekeeping gene control. M, 100 bp DNA ladder; p, A522 plasmid carrying ptxD gene as 
positive control; WT, non-transgenic B73 maize as negative control; (-), H2O negative control. 
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CHAPTER 6: GENERAL CONCLUSIONS 
 
The reliability of plants as biofactories for the accumulation of valuable recombinant 
products by means of plant genetic manipulation was evaluated. In this dissertation, industrial 
enzyme and vaccines were presented as the examples of valuable products that can be 
accumulated in transgenic plants. The accumulation of industrial enzymes in plants simplifies 
bioprocessing and possibly reduce manufacturing cost. On the other hand, vaccine production 
in food crops such as maize and soybean offer the advantage of oral vaccine administration.  
The success of plant genetic manipulation is determined by the ability to generate transgenic 
plants through plant transformation process. A new approach of selecting transgenic events 
using a non-antibiotic selectable marker gene is also presented. Works presented in this 
dissertation provided evidence of: 1) proof of concepts of transgenic plants as host for 
molecular farming; 2) stability of plant-derived recombinant products; and 3) bioactivity and 
immunogenicity of plant recombinant products. 
Chapter 2 demonstrated the accumulation of industrial enzyme in transgenic maize 
seeds. A thermostable alpha amylase enzyme, amylopullulanase (TrAPU) derived from 
Thermoanaerobacter thermohydrosulfuricum was presented as an example. Several strategies 
such as tissue-specific promoter (maize 27 kDa γ-zein promoter), gene codon optimization, 
and subcellular targeting element (SEKDEL) were applied to increase the accumulation of 
TrAPU enzyme in maize. The analyses showed the thermostability and specific activity of 
maize-derived TrAPU enzyme. The unique characteristics of APU enzyme lies in its dual 
active sites that enables the enzyme to digest both α-1,4 and α-1,6 glucosidic linkages of starch 
into disaccharides and glucose. In a regular starch hydrolysis process, two kinds of enzymes: 
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α-amylase and amyloglucosidase are utilized to digest α-1,4 and α-1,6 glucosidic linkages of 
starch, respectively. In this work, incubation of transgenic TrAPU maize seed extract at 85 °C 
led to the autohydrolysis of starch into glucose and disaccharides without the addition of 
exogenous enzymes. Subsequent reaction of yeast fermentation with Saccharomyces showed 
40.2 ± 2.63 % (14.7 ± 0.90 g ethanol per 100 g seed) conversion of starch into bioethanol. This 
strategy showed the simplification of starch processing and bioethanol production from maize 
grains through genetic engineering approach.  
Production of subunit vaccine for influenza is presented in chapter 3. The conserved 
nucleoprotein (NP) gene of H3N2 influenza virus was expressed in maize seeds as a universal 
vaccine candidate for influenza. A universal vaccine holds promising application to provide 
broad protection against heterosubtypic strains of influenza virus. Preliminary study performed 
in pigs showed that intramuscular injection of maize-NP (MNP) induced NP-specific 
antibodies response. This result suggested the immunogenicity of maize-expressed NP. A 
Study in mice showed that oral gavage administration of 20 µg MNP elicited humoral immune 
responses as shown by the predominant production of IgG. No notable level of IgA was 
observed indicating poor mucosal immune responses induced by MNP. These results were 
further confirmed by cytokine analyses wherein interleukin-4 (IL-4) but not interferon-γ (IFN-
γ) was induced in mice treated with MNP suggesting the stimulation of TH2 mediated immune 
responses. The production of IL-4 was observed in the MNP-treated spleenocytes stimulated 
with H3N2 and the pandemic H1N1 suggesting that MNP administration induced antibody 
responses against different strains of influenza virus. In this study, MNP administration did 
not induce cell-mediated immunity which is an important aspect of vaccine. For future work, 
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mice study testing higher dose of MNP and influenza virus challenge experiment should be 
included.  
RNA-interference (RNAi) pathway is double-stranded RNA (dsRNA) mediated gene 
silencing. This mechanism has shown promising applications for pest control, therapeutics and 
vaccine. Application of exogenous dsRNA molecule activates antiviral mechanism through 
RNA interference (RNAi) pathway. An attempt to utilize plants as the production system for 
the accumulation of double stranded RNA (dsRNA) vaccine for shrimp is demonstrated in 
Chapter 4. The work presented in this chapter also evaluated the effect of promoters in regards 
to the accumulation levels of dsRNAs. DsRNA constructs, dsRNA308 and dsRNA381 specific 
to white spot syndrome virus (WSSV) and infectious myonecrosis virus (IMNV), respectively 
were expressed in maize and soybean. An interesting observation was shown when CaMV 35S 
promoter was used to drive the dsRNAs expression. Expression of dsRNA308 driven by 
CaMV 35S promoter in maize resulted in poor callus growth that were not regenerable into 
plants. Negative effects also observed in the ds381 constructs driven by CaMV35S promoter. 
Expression of the dsRNA381 driven by CaMV 35S was detrimental to soybean. On the other 
hand, the same construct infected into maize genome resulted in gene silencing. Evaluation of 
endogenous promoters, both constitutive and seed-specific promoters on dsRNAs expression 
showed the accumulation of dsRNAs in these constructs. Expression levels between constructs 
driven by the endogenous constitutive and seed-specific promoters showed higher 
accumulation of dsRNAs in the constructs driven by constitutive promoters. Despite the type 
of promoters to drive gene expression, dsRNA308 and dsRNA381 were accumulated in low 
levels in transgenic soybean and maize. 
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Preliminary study showed that full length dsRNA provided higher protection against 
virus challenge. In this study, we aimed to accumulate full length dsRNAs in transgenic plants 
to be utilized as vaccine for shrimp. Transcript analysis showed full length dsRNA308 and 
dsRNA381 were accumulated in transgenic soybean and maize. Next generation sequencing 
analysis on dsRNA308 expressed in soybean and maize demonstrated the presence of sense 
and antisense strands suggesting the accumulation of dsRNA308 in double stranded form. 
Shrimp were injected with total RNA isolated from soybean seeds expressing dsRNA308 
specific to WSSV and challenged with WSSV 72 hours post injection. Moderate protection 
was shown in the group receiving soybean-derived ds308 that might be caused by a low level 
of dsRNA308 in the total RNA injected into shrimp. The works in this chapter demonstrated 
that transgenic plants can express long dsRNA specific to shrimp viral pathogens however 
currently it is not an efficient platform for the accumulation. Modification in the DNA 
construct might improve the expression levels of dsRNA in transgenic plants.  
Plant transformation is an important aspect of plant genetic manipulation to generate 
transgenic plants expressing desired products. Most of plant transformation methods utilize 
antibiotics or herbicide resistance genes as selectable markers for the identification of 
transgenic plants. Current popular selection system involves herbicides marker that are under 
proprietary patent that limits its utilization for public sector. Chapter 5 provided an alternative 
selection system utilizing phosphite oxidoreductase (PTXD), a non-antibiotic gene for maize 
transformation. The PTXD enzyme allows transformed cells to grow in the media containing 
phosphite (Phi) as selective agent. Selection of Hi II and B104 maize in the media containing 
1.25 mM Phi resulted in the positive selection of transgenic events. However, slow callus 
growth was observed in the Phi selection. Low transformation frequency was also shown in 
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PTXD/Phi system compared to the system selected with herbicide bialaphos. Nevertheless, the 
PTXD/Phi selection system has allowed plant to convert the non-useful molecule into a 
nutritional component for plant growth. This system also offers an alternative selection system 
when a non-antibiotic/herbicide selection system is preferable. Future work should include 
media modification to increase transformation frequency and recovery of transgenic events. 
The work presented in this dissertation provide evidence of the reliability of transgenic 
plants as host for the accumulation of valuable proteins and therapeutic dsRNA. Recombinant 
products accumulated in transgenic plants maintain its activity and immunogenicity. Maize 
and soybean provide seeds as storage organ for the accumulation of industrial enzyme, subunit 
vaccine and therapeutic dsRNA. This strategy offers an advantage for long-term storage of 
valuable products at room temperature while preserving its activity. Transgenic plants show 
promising potential for the accumulation of therapeutic dsRNA. Improvement of constructs 
remains to be explored to increase the accumulation of therapeutic dsRNA in transgenic plants 
and make this system as efficient production system of therapeutic dsRNA. 
 
 
